000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1642|3225|lyfalmen|V0045|1588|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1642||1642|3225||1
000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|32995|43291|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||32995||32995|43291||2
000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|49568|64090|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||49568||49568|64090||2
000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|10484|15320|lyfalmen|V0457|4875|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10484||10484|15320||2
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|30556|40893|lyfalmen|V0475|19417|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30556||30556|40893||2
000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|39739|52418|lyfalmen|V0540|31239|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||39739||39739|52418||2
000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|21375|29371|lyfalmen|V0456|9608|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21375||21375|29371||2
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4964|7164|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4964||4964|7164||1
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7509|14591|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7509||7509|14591||1
000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|13297|18570|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||13297||13297|18570||1
000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|19999|27644|lyfalmen|||1|0,36|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||19999||19999|27644||1
000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|38817|51260|lyfalmen|||1|0,72|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||38817||38817|51260||1
000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|0|0|0|0|E|0|MSD|0|0|0|100|DKK|5277|8198|lyfalmen|||1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5277||5277|8198||1
000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr|||1|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657||1
000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139||1
000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|3240|5411|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||||3240|5411||1
000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|27685|37290|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||27685||27685|37290||2
000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|0|0|0|0|E|0|LTH|0|0|0|100|SEK|1848|3507|lyfalmen|||1|5|0||Vistor hf|Laboratoires THEA|Ketotifen||1848||1848|3507||1
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4824|7578|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4824||4824|7578||1
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|3763|6126|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3763||3763|6126||1
000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|0|0|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||||1
000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|0|0|0|0|E|0|LTH|0|0|0|100|SEK|5487|8485|lyfalmen|||1|24|0||Vistor hf|Laboratoires THEA|Ketotifen||5487||5487|8485||1
000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7027|10142|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||7027||7027|10142||2
000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|3041|5139|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3041||3041|5139||1
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3744|6101|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3744||3744|6101||1
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|173324|219404|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||173324||173324|219404||2
000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|22184|29723|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||22184||22184|29723||1
001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|5661|8170|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5661||5661|8170||1
001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1445|2956|lyfalmen|V0037|2396|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1445||1445|2956||1
001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6310|9611|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6310||6310|9611||1
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|20880|28750|lyfalmen|V0115|11923|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||20880||20880|28750||1
001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2405|4269|lyfalmen|V0050|2370|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2405||2405|4269||1
001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|28305|37405|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||28305||28305|37405||1
001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|*|0|POF|0|0|0|100|XEU|2547|1846|lyfalmen|V0278|1846|2|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||634||634|1846||2
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6060|9269|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6060||6060|9269||1
001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|4354|6935|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4354||4354|6935||1
001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|883|2187|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2187||1
001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2456|4339|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4339||1
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21814|29259|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||21814||21814|29259||2
001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|0|0|0|0|E|0|VIF|0|0|1|100|CHF|15115|21514|lyfalmen|V0034|19087|1|25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||15115||15115|21514||1
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31786|41774|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||31786||31786|41774||2
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|2405|3471|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2405||2405|3471||1
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|4154|6661|lyfalmen|V0444|6661|0|15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4154||4154|6661||1
001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|863|2159|lyfalmen|V0004|516|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||863||863|2159||1
001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|1946|3373|lyfalmen|V0291|3373|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3373||1
001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|6936|10467|lyfalmen|V0294|10467|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10467||1
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|4425|7032|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||4425||4425|7032||2
001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|3353|5566|lyfalmen|V0292|5566|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5566||1
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4498|7132|lyfalmen|V0004|2066|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4498||4498|7132||1
001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|5263|8178|lyfalmen|V0293|8178|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8178||1
001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8931|13196|lyfalmen|V0011|2864|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8931||8931|13196||1
002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1418|2919|lyfalmen|V0005|529|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1418||1418|2919||1
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6294|9589|lyfalmen|V0005|2114|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6294||6294|9589||1
002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|1|0|0|0|B|0|TIL|0|0|0|100|DKK|5583|8616|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5583||5583|8616||2
002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5512|8519|lyfalmen|V0011|2557|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5512||5512|8519||1
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25679|34110|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||25679||25679|34110||2
002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13688|7374|lyfalmen|V0011|5114|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4675||4675|7374||1
002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10039|14712|lyfalmen|V0012|2557|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||10039||10039|14712||1
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3104|5225|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3104||3104|5225||1
002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|18202|25389|lyfalmen|V0012|5114|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||18202||18202|25389||1
002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003|31.08.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|17028|23915|lyfalmen|V0492|19529|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||17028||17028|23915||1
002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|103547|131834|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||103547|131834||2
002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|52779|68120|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||52779|68120||2
002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|0|0|1|BAY|0|0|0|100|SEK|27325|36175|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||27325|36175||2
002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3357|5571|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||||3357|5571||2
002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3357|5571|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3357||3357|5571||2
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2202|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2202||1
002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|3571|6229|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3571||3571|6229||2
002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1253|2693|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1253||1253|2693||2
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|0|0|100|SEK|31370|41252|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||31370||31370|41252||1
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14073|15279|lyfalmen|V0089|2042|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10454||10454|15279||1
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|10403|15210|lyfalmen|V0515|4832|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10403||10403|15210||1
003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|0|0|0|1|0|1|ZEP|0|0|0|100|DKK|244695|308975|lyfsjukr|||1|2|0||Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||244695||244695|308975||2
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|17960|25085|lyfalmen|V0253|7471|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17960||17960|25085||1
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|34898|46342|lyfalmen|V0516|14714|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||34898||34898|46342||1
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|*|0|PFP|0|0|0|100|SEK|10627|15516|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10627||10627|15516||1
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|*|0|PFP|0|0|0|100|SEK|15797|22370|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||15797||15797|22370||1
003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|199541|252306|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||199541||199541|252306||2
003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|9606|14119|lyfalmen|V0356|12903|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9606||9606|14119||1
003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|8904|13159|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8904||8904|13159||1
003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|0|0|0|1|*|0|WTE|0|0|0|100|DKK|59123|76745|lyfalmen|V0567|76745|1|100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||59123||59123|76745||2
003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TKE|0|0|0|100|SEK|4530|7176|lyfalmen|V0578|5170|1|28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4530||4530|7176||1
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|3217|5380|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3217||3217|5380||1
003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TKE|0|0|0|100|SEK|15653|22190|lyfalmen|V0572|13787|1|98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||15653||15653|22190||1
003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TKE|0|0|0|100|SEK|6852|10352|lyfalmen|||1|28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6852||6852|10352||1
003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|1|1|0|0|*|0|TKE|0|0|0|100|SEK|23388|31897|lyfalmen|V0573|27461|1|98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||23388||23388|31897||1
003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|872|2172|lyfalmen|||1|10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||872||872|2172||1
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1017|1972|lyfalmen|V0151|1972|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|1972||1
003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|587|1782|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||587||587|1782||1
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2389|4247|lyfalmen|V0322|4247|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4247||1
003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|5|glös|80 + 20 mg/ml|J05AE06|01.08.2003||R|0|0|0|1|0|1|ABL|0|0|0|100|DKK|72684|93101|lyfsjukr|||1|300|0|30,0000|Vistor hf|Abbott Laboratories A/S|Lopinavír||72684||72684|93101||1
003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|2127|3889|lyfalmen|V0469|2448|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2127||2127|3889||1
004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|21805|29248|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||21805||21805|29248||1
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|7915|11806|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7915||7915|11806||1
004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1
004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|4303|6865|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4303||4303|6865||1
004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|592|1789|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||592||592|1789||1
004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|DKK|1059|2428|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1059||1059|2428||1
004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5473|8466|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5473||5473|8466||1
004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|7950|11854|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7950||7950|11854||1
004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|11167|16255|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||11167||11167|16255||1
004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|634|1846|lyfalmen|V0366|752|1|10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||634||634|1846||1
004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|5928|9088|lyfalmen|||1|66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||5928||5928|9088||1
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|21067|28322|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||21067||21067|28322||1
004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|1654|3241|lyfalmen|V0366|2255|1|30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1654||1654|3241||1
004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|7427|5137|lyfalmen|V0381|4734|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3040||3040|5137||1
004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|4632|7315|lyfalmen|V0458|4932|1|100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4632||4632|7315||1
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4796|9382|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4796||4796|9382||1
004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|0|0|E|0|NOP|0|0|1|100|DKK|3247|5421|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3247||3247|5421||2
004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|662|1884|lyfalmen|||1|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||662||662|1884||1
004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|0|0|E|0|NOP|0|0|1|100|DKK|4331|6903|lyfalmen|V0226|2757|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4331||4331|6903||2
004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|0|0|E|0|NOP|0|0|1|100|DKK|6117|9347|lyfalmen|V0227|4211|1|56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6117||6117|9347||2
004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|0|0|E|0|NOP|0|0|1|100|DKK|8142|12117|lyfalmen|V0228|5422|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8142||8142|12117||2
004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2280|4098|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||2280||2280|4098||1
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|1|0|0|0|*|0|AVP|0|0|0|100|NOK|3660|3225|lyfalmen|V0494|3124|1|90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1642||1642|3225||1
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2556|3542|lyfalmen|V0318|3232|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1874||1874|3542||1
004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|37157|48515|lyfsjukr|||1|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||37157||37157|48515||2
004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1418|2919|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1418||1418|2919||1
004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3367|5585|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||3367||3367|5585||1
004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1836|2164|lyfalmen|V0071|2164|2|28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2164||1
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|5614|6150|lyfalmen|V0320|5909|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||3780||3780|6150||1
004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|776|1817|lyfalmen|V0062|1694|2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||613||613|1817||1
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2703|3542|lyfalmen|V0317|3232|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1874||1874|3542||1
004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|926|1709|lyfalmen|V0067|1562|2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||534||534|1709||1
004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1761||1
004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|38113|49714|lyfsjukr|||1|4,69|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||38113||38113|49714||1
004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1778|3411|lyfalmen|V0318|1810|2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3411||1
004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan|||||||1
004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|185786|235044|lyfsjukr|||1|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||185786||185786|235044||2
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|0|0|0|0|*|0|SDE|0|0|0|100|NOK|10859|15833|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10859||10859|15833||1
004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|6882|7447|lyfalmen|V0250|4556|1|100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4728||4728|7447||1
004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|8893|3969|lyfalmen|V0251|3969|1|100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||2186||2186|3969||1
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|649|1867|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||649||649|1867||1
004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|XEU|14905|7170|lyfalmen|V0282|6504|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||4526||4526|7170||2
004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5416|7817|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5416||5416|7817||1
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|373|1489|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||373||373|1489||1
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|656|1876|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||656||656|1876||1
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1241|2677|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1241||1241|2677||1
005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1847|3506|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1847||1847|3506||1
005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2320|4153|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2320|4153||2
005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|8782|7094|lyfalmen|V0148|4051|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4470||4470|7094||1
005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2216|4010|lyfalmen|||2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2216||2216|4010||1
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2552|4470|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2552||2552|4470||1
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3489|5752|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3489||3489|5752||1
005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|28817|38710|lyfalmen|V0356|38710|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28817||28817|38710||1
005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|52946|68992|lyfalmen|V0287|44612|1|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||52946||52946|68992||1
005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|E|0|ASZ|0|0|0|100|SEK|3472|5728|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3472||3472|5728||1
005330|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|0|0|0|0|E|0|LEP|0|0|1|100|DKK|1126|2519|lyfalmen|||1|2,4|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1126||1126|2519||1
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|*|0|AZA|0|0|0|100|SEK|64038|82913|lyfalmen|V0451|79753|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||64038||64038|82913||1
005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|B|0|BOI|0|0|0|100|DKK|1486|3012|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1486||1486|3012||1
005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|29603|18441|lyfalmen|V0283|7921|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12666||12666|18441||2
005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|37650|49796|lyfalmen|||1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||37650||37650|49796||2
005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|1303|2761|lyfalmen|V0545|2730|1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1303||1303|2761||2
005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||||1
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6257|9538|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6257||6257|9538||1
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6594|9999|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||6594|9999||1
005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|BAX|0|0|0|100|USD|4175|6690|lyfalmen|||1|0,5|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4175||4175|6690||2
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|1597|3164|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1597||1597|3164||2
005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|2784|4787|lyfalmen|V0020|3697|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||2784||2784|4787||2
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|7392|11091|lyfalmen|V0020|11091|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||7392||7392|11091||2
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|*|0|LLS|0|0|0|100|DKK|4062|6536|lyfalmen|V0020|5546|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4062||4062|6536||2
005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra|||||||1
005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|1787|3423|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1787||1787|3423||1
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6644|9079|lyfalmen|V0324|2574|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5921||5921|9079||1
005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3150|4958|lyfalmen|V0035|3642|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2909||2909|4958||1
005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|17976|31358|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||17976||17976|31358||1
005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6262|9545|lyfalmen|V0325|2572|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6262||6262|9545||1
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|10564|14203|lyfalmen|V0325|4592|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9667||9667|14203||1
005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5060|7479|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4752||4752|7479||1
005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|3494|5759|lyfalmen|||1|8|0|2,0000|Icepharma hf|Roche|Meflókvín||3494||3494|5759||2
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|884|2188|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||884||884|2188||2
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|16355|20863|lyfalmen|V0326|4451|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14596||14596|20863||1
005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3568|5860|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3568||3568|5860||1
005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6463|8763|lyfalmen|V0246|4516|1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5690||5690|8763||1
005932|C09CA0301|Diovan|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|9440|12493|lyfalmen|V0072|2042|1|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8417||8417|12493||1
005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12664|18438|lyfalmen|V0327|2493|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12664||12664|18438||1
005954|C09CA0301|Diovan|filmhtfl|160|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|4690|7395|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4690||4690|7395||1
005976|C09CA0301|Diovan|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|12830|17830|lyfalmen|V0073|2042|1|98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12179||12179|17830||1
006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|84135|107472|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||84135||84135|107472||1
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|5780|8886|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5780||5780|8886||1
006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|104346|132837|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||104346||104346|132837||1
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|5607|8649|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5607||5607|8649||1
006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|156674|198508|lyfsjukr|||1|3|0|1,5000|Vistor hf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||156674||156674|198508||1
006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|79689|101892|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||79689||79689|101892||1
006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2656|4612|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2656||2656|4612||1
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|7867|15278|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||7867|15278||1
006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|6818|10306|lyfalmen|||1|5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6818||6818|10306||1
006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011|31.10.2012|R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|13221|19137|lyfalmen|||1|10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13221||13221|19137||1
006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|6982|10530|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6982||6982|10530||1
006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GZE|0|0|0|100|XEU|541914|681985|lyfsjukr|||1|35|0|35,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||541914||541914|681985||1
006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||||1
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14640|20918|lyfalmen|||1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14640||14640|20918||1
007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4694|7400|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4694||4694|7400||1
007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995|30.09.2012|R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|690|1923|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||690||690|1923||1
007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|25402|48948|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim Danmark|||25402||25402|48948||1
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14192|20356|lyfalmen|V0117|20356|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14192||14192|20356||1
007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|2093|3842|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2093||2093|3842|31.10.2012|1
007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7079|10663|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7079||7079|10663||1
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|21423|29431|lyfalmen|V0118|29431|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21423||21423|29431||1
007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|5314|8248|lyfalmen|||1|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5314||5314|8248|31.10.2012|1
007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8897|13150|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8897||8897|13150||1
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|26800|36179|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||26800||26800|36179||1
007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|173677|219847|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||173677||173677|219847||2
007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|331431|417828|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||331431||331431|417828||2
007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|3104|5225|lyfalmen|V0377|4494|1|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3104||3104|5225||1
007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|98239|125172|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||98239||98239|125172||1
007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|1|0|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín|||||||1
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|280854|354354|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||280854||280854|354354||1
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|3229|5396|lyfalmen|V0374|4322|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3229||3229|5396||1
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|8922|12877|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||8922||8922|12877||2
007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|118486|150582|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||118486||118486|150582||3
007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABS|0|0|0|100|DKK|23370|31212|lyfsjukr|||1|250|0||Vistor hf|Abbott Scandinavia AB|Sevóflúran||23370||23370|31212||1
007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1968|3433|vetorma|||0|6,67|0||Icepharma hf|Bayer Animal Health GmbH|||||1968|3433||2
007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|6243|9519|lyfalmen|||1|30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6243||6243|9519||1
007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3709|6053|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3709||3709|6053|31.10.2012|1
007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|0|0|0|0|0|0|SPL|0|0|0|100|DKK|4956|7758|lyfalmen|||1|30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||4956||4956|7758||1
007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4492|6483|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4492||4492|6483||1
007541|J07BL0101|Stamaril|bóluefni|||0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996|30.09.2012|R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|20064|27725|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||20064||20064|27725||2
007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|0|0|0|0|B|0|SPL|0|0|0|100|DKK|9659|14192|lyfalmen|||1|60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9659||9659|14192||1
007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|6410|9747|lyfalmen|||1|30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6410||6410|9747||1
007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|21762|29856|lyfalmen|||1|100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||21762||21762|29856||1
007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|*|0|ACA|0|0|0|100|IKR|1728|3099|lyfalmen|V0290|3099|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3099||1
007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4000|6451|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||4000||4000|6451||1
007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|0|0|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALC|0|0|0|100|USD|1327|2794|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Ólópatadín||1327||1327|2794||1
007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1
007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|AGA|0|0|0|100|XEU|20549|27671|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|Nituroxíđ||20549||20549|27671||5
007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|1976|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1976||3
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|1|0|0|0|*|0|MCK|0|0|0|100|SEK|628|1838|lyfalmen|V0502|1537|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||628||628|1838||2
008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|24606|32763|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||24606||24606|32763||2
008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|30528|40195|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||30528||30528|40195||2
008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|0|0|0|0|E|0|MSD|0|0|0|100|DKK|5505|8509|lyfalmen|||1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5505||5505|8509||1
008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|55200|71159|lyfsjukr|||1|4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||55200||55200|71159||1
008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|110402|140437|lyfsjukr|||1|4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||110402||110402|140437||1
008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|87977|112294|lyfsjukr|||1|4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||87977||87977|112294||1
008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|130147|165217|lyfsjukr|||1|4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||130147||130147|165217||1
008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|152885|193753|lyfsjukr|||1|4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||152885||152885|193753||1
008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1
008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1529|3070|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1529||1529|3070||1
008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|299|1388|lyfalmen|||1|20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||299||299|1388||1
008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|38070|49660|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||38070||38070|49660||2
008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|29810|39294|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||29810||29810|39294||2
008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|585|1779|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||585||585|1779||1
008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|34831|45595|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||34831||34831|45595||2
008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|893|2049|lyfalmen|||2|20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||782||782|2049||1
008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|1321|2786|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1321||1321|2786||1
008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|2884|4924|lyfalmen|V0226|4924|2|100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2884||2884|4924||1
008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|4781|7519|lyfalmen|V0227|7519|2|100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4781||4781|7519||1
008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|6451|9686|lyfalmen|V0228|9683|2|100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6365||6365|9686||1
008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|XEU|154018|195175|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||154018||154018|195175||1
008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|B|0|MKA|0|0|0|100|SEK|851|2143|lyfalmen|V0153|2142|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||851||851|2143||2
008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|B|0|MKA|0|0|0|100|SEK|740|1991|lyfalmen|V0154|1991|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||740||740|1991||2
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|USD|5115|8923|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5115||5115|8923||2
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|12718|24593|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||12718||12718|24593||2
008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||R|0|0|0|0|E|0|RGM|0|0|1|100|XEU|2304|3214|lyfalmen|V0575|3214|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín||1634||1634|3214||2
008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2889|4931|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2889||2889|4931||1
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2
008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|109106|138811|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||109106||109106|138811||2
008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|115095|146327|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||115095||115095|146327||2
008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|3044|5143|lyfalmen|||0|15|0||Vistor hf|Meda AB|Pímekrólímus||3044||3044|5143||1
008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1936|3627|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1936||1936|3627||1
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6051|9256|lyfalmen|V0145|8643|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6051|9256||2
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|11920|17285|lyfalmen|V0145|17285|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11920|17285||2
009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|5136|8005|lyfalmen|||0|30|0||Vistor hf|Meda AB|Pímekrólímus||5136||5136|8005||1
009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8778|12669|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8778||8778|12669||2
009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8778|12669|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8778||8778|12669||2
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|14291|20480|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||14291||14291|20480||1
009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8778|12669|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8778||8778|12669||2
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|PER|0|0|0|100|DKK|52134|67311|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer ApS|Voricónazól||52134||52134|67311||1
009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1812||2
009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|5455|8441|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5455||5455|8441||1
009340|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1140|2538|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1140||1140|2538||1
009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1258|2700|lyfalmen|V0130|1705|1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1258||1258|2700||1
009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1455|2969|lyfalmen|V0131|2502|1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1455||1455|2969||1
009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1822|3471|lyfalmen|V0132|2778|1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1822||1822|3471||1
009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7424|10715|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7424||7424|10715||2
009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7424|10715|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7424||7424|10715||2
009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7424|10715|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7424||7424|10715||2
009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|PER|0|0|0|100|DKK|199011|251641|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||199011||199011|251641||1
009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|5284|8207|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5284||5284|8207||1
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GIS|0|0|0|100|DKK|59552|76620|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||59552||59552|76620||3
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8723|12912|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8723||8723|12912||1
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8210|12210|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8210||8210|12210||1
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8056|11999|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8056||8056|11999||1
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9442|13895|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9442||9442|13895||1
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8225|12230|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8225||8225|12230||1
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8084|12037|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8084||8084|12037||1
010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2172|3950|lyfalmen|V0329|2474|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2172||2172|3950||1
010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|4134|6634|lyfalmen|V0330|2848|1|30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4134||4134|6634||1
010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|5908|9061|lyfalmen|||1|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5908||5908|9061||1
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|226419|286038|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||226419||226419|286038||2
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|7261|10479|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7261||7261|10479||1
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|12833|18651|lyfalmen|V0331|5232|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12833||12833|18651||1
010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|18094|25253|lyfalmen|V0332|8594|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||18094||18094|25253||1
010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|0|0|0|0|E|0|LBK|0|0|0|100|DKK|14303|20495|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14303|20495||1
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|23186|31644|lyfalmen|||1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||23186||23186|31644||1
010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1995||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7387|11084|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||7387||7387|11084||2
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|12544|18288|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12544||12544|18288||1
010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|74018|129121|vetorma|||0|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||74018||74018|129121||2
010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|1|0|0|0|B|0|TIL|0|0|0|100|DKK|7215|10849|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7215||7215|10849||2
010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7519|10852|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7519||7519|10852||2
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9211|13294|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||9211||9211|13294||2
010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1189|2605|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1189||1189|2605||2
010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.12.2002|30.09.2012|R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|5438|8418|lyfalmen|||1|4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5438||5438|8418||1
010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6171|8906|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||6171||6171|8906||2
010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9490|13696|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9490||9490|13696||2
010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4198|6059|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4198||4198|6059||2
010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2407|3474|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2407||2407|3474||2
010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|9139|13481|lyfalmen|V0377|13481|1|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||9139||9139|13481||1
010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9477|13678|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9477||9477|13678||2
010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|E|0|RAT|0|0|0|100|IKR|1345|2819|lyfalmen|V0006|2318|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1345||1345|2819||2
010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6804|9820|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6804||6804|9820||2
010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4130|5961|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4130||4130|5961||2
010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|15007|6036|lyfalmen|V0207|2689|1|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3697||3697|6036||1
010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2223|3208|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2223||2223|3208||2
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACT|0|0|0|100|DKK|353550|445588|lyfsjukr|||1|56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||353550||353550|445588||3
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACL|0|0|0|100|DKK|353550|445588|lyfsjukr|||1|56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||353550||353550|445588||3
010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1269|1470|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||359||359|1470||1
010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1
010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|4614|4385|lyfalmen|V0006|4139|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||2490||2490|4385||1
010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|2975|2842|lyfalmen|V0006|2318|2|56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||1362||1362|2842||1
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|50692|65501|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||50692||50692|65501||2
010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|3282|4737|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3282||3282|4737||1
010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2969|5040|lyfalmen|||1|28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2969||2969|5040||1
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|20247|27955|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20247||20247|27955||1
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|20011|27659|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20011||20011|27659||1
010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|34474|45810|lyfalmen|||1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34474||34474|45810||1
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|34239|45515|lyfalmen|||1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34239||34239|45515||1
011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|19769|27355|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||19769||19769|27355||1
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|4522|7165|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4522||4522|7165||1
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|4699|7407|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4699||4699|7407||1
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20346|26504|lyfalmen|V0327|4451|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||19091||19091|26504||1
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|1199|2619|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1199||1199|2619||1
011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002|31.08.2012|R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|761|2020|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||761||761|2020||1
011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|7436|4957|lyfalmen|V0457|4875|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||2908||2908|4957||2
011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|12204|17861|lyfalmen|||1|5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12204||12204|17861||1
011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1066|2437|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1066||1066|2437||1
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2942|2432|lyfalmen|V0069|1830|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1062||1062|2432||1
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|9633|14156|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9633||9633|14156||1
011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|7437|11152|lyfalmen|||1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7437||7437|11152||1
011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007|31.08.2012|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9205|13285|lyfsjukr|||0|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9205||9205|13285||2
011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2437|3517|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2437||2437|3517||1
011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|9760|14330|lyfalmen|||1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9760||9760|14330||1
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1936|3851|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1936||1936|3851||2
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4968|7170|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4968||4968|7170||1
011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|0|0|0|0|E|0|OYL|0|0|0|100|SEK|1660|3250|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1660||1660|3250||1
011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|88547|113009|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||88547||88547|113009||2
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2926|5791|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2926||2926|5791||2
011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002|31.08.2012|R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|10218|14957|lyfalmen|||0|60|0||Vistor hf|Meda AB|Pímekrólímus||10218||10218|14957||1
011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1486|1972|lyfalmen|V0152|1972|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|1972||1
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|4738|6307|lyfalmen|V0323|6307|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||3895||3895|6307||1
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|4587|6620|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4587||4587|6620||1
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2654|3830|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2654||2654|3830||1
011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|8010|11936|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8010|11936||1
012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|40718|52984|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||40718||40718|52984||1
012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1317|2254|lyfalmen|V0551|2254|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||932||932|2254||2
012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003|31.08.2012|R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|13574|19581|lyfalmen|||1|90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||13574||13574|19581||1
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|4750|7477|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4750||4750|7477||1
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6030|9228|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6030||6030|9228||2
012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|1875|3034|lyfalmen|V0556|3034|2|4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1502||1502|3034||2
012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|12436|18152|lyfalmen|||1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||12436||12436|18152||1
012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|ţpakki||J02AC01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|3952|5655|lyfalmen|V0552|5655|2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||3418||3418|5655||2
012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|448354|564567|lyfsjukr|||1|1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||448354||448354|564567||2
012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|1961|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1961||1
012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|4866|7635|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4866||4866|7635||1
012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|E|0|LBI|0|0|0|100|DKK|7161|10775|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||7161||7161|10775||2
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|E|0|RGM|0|0|0|100|XEU|3370|4604|lyfalmen|V0250|4556|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2650||2650|4604||2
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|E|0|RGM|0|0|0|100|XEU|3669|4820|lyfalmen|V0251|3969|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2808||2808|4820||2
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|6185|9440|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6185||6185|9440||1
013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|6986|13587|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||6986||6986|13587||2
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|9338|13753|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9338||9338|13753||1
013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1759|3499|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||1759||1759|3499||2
013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|0|1|0|1|0|1|AGA|0|0|0|100|XEU|22269|29830|lyfsjukr|||1|2|0||Ísaga ehf|AGA AB|Nituroxíđ||22269||22269|29830||5
013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|7295|10529|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7295||7295|10529||2
013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|29639|39079|lyfsjukr|||1|250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||29639||29639|39079||2
013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|50166|64841|lyfsjukr|||1|500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||50166||50166|64841||2
013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|1|0|0|0|E|0|ANO|0|0|0|100|XEU|3384|4708|lyfalmen|V0042|4708|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2726||2726|4708||1
013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4588|8982|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||4588||4588|8982||2
013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|10706|20730|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||10706||10706|20730||2
013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1123|2234|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||1123||1123|2234||2
013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BAL|0|0|0|100|SEK|155321|196810|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||155321|196810||3
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|0|0|100|SEK|423422|470837|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||373669||373669|470837||1
013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|27319|36168|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||27319|36168||3
013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|103547|131834|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||103547|131834||3
013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|0|0|1|BER|0|0|0|100|SEK|52779|68120|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||52779|68120||3
013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5436|8415|lyfalmen|||1|28|0||Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5436||5436|8415||1
013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|18509|25774|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||18509||18509|25774||1
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1319|2783|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1319||1319|2783||2
013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1510||1
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2522|4429|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2522||2522|4429||2
013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1492|2938|lyfalmen|||1|40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1432||1432|2938||1
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|424|1559|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||424||424|1559||1
013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|37515|48964|lyfsjukr|||1|5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||37515||37515|48964||1
013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|4709|7421|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4709||4709|7421||1
013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|968|2303|lyfalmen|||1|1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||968|2303||1
013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2641|lyfalmen|V0168|2641|1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2641||1
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6222|9490|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6222||6222|9490||1
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|2591|4523|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2591||2591|4523||1
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|4647|7336|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4647||4647|7336||1
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|178141|225449|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||178141||178141|225449||1
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|378679|477125|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||378679||378679|477125||1
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|2508|4410|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2508||2508|4410||1
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|9384|13543|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9384||9384|13543||1
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|18195|25380|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||18195||18195|25380||1
014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|57456|74652|lyfalmen|||1|3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||57456||57456|74652||2
014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29868|39367|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||29868||29868|39367||2
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|28392|38177|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28392||28392|38177|31.10.2012|1
014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1632|3211|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1632||1632|3211||2
014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|19840|26782|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||19840||19840|26782||2
014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25972|34477|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||25972||25972|34477||2
014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2686|4653|lyfalmen|||0|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2686||2686|4653||1
014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2301|4577|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2301|4577||2
014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|19469|26979|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||19469||19469|26979||2
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GIS|0|0|0|100|DKK|82968|106007|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||82968|106007||3
014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|PAL|0|0|0|100|XEU|5720|11156|vetalmen|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||5720||5720|11156||2
014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|241765|305298|lyfsjukr|||1|60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||241765||241765|305298||2
014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|2304|4131|lyfalmen|||1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2304||2304|4131||2
014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|1390|2880|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1390||1390|2880||1
014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|63190|81186|lyfsjukr|||1|2,5|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||63190||63190|81186||1
014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|101101|128764|lyfsjukr|||1|2,5|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||101101||101101|128764||1
014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|914|2229|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||914|2229||1
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|19362|26844|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||19362||19362|26844||1
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|58425|75869|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||58425||58425|75869||1
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|38890|51352|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||38890||38890|51352||1
015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2
015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|799|2072|lyfalmen|||1|10|0|17,8571|Vistor hf|Meda AB|Azelastínum||799||799|2072||1
015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3208|5367|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3208||3208|5367||1
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|8627|12780|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8627||8627|12780||1
015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|ţpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1110|2474|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1093||1093|2474||1
015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4754|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4754||3
015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1093|2474|lyfalmen|V0129|1726|1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1093||1093|2474||1
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|2011|2380|lyfalmen|V0234|2246|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1024||1024|2380||1
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|2872|2874|lyfalmen|V0233|2790|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1385||1385|2874||1
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|10278|15039|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||10278||10278|15039||1
015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|346705|436997|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||346705||346705|436997||3
015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|92152|117533|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||92152||92152|117533||3
015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5329|8269|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5329||5329|8269||1
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|13549|19549|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13549||13549|19549||1
015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5329|8269|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5329||5329|8269||1
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|14647|20927|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14647||14647|20927||1
015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|70688|90596|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70688||70688|90596||1
015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|70688|90596|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70688||70688|90596||1
015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|61468|79025|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||61468||61468|79025||1
015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|5329|8269|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5329||5329|8269||1
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|13406|19370|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13406||13406|19370||1
015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|70688|90596|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70688||70688|90596||1
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|22667|30992|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||22667||22667|30992||1
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|*|0|NOH|0|0|0|100|DKK|47214|61799|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||47214||47214|61799||1
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3197|5577|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||3197||3197|5577||2
015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4493|7838|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4493||4493|7838||2
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2852|4975|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2852||2852|4975||2
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3576|6238|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||3576||3576|6238||2
015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|4557|7213|lyfalmen|V0200|5505|1|50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4557||4557|7213||3
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4006|6988|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4006||4006|6988||2
015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2
015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|2017|3738|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||2017|3738||1
015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|E|0|ASP|0|0|1|100|XEU|2265|4077|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2265||2265|4077||1
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1630|3209|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1630||1630|3209||2
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3197|5577|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||3197||3197|5577||2
015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|2080|3824|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2080||2080|3824||1
016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15392|21862|lyfalmen|V0117|20771|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15392||15392|21862||1
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1211|2635|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1211||1211|2635||2
016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|23048|31470|lyfalmen|V0118|30032|1|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||23048||23048|31470||1
016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1284|2735|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1284||1284|2735||2
016038|N02CC0501|Almogran|filmhtfl|12,5|mg|3|stk|1|ţpakki||N02CC05|01.05.2001||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|2632|4579|lyfalmen|V0236|3947|1|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2632||2632|4579||1
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2667|4627|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2667||2667|4627||1
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6714|10163|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6714||6714|10163||1
016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|5310|8243|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5310||5310|8243||2
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10182|14907|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10182||10182|14907||1
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1759|3385|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1759||1759|3385||1
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14791|21108|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14791||14791|21108||1
016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|8879|13125|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||8879||8879|13125||1
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|96615|123134|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||96615||96615|123134||1
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|4278|6174|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4278||4278|6174||1
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2625|4570|lyfalmen|||1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2625||2625|4570||1
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|17647|24692|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17647||17647|24692||1
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7821||1
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|34473|45809|lyfalmen|||1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34473||34473|45809||1
016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2367|lyfalmen|V0169|2367|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2367||1
016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|185855|235131|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||185855||185855|235131||2
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|7867|11741|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7867||7867|11741||1
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|E|0|LVR|0|0|0|100|DKK|3080|5192|lyfalmen|V0240|5192|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3080||3080|5192||3
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|E|0|LVR|0|0|0|100|DKK|5684|8754|lyfalmen|V0433|8754|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5684||5684|8754||3
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|61497|79724|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||61497||61497|79724||1
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|90616|116268|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||90616||90616|116268||1
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEU|0|0|0|100|DKK|29284|39297|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||29284||29284|39297||1
016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GZE|0|0|0|100|XEU|79238|101326|lyfsjukr|||1|5|0|5,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||79238||79238|101326||1
016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2021|3744|lyfalmen|||1|14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2021||2021|3744||1
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3574|5868|lyfalmen|V0007|5868|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3574|5868||1
016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|7881|11760|lyfalmen|V0007|10269|1|98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7881||7881|11760||1
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GIS|0|0|0|100|XEU|40042|52135|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||40042||40042|52135||3
016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|14023|20144|lyfalmen|||1|98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||14023||14023|20144||1
016979|N02AE0103|Norspan|forđapl|5|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|3166|5310|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3166||3166|5310||2
016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|18913|36488|vetalmen|||0|60|0||Icepharma hf|Pfizer Oy Animal Health|||18913||18913|36488||2
017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25679|34110|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||25679||25679|34110||2
017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|1540|3086|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1540||1540|3086||1
017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|1|0|0|0|E|0|DSG|0|0|0|100|XEU|1446|2957|lyfalmen|||1|100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1446||1446|2957||2
017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|0|0|100|DKK|265890|335574|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||265890||265890|335574||2
017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|1|0|0|0|B|0|FRO|0|0|0|100|DKK|7960|11868|lyfalmen|||1|60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||7960||7960|11868||1
017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|0|0|0|0|0|0|AGT|0|0|0|100|XEU|6087|9306|lyfalmen|||2|500|0|333,0000|Actavis Group hf|Actavis Group hf|Zópíklón||6087||6087|9306||1
017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|186314|235707|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||186314||186314|235707||1
017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|40582|52813|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||40582||40582|52813||2
017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|1374|2858|lyfalmen|V0046|2255|2|100|0|33,3333|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||1374||1374|2858||1
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|129087|163887|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||129087||129087|163887||2
017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|48230|63074|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||48230||48230|63074||2
017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|149775|190513|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||149775||149775|190513||2
017266|N02AE0103|Norspan|forđapl|10|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|5496|8497|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5496||5496|8497||2
017326|N02AE0103|Norspan|forđapl|20|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|E|0|NOP|0|0|0|100|DKK|10466|15296|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10466||10466|15296||2
017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|2716|4694|lyfalmen|||2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Spírónólaktón||2716||2716|4694||1
017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|0|0|0|0|0|1|MSD|0|0|0|100|DKK|9094|13125|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||9094||9094|13125||1
017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|895|2203|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||895||895|2203||1
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|3117|5243|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||3117||3117|5243||1
017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2641|lyfalmen|V0168|2641|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2641||1
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6750|13134|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6750||6750|13134||1
017763|N06DA0401|Reminyl|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.08.2005|31.10.2012|R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|41300|32512|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||23878||23878|32512||1
017773|N06DA0401|Reminyl|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.08.2005|31.10.2012|R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|13456|12047|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||8091||8091|12047||1
017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10507|15352|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10507||10507|15352||1
017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|45183|59250|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||45183||45183|59250||1
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9595|14104|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9595||9595|14104||1
018268|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.06.2005|30.09.2012|R|0|0|0|0|0|0|BGB|0|0|0|100|SEK|7122|10721|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7122||7122|10721||2
018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|0|0|0|0|0|0|DSH|0|0|0|100|DKK|2286|4106|lyfalmen|||1|28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2286||2286|4106||1
018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|0|0|0|0|0|0|DSH|0|0|0|100|DKK|3356|5570|lyfalmen|||1|28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3356||3356|5570||1
018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|0|0|0|0|0|0|DSH|0|0|0|100|DKK|10833|15798|lyfalmen|||1|98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10833||10833|15798||1
018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|0|0|0|0|0|0|DSH|0|0|0|100|DKK|7540|11293|lyfalmen|||1|98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7540||7540|11293||1
018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4022|6481|lyfalmen|||1|0,25|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4022||4022|6481||2
018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4393|6988|lyfalmen|||1|0,5|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4393||4393|6988||2
018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|0|0|0|0|0|0|DSH|0|0|0|100|DKK|8960|13236|lyfalmen|||1|98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||8960||8960|13236||1
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|1499|1800|lyfalmen|V0243|1644|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||600||600|1800||1
018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|0|0|0|0|0|0|DSH|0|0|0|100|DKK|2807|4819|lyfalmen|||1|28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2807||2807|4819||1
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|8337|12383|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8337||8337|12383||1
018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|13785|19183|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13785||13785|19183||2
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|20441|28199|lyfalmen|V0441|28199|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||20441||20441|28199||1
018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|2943|5005|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2943||2943|5005||1
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|1|0|0|0|B|0|MKA|0|0|1|100|SEK|1007|2356|lyfalmen|V0414|2028|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||1007||1007|2356||2
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|5904|9055|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5904||5904|9055||1
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|16643|23432|lyfalmen|V0440|23432|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16643||16643|23432||1
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|34681|46070|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||34681||34681|46070||1
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|127260|161594|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||127260||127260|161594||1
018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|62412|80210|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||62412||62412|80210||1
018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|600|1800|lyfalmen|||2|100|0|50,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||600||600|1800||1
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1360|2705|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1360||1360|2705||2
018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|10633|15524|lyfalmen|V0221|11366|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10633||10633|15524||1
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22147|29677|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||22147||22147|29677||2
019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|7600|11375|lyfalmen|V0220|8986|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7600||7600|11375||1
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|24995|33251|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||24995||24995|33251||2
019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|4214|6743|lyfalmen|V0219|5630|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4214||4214|6743||1
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|34701|45432|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||34701||34701|45432||2
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|35581|46537|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||35581||35581|46537||2
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|43476|56445|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||43476||43476|56445||2
019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|9891|14509|lyfalmen|V0223|13081|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||9891||9891|14509||1
019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14654|20936|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14654||14654|20936||1
019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5026|7854|lyfalmen|||1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5026||5026|7854||1
019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|0|0|0|1|0|1|NYC|0|0|0|100|DKK|52288|67504|lyfsjukr|||2|1|0||Vistor hf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||52288||52288|67504||1
019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|748680|941476|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||748680||748680|941476||1
019308|QG03X0001|Alizin, vet.|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03X|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|IKR|4877|9537|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristóne||4877||4877|9537||1
019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dćlur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|21288|41049|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||21288|41049||1
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6886|10399|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6886||6886|10399||2
019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|52700|68021|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||52700||52700|68021||2
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6886|10399|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6886||6886|10399||2
019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|603|1804|lyfalmen|||2|100|0|100,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||603||603|1804||1
019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|3770|5441|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3770||3770|5441||2
019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|1|0|0|0|E|0|NYC|0|0|0|100|DKK|630|1841|lyfalmen|||2|250|0|250,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||630||630|1841||1
019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|16564|22670|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||16564||16564|22670||2
019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|195701|247487|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||195701||195701|247487||2
019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1158|2563|lyfalmen|V0159|2562|2|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1158||1158|2563||1
019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|199667|252465|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||199667||199667|252465||2
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12984|18840|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12984||12984|18840||2
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12984|18840|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12984||12984|18840||2
019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|56004|72830|lyfalmen|||1|1,08|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||56004||56004|72830||1
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12984|18840|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12984||12984|18840||2
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12984|18840|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12984||12984|18840||2
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12984|18840|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12984||12984|18840||2
019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIA|0|0|0|100|DKK|790571|994049|lyfsjukr|||1|6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||790571||790571|994049||1
019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|412|1542|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||412|1542||1
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|70723|90640|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||70723||70723|90640||1
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1734|3296|lyfalmen|V0160|3295|2|30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1694||1694|3296||1
020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Ferrósúlfat|||||||1
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|2936|4995|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2936||2936|4995||1
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|27575|37152|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||27575||27575|37152||1
020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2894|4938|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2894||2894|4938||3
020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|581|1774|lyfalmen|V0333|1600|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||581||581|1774||1
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|6855|10356|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6855||6855|10356||1
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|53508|69698|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||53508||53508|69698||1
020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|6548|5358|lyfalmen|V0530|5352|1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3201||3201|5358||1
020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|14590|6291|lyfalmen|V0531|6284|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3883||3883|6291||1
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|24147|32850|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||24147||24147|32850||1
020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|608|1811|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||608||608|1811||1
020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|5726|8812|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5726||5726|8812||2
020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1852|3512|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1852||1852|3512||1
020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|0|0|0|0|0|0|SEV|0|0|0|100|DKK|16675|23472|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16675||16675|23472||2
020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2238|3904|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2238||2238|3904||1
020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|157034|198960|lyfsjukr|||1|4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||157034||157034|198960||2
020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2617|4565|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2617||2617|4565||2
020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2030|3756|lyfalmen|V0174|3756|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2030||2030|3756||2
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|3027|5120|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||3027||3027|5120||2
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2585|4515|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2585||2585|4515||2
021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|DAC|0|0|1|100|IKR|827|1956|lyfalmen|||3|12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1956||2
021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|DAC|0|0|1|100|IKR|1025|2381|lyfalmen|V0169|2367|3|12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1025||1025|2381||2
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|E|0|ACA|0|0|1|100|IKR|453|1389|lyfalmen|V0188|1389|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||300||300|1389||1
021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|E|0|GEM|0|0|0|100|XEU|1024|2380|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1024||1024|2380||1
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|E|0|ACA|0|0|1|100|IKR|1187|2116|lyfalmen|V0189|2116|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||831||831|2116||1
021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005|30.09.2012|R|0|0|0|0|E|0|BAP|0|0|0|100|SEK|17496|24503|lyfalmen|||0|4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||17496||17496|24503||2
021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|0|0|LVR|0|0|0|100|GBP|9975|14400|lyfalmen|V0437|14400|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9811||9811|14400||3
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|17227|24165|lyfalmen|V0490|10444|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||17227||17227|24165||1
021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|0|0|LVR|0|0|0|100|GBP|7107|10701|lyfalmen|V0436|10701|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7107||7107|10701||3
021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.11.2004||R|0|0|0|0|E|0|DAC|0|0|1|100|SEK|1739|3306|lyfalmen|V0443|3306|3|120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1701||1701|3306||2
021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1
021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|B|0|MSD|0|0|0|100|DKK|17500|24508|lyfalmen|V0491|19529|1|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||17500||17500|24508||1
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1589|2293|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1589||1589|2293||2
021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|4416|7020|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4416||4416|7020||1
021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|13516|19508|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13516||13516|19508||1
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15048|21430|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||15048||15048|21430||1
021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|7143|10750|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||7143||7143|10750||1
021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|15178|21594|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15178||15178|21594||1
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15889|21823|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||15889||15889|21823||2
021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|22753|31100|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||22753||22753|31100||1
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15889|21823|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||15889||15889|21823||2
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|24457|33239|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24457||24457|33239||1
021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4691|7396|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4691||4691|7396||1
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|9137|13187|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||9137||9137|13187||2
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4611|6655|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4611||4611|6655||1
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|19580|27118|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19580||19580|27118||1
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|3856|6254|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3856||3856|6254||2
021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21689|29102|lyfsjukr|||1|2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||21689||21689|29102||2
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|5329|8269|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5329||5329|8269||2
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|18364|25592|lyfalmen|||1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18364||18364|25592||2
021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|82138|104966|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||82138||82138|104966||3
022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|19580|27118|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19580||19580|27118||1
022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|84314|107697|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||84314||84314|107697||2
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|128675|163370|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||128675||128675|163370||2
022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||||1
022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7236|10877|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7236||7236|10877||1
022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8480|12579|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8480||8480|12579||1
022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|26004|35180|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||26004||26004|35180||1
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|0|0|0|0|*|0|SAA|0|0|0|100|NOK|5647|8704|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5647||5647|8704||1
022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|9043|13349|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||9043||9043|13349||1
022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|295066|372190|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||295066||295066|372190||2
022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|325628|410546|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||325628||325628|410546||2
022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|11349|19798|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||11349||11349|19798||2
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|25641|34725|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||25641||25641|34725||1
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2282|3981|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2282||2282|3981||2
022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1304|2763|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1304||1304|2763||1
022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1389|2423|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1389|2423||2
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|3854|2723|lyfalmen|V0056|1724|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1275||1275|2723||1
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|6775|3746|lyfalmen|V0057|2114|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2023||2023|3746||1
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2161|3770|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||2161||2161|3770||2
022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|633|1845|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||633||633|1845||1
022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1900|3578|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1900||1900|3578||1
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1399|2440|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1399||1399|2440||2
022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|4707|7418|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4707||4707|7418||1
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2129|2993|lyfalmen|V0321|2993|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2993||1
022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1554|2046|lyfalmen|V0321|1796|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2046||1
022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4800||2
022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|27130|36593|lyfalmen|||1|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||27130||27130|36593||1
022802|L01XC0401|MabCampath|irţ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007|30.09.2012|R|0|0|0|1|0|1|GEU|0|0|0|100|SEK|225694|285128|lyfsjukr|||0|3|0||Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||225694||225694|285128||0
022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|13565|19569|lyfalmen|||1|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13565||13565|19569||1
022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|0|0|0|0|E|0|GGL|0|0|0|100|GBP|20369|28108|lyfalmen|||1|6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||20369||20369|28108||1
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2889||2
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|C|0|ACA|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827|2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2827||1
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|C|0|ACA|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4196||1
022962|V01AA1104|Alutard SQ, hrossavćrur|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|24457|33239|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24457||24457|33239||1
022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|19580|27118|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19580||19580|27118||1
023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|5692|8765|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5692||5692|8765||1
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GIS|0|0|0|100|DKK|84307|107688|lyfsjukr|||1|30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||84307||84307|107688||3
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|25884|35030|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||25884||25884|35030||3
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|40411|53261|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||40411||40411|53261||3
023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|20464|28227|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20464||20464|28227||1
023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|5749|8843|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5749||5749|8843||1
023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|E|0|NOE|0|0|0|100|DKK|20672|28489|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20672||20672|28489||1
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|5060|4556|lyfalmen|V0250|4556|2|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2615||2615|4556||1
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|3789|6162|lyfalmen|V0251|3969|2|100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3789||3789|6162||1
023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|18594|25881|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||18594||18594|25881||1
023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|7447|10748|lyfsjukr|||1|0,5|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7447||7447|10748||1
023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|28635|37819|lyfsjukr|||1|0,4|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||28635||28635|37819||1
023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|21684|29096|lyfsjukr|||1|0,3|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||21684||21684|29096||1
023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|51642|66693|lyfsjukr|||1|0,3|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||51642||51642|66693||1
023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|34896|45677|lyfsjukr|||1|0,5|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||34896||34896|45677||1
023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|8839|12757|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8839||8839|12757||2
023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|104012|132418|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||104012||104012|132418||1
023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|22098|29615|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||22098||22098|29615||2
023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|14969|20669|lyfsjukr|||1|0,4|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||14969||14969|20669||1
023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|41051|53402|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||41051||41051|53402||2
023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|82101|104919|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||82101||82101|104919||2
023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|181262|229366|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||181262||181262|229366||1
023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|164201|207955|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||164201||164201|207955||2
023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|135974|172530|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||135974||135974|172530||1
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|1|0|0|0|E|0|SBM|0|0|0|100|NOK|27806|32269|lyfalmen|V0029|8070|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||23684||23684|32269||1
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|3633|5949|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3633||3633|5949||2
023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|162039|205241|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||162039||162039|205241||2
023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|57016|73438|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||57016||57016|73438||2
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|77192|98758|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||77192||77192|98758||1
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|E|0|MSD|0|0|0|100|DKK|2951|5016|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2951||2951|5016||1
024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|0|0|1|0|E|0|JAS|0|0|0|100|SEK|2683|4649|lyfalmen|||1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2683||2683|4649||1
024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|E|0|TPG|0|0|0|100|DKK|19503|27021|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||19503||19503|27021||1
024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1893|2732|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1893||1893|2732||2
024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22816|30517|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||22816||22816|30517||2
024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|14561|9698|lyfalmen|V0456|9608|2|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||6374||6374|9698||2
024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|1|0|0|0|E|0|TPG|0|0|0|100|DKK|64326|83274|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||64326||64326|83274||1
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|24457|33239|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24457||24457|33239||1
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7699|11511|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7699||7699|11511||1
024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|453|1599|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||453||453|1599||1
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7699|11511|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7699||7699|11511||1
024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12973|18826|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12973||12973|18826||1
024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12995|18854|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12995||12995|18854||1
024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13128|19021|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13128||13128|19021||1
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5551|8572|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5551||5551|8572||1
024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|70532|91063|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||70532||70532|91063||1
024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|13128|19021|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13128||13128|19021||1
024603|V04CL0001|Soluprick  Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1581|3142|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1581||1581|3142||1
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5551|8572|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5551||5551|8572||1
024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7699|11511|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7699||7699|11511||1
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7699|11511|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7699||7699|11511||1
024681|V04CL0002|Soluprick  Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1581|3142|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1581||1581|3142||1
024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|0|0|0|0|E|0|OPF|0|0|1|100|XEU|381|1500|lyfalmen|||2|30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||381||381|1500||2
025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|0|0|0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen|||||||2
025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|0|0|0|0|E|0|OPF|0|0|1|100|XEU|763|2023|lyfalmen|V0562|2023|2|100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||763||763|2023||2
025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|0|0|0|0|E|0|OPF|0|0|1|100|XEU|927|2247|lyfalmen|V0564|2247|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||927||927|2247||2
025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|642|1857|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||642||642|1857||1
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|19580|27118|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19580||19580|27118||1
025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1955|3653|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1955||1955|3653||1
025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|19580|27118|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19580||19580|27118||1
025306|M05BB0301|Fosavance|töflur|||12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13903|19993|lyfalmen|||1|12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||13903||13903|19993||1
025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|84655|108125|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||84655||84655|108125||1
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|79071|101117|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||79071||79071|101117||1
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|9703|18804|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||9703||9703|18804||1
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|16795|23623|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||16795||16795|23623||1
025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki||C09CA03|01.04.2007||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|19934|27562|lyfalmen|||1|98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||19934||19934|27562||1
025455|C09CA0301|Diovan|filmhtfl|320|mg|28|stk|1|ţpakki||C09CA03|01.04.2007||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|6376|9701|lyfalmen|||1|28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6376||6376|9701||1
025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2333|2932|lyfalmen|V0462|2920|2|90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1428||1428|2932||2
025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2539|3060|lyfalmen|V0471|3060|2|90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1521||1521|3060||2
025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010|31.10.2012|R|0|0|0|0|*|0|DAC|0|0|0|100|DKK|1783|3418|lyfalmen|||3|5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíđ||1783||1783|3418||2
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|5313|8247|lyfalmen|V0205|1219|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5313||5313|8247||2
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|14238|20414|lyfalmen|V0205|3656|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14238||14238|20414||2
025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|*|0|POF|0|0|0|100|DKK|2730|3300|lyfalmen|V0472|3300|2|90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1697||1697|3300||2
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|53950|70252|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||53950||53950|70252||1
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7718|11139|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7718||7718|11139||1
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|24457|33239|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||24457||24457|33239||1
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|58366|75132|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||58366|75132||2
025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|13533|19529|lyfalmen|V0492|19529|2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||13533||13533|19529||2
025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991|31.08.2012|R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|1022|2377|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1022||1022|2377||1
025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|16414|19529|lyfalmen|V0491|19529|2|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||13533||13533|19529||2
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|4770|8321|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||4770||4770|8321||1
025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009|31.08.2012|R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|531|1705|lyfalmen|||2|25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||531||531|1705||1
025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|13843|10463|lyfalmen|V0490|10444|2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||6933||6933|10463||2
025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||||2
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|SEK|2776|5503|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2776||2776|5503||1
026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|820|2101|lyfalmen|V0447|2101|2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2101||2
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|9398|16394|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||9398||9398|16394||1
026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|23430|19498|lyfalmen|V0475|19417|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||13508||13508|19498||2
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|19580|27118|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19580||19580|27118||1
026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|43187|56082|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||43187||43187|56082||1
026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|215960|272912|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||215960||215960|272912||1
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|1840|3496|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1840|3496||1
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|6972|10516|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6972|10516||1
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|3635|5951|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3635|5951||1
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|14397|20613|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||14397|20613||1
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|21574|29621|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||21574|29621||1
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|E|0|UCB|0|0|0|100|DKK|28752|38629|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||28752|38629||1
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1517|3054|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1517||1517|3054||1
026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
026702|C10AA0505|Atorvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|0|0|0|0|0|0|BLP|0|0|0|100|XEU|4560|4521|lyfalmen|V0114|4521|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||2589||2589|4521||2
026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1693|3295|lyfalmen|V0160|3295|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1693||1693|3295||2
026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|1203|2562|lyfalmen|V0159|2562|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1157||1157|2562||2
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|451|1596|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||451||451|1596||1
027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|2734|4719|lyfalmen|V0199|3521|1|50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2734||2734|4719||3
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|*|0|ALA|0|0|0|100|USD|2493|4389|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2493||2493|4389||1
027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|0|0|0|0|*|0|MYL|0|0|0|100|SEK|7417|11125|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7417||7417|11125||1
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|29957|14057|lyfalmen|V0341|13768|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||9560||9560|14057||1
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|33620|15438|lyfalmen|V0342|15143|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||10570||10570|15438||1
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|7661|11459|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7661||7661|11459||1
027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|10096|14790|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||10096||10096|14790||1
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|B|0|NYC|0|0|0|100|DKK|850|2142|lyfalmen|V0153|2142|2|100|0|33,3300|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||850||850|2142||1
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|B|0|NYC|0|0|0|100|DKK|850|2142|lyfalmen|V0154|1991|2|100|0|66,6667|Vistor hf|Nycomed Danmark A/S|Levótýroxínnatríum||850||850|2142||1
027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|0|0|0|0|*|0|OPF|0|0|0|100|IKR|2109|2853|lyfalmen|V0284|2853|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||1370||1370|2853||2
027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|0|0|0|1|0|1|SPE|0|0|0|100|DKK|101764|129596|lyfsjukr|||1|105|0|5,2500|Vistor hf|SP Europe|Posacónazól||101764||101764|129596||1
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|20764|28604|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20764||20764|28604||1
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|32378|42517|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||32378|42517||2
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|23998|32663|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23998||23998|32663||1
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|47709|61757|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||47709||47709|61757||2
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|60099|77307|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||60099|77307||2
028045|G03AB0001|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|5378|8336|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5378||5378|8336||2
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín|||||||1
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|24577|33389|lyfalmen|V0386|33389|1|196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||24577||24577|33389||1
028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|3782|4908|lyfalmen|V0364|4908|2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||2872||2872|4908||1
028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|19016|26410|lyfalmen|V0120|26410|1|196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||19016|26410||1
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|57404|73925|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||57404||57404|73925||1
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2563|4485|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2563||2563|4485||2
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|21520|29553|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21520||21520|29553||2
028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|MEX|0|0|0|100|SEK|10857|15831|lyfalmen|||1|1|0||Icepharma hf|Aventis Pasteur MSD A/S|Hundaćđi, dauđ veira||10857||10857|15831||2
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|1979|3686|lyfalmen|V0202|3686|2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1979||1979|3686||1
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2218|4013|lyfalmen|V0428|3496|2|50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2218||2218|4013||1
028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|1|0|0|0|B|0|FRO|0|0|0|100|DKK|5325|8263|lyfalmen|||1|60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5325||5325|8263||1
028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|1278|2727|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2727||1
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|5812|4741|lyfalmen|V0245|4615|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2750||2750|4741||1
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|10358|9665|lyfalmen|V0232|9291|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||6350||6350|9665||1
028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|808|1404|lyfalmen|V0266|1304|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||311||311|1404||2
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|8052|15634|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||8052||8052|15634||2
028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|4652|7343|lyfalmen|||2|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4652||4652|7343||2
028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|5256|2574|lyfalmen|V0267|2574|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1166||1166|2574||2
028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|18952|10100|lyfalmen|V0269|9675|2|100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||6668||6668|10100||2
028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|2842|lyfalmen|V0551|2254|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2842||2
028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|7816|lyfalmen|V0552|6059|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7816||2
028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|577|1768|lyfalmen|V0554|1768|2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1768||2
028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|563|1749|lyfalmen|V0555|1749|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1749||2
028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|3757|lyfalmen|V0556|3034|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3757||2
029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|1148|2549|lyfalmen|||1|16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1148|2549||1
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|SEV|0|0|0|100|DKK|7686|11493|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Agómelatín||7686||7686|11493||2
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|SEV|0|0|0|100|DKK|21925|30061|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Agómelatín||21925||21925|30061||2
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|2933|4991|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2933||2933|4991||1
029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|0|0|0|0|E|0|AUK|0|0|0|100|GBP|268|1346|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||268|1346||1
029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005||R|1|0|0|0|0|0|LVR|0|0|0|100|XEU|7674|9367|lyfalmen|V0109|1750|3|98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6132||6132|9367||3
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|68017|87244|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||68017||68017|87244||1
029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|22866|30579|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22866||22866|30579||1
029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|5912|8532|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5912||5912|8532||1
029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4542|6555|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4542||4542|6555||1
029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5374|8330|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5374|8330||1
029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16877|23726|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16877|23726||1
029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5374|8330|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5374|8330||1
029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16877|23726|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16877|23726||1
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|6837|10332|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6837||6837|10332||2
029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|101674|129483|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||101674||101674|129483||1
029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|203347|257083|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||203347||203347|257083||1
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
030108|R06AX2701|Aerius|filmhtfl|5|mg|10|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|634|1846|lyfalmen|V0366|752|1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||634||634|1846||1
030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|5086|4062|lyfalmen|V0148|4051|2|90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2254||2254|4062||2
030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|E|0|EIS|0|0|0|100|SEK|23994|32658|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||23994||23994|32658||1
030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.07.2006|31.10.2012|L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2
030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|*|0|NOH|0|0|0|100|DKK|9359|13782|lyfalmen|V0277|13780|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9359||9359|13782||1
030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|*|0|NOH|0|0|0|100|IKR|2884|4924|lyfalmen|V0276|4923|1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||2884||2884|4924||1
030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|16367|28551|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||16367|28551||2
030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1466|2984|lyfalmen|V0051|2984|2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1466||1466|2984||1
031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|2316|4147|lyfalmen|||2|100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||2316||2316|4147||1
031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2687||1
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|3201|5358|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3201||3201|5358||2
031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|66465|85296|lyfsjukr|||1|20|0||Vistor hf|Schering-Plough|Temozolomid||66465||66465|85296||1
031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|80977|103509|lyfsjukr|||1|5|0||Vistor hf|Schering-Plough|Temozolomid||80977||80977|103509||1
031394|L01AX0301|Temodal|hylki|250|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|178530|225938|lyfsjukr|||1|5|0||Vistor hf|Schering-Plough|Temozolomid||178530||178530|225938||1
031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|2225|4023|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2225||2225|4023||1
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|6022|9217|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||6022||6022|9217||1
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|23587|31484|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||23587||23587|31484||1
031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|2123|3883|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2123||2123|3883||1
032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|0|0|0|0|0|1|STM|0|0|0|100|DKK|9769|14099|lyfsjukr|||2|4|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||9769|14099||4
032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|0|0|0|0|0|1|STM|0|0|0|100|DKK|14279|19803|lyfsjukr|||2|10|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||14279|19803||4
032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|0|0|0|0|0|1|STM|0|0|0|100|DKK|49407|63888|lyfsjukr|||2|50|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||49407|63888||4
032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|0|0|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni|||||||4
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|*|0|OTS|0|0|0|100|DKK|21409|29413|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21409||21409|29413||1
032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|3860|6734|vetorma|||0|50|0||Vistor hf|Merial (MSD)|Ivermectinum||3860||3860|6734||1
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|15064|26278|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||15064||15064|26278||1
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|*|0|FER|0|0|0|100|DKK|21699|29777|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||21699|29777||1
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|*|0|FER|0|0|0|100|DKK|43278|56859|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||43278|56859||1
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||L|0|0|0|0|0|0|NOB|1|0|0|100|XEU|1244|2170|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||||1244|2170||2
033195|N02AA5501|Targin|forđatfl|15|mg|28|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|3127|5256|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||3127||3127|5256||2
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9315|18059|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9315|18059||2
033206|N02AA5501|Targin|forđatfl|15|mg|98|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|10656|15556|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||10656||10656|15556||2
033218|N02AA5501|Targin|forđatfl|30|mg|28|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|6258|9540|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||6258||6258|9540||2
033229|N02AA5501|Targin|forđatfl|30|mg|98|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|18472|25728|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||18472||18472|25728||2
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|E|0|ALC|0|0|1|100|USD|1282|2733|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Dexametasón||1282||1282|2733||1
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|0|0|0|0|*|0|WIH|0|0|0|100|XEU|47388|22231|lyfalmen|V0185|22219|2|100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||15686||15686|22231||2
033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|85374|109027|lyfsjukr|||1|60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||85374||85374|109027||1
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|111357|141636|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||111357||111357|141636||1
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2517|5006|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2517|5006||2
034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|759|2017|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||759||759|2017||2
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|24564|32710|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||24564||24564|32710||2
034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|0|0|0|0|0|0|IAG|0|0|0|100|SEK|15898|22497|lyfalmen|||1|0,5|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||15898||15898|22497||2
034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|E|0|ELD|0|0|0|100|XEU|8267|12288|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8267|12288||2
034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|E|0|ELD|0|0|0|100|XEU|8267|12288|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8267|12288||2
034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|77925|99678|lyfsjukr|||1|40|0||Vistor hf|Orion Corporation|Dexmedetómid||77925||77925|99678||1
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|E|0|NOH|0|0|1|100|DKK|1861|3525|lyfalmen|V0367|3525|1|6|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1861||1861|3525||1
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|E|0|NOH|0|0|1|100|DKK|3083|5196|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||3083||3083|5196|31.10.2012|1
034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|183743|232480|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||183743||183743|232480||2
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|7579|10938|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7579||7579|10938||1
035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2302|3322|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2302||2302|3322||2
035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|B|0|FER|0|0|0|100|DKK|16246|22934|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16246||16246|22934||1
035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3775|6143|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3775|6143||1
035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|0|0|0|0|B|0|RGM|0|0|0|100|XEU|1017|2370|lyfalmen|V0050|2370|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1017||1017|2370||2
035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1844|2575|lyfalmen|V0244|2575|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1167||1167|2575||1
035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|0|0|0|0|B|0|RGM|0|0|0|100|XEU|1356|2834|lyfalmen|V0048|2834|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1356||1356|2834||2
035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|0|0|0|0|B|0|RGM|0|0|0|100|XEU|2422|4292|lyfalmen|V0049|4292|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2422||2422|4292||2
035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10827|15790|lyfalmen|V0080|12633|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10827||10827|15790||1
035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|0|0|0|0|B|0|RGM|0|0|0|100|XEU|5293|7503|lyfalmen|V0054|7503|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||4769||4769|7503||2
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|XEU|31093|37811|lyfalmen|||1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||28100||28100|37811||1
036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|150658|190958|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||150658||150658|190958||2
036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|6295|9590|lyfalmen|||1|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6295||6295|9590||1
036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3089|5204|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3089||3089|5204||1
036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8997|13286|lyfalmen|V0081|10661|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8997||8997|13286||1
036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|1|0|0|1|0|1|ABL|0|0|0|100|DKK|6168|8902|lyfsjukr|||1|30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||6168||6168|8902||1
036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|200057|252954|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||200057||200057|252954||1
036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|399032|502668|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||399032||399032|502668||1
036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|796386|1001347|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||796386||796386|1001347||1
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|861|2157|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||861||861|2157||1
036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1514|3050|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1514||1514|3050||1
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|GSC|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Silíkonsambönd|||||||1
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2988|5066|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2988||2988|5066||1
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|906|2218|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||906||906|2218||1
037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|12773|18575|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12773||12773|18575||1
037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|23449|31974|lyfalmen|||1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||23449||23449|31974||1
037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|45858|60097|lyfalmen|||1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||45858||45858|60097||1
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|2555|4474|lyfalmen|V0434|4474|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2555||2555|4474||2
037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1168|2577|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1168||1168|2577||1
037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2273||1
037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3692||1
037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8866|13107|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8866|13107||1
038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|0|0|GSK|0|0|0|100|IKR|664|1499|lyfalmen|||1|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1499||1
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|B|0|GSK|0|0|0|100|IKR|2667|3155|lyfalmen|V0321|2993|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3155||1
038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|1058|2426|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1058||1058|2426||2
038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2722|4702|lyfalmen|||1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2722||2722|4702||1
038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|177478|224617|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||177478||177478|224617||1
038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|76709|98152|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||76709||76709|98152||2
039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|43197|56095|lyfsjukr|||1|10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||43197||43197|56095||1
039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|72210|92506|lyfsjukr|||1|20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||72210||72210|92506||1
039141|B01AX0601 |Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|16738|23551|lyfalmen|V0031|21995|1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||16738|23551||2
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|7449|11059|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7369||7369|11059||1
039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|15|0||D.A.C. ehf|D.A.C. ehf|Terbínafín|||||||2
039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SAA|0|0|0|100|NOK|4805|7552|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4805|7552||1
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SAA|0|0|0|100|NOK|23544|32093|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||23544|32093||1
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|3496|5761|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3496||3496|5761||1
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|604|1615|lyfalmen|V0541|1587|2|98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||465||465|1615||1
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|680|1666|lyfalmen|V0542|1633|2|98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||502||502|1666||1
039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1311|2772|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1311||1311|2772||1
039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1890|3564|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1890||1890|3564||1
039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|698|1007|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||698||698|1007||2
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|1630|2333|lyfalmen|V0110|2232|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||990||990|2333||1
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|E|0|AGP|0|0|1|100|GBP|8937|9140|lyfalmen|V0182|9140|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||5966||5966|9140||1
039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1130|1631|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1130||1130|1631||2
039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|E|0|AGP|0|0|1|100|GBP|1936|2117|lyfalmen|V0033|2117|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||832||832|2117||1
040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2623|3786|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||2623||2623|3786||2
040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|E|0|APC|0|0|1|100|XEU|1326|2313|lyfalmen|V0366|2255|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||975||975|2313||1
040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen|||0|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1723||1
040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2449|2|100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1132||1132|2527||2
041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3554|5841|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3554||3554|5841||2
041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|0|0|0|0|B|0|BLP|0|0|0|100|XEU|2521|3232|lyfalmen|V0318|3232|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1647||1647|3232||2
041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|0|0|0|0|0|0|IPF|1|0|0|100|DKK|28402|49546|vetorma|||0|240|0||Icepharma hf|Pfizer Limited|GnRF hliđstćđa samtengd próteini||||28402|49546||2
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4448|7759|vetorma|||0|100|0||Vistor hf|Intervet International BV|||4448||4448|7759||1
041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0||D.A.C. ehf|D.A.C. ehf|Díklófenak|||||||2
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1251|2690|lyfalmen|||2|90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1251|2690||1
041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|4079|2155|lyfalmen|V0005|2114|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||860||860|2155||1
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||||1
042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|1608|3179|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1608||1608|3179||1
042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|13530|18863|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||13530||13530|18863||1
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2568|3706|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2568||2568|3706||2
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3104|4480|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3104||3104|4480||2
042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4395|6343|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4395||4395|6343||2
042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4504|6500|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4504||4504|6500||2
042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2009|30.09.2012|L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín|||||||2
042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5738|8281|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5738||5738|8281||2
042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7082|10221|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7082||7082|10221||2
042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3838|5539|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3838||3838|5539||2
042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2937|4239|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2937||2937|4239||2
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2245|3240|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2245||2245|3240||2
042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2810|4056|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2810||2810|4056||2
042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3687|5321|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3687||3687|5321||2
042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2519|3636|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2519||2519|3636||2
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1814|2618|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1814||1814|2618||2
042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6158|8888|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6158||6158|8888||2
042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2055|2966|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2055||2055|2966||2
042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|783|2050|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||783||783|2050||2
042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2909|4198|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2909||2909|4198||2
042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|14970|21332|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||14970||14970|21332||2
042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|1357|2699|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1357||1357|2699||2
042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|2023|4024|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2023||2023|4024||2
042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|2713|5382|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2713||2713|5382||2
042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|5427|10593|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5427||5427|10593||2
042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|IPF|0|0|0|100|DKK|6240|12154|vetalmen|||0|2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6240||6240|12154||2
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2449|3535|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2449||2449|3535||2
042669|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|0|0|0|0|0|0|ICE|0|0|0|100|GBP|2381|4236|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||2381||2381|4236||2
043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|604|1805|lyfalmen|||2|30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||604||604|1805||1
043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3351|4836|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3351||3351|4836||1
043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|24200|14999|lyfalmen|V0516|14714|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||10249||10249|14999||2
043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|5154|6215|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3828||3828|6215||1
043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6196|8942|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||6196||6196|8942||1
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|570|1759|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||570||570|1759||1
043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|1240|2675|lyfalmen|||1|30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1240||1240|2675||1
043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
043935|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1
044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|0|0|0|0|E|0|LVR|0|0|1|100|CHF|13181|19087|lyfalmen|V0034|19087|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||13181||13181|19087||3
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|385498|485682|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||385498|485682||1
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|544006|684610|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||544006|684610||1
044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|23411|31926|lyfalmen|||1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||23411||23411|31926||1
044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|89421|114768|lyfalmen|||1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||89421||89421|114768||1
044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|2709|4685|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2709||2709|4685||1
044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2110|4197|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2110||2110|4197||2
045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7484|11217|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7484||7484|11217||2
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|1050|1817|lyfalmen|V0109|1750|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||613||613|1817||1
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|868|1683|lyfalmen|V0108|1616|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||515||515|1683||1
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|3024|4364|lyfsjukr|||1|10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||3024||3024|4364||3
045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VIL|0|0|0|100|NOK|6047|8727|lyfsjukr|||1|10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||6047||6047|8727||3
045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|381|1500|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||381||381|1500||1
046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|PFV|0|0|0|100|DKK|21395|41254|vetalmen|||0|10|0||Icepharma hf|Pfizer vet.|||21395||21395|41254||2
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1041|2403|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1041||1041|2403||1
046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|E|0|VIS|0|0|0|100|DKK|3978|6421|lyfalmen|V0382|6421|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3978||3978|6421||2
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|686|1917|lyfalmen|V0021|1917|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||686||686|1917||1
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|1127|2410|lyfalmen|V0022|2410|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1046||1046|2410||1
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|1417|2800|lyfalmen|V0023|2800|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1331||1331|2800||1
046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|E|0|VIS|0|0|0|100|DKK|6625|10042|lyfalmen|V0383|10042|1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6625||6625|10042||2
046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|E|0|POF|0|0|0|100|GBP|5294|5352|lyfalmen|V0530|5352|2|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||3197||3197|5352||2
046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|0|0|0|0|E|0|POF|0|0|0|100|GBP|6641|6284|lyfalmen|V0531|6284|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||3878||3878|6284||2
046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|XEU|10558|7921|lyfalmen|V0283|7921|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||5075||5075|7921||2
046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|10969|3656|lyfalmen|V0205|3656|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3656||2
046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|*|0|POF|0|0|0|100|XEU|3407|2434|lyfalmen|V0279|2434|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1064||1064|2434||2
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1072|2445|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1072||1072|2445||1
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684||5
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564||5
047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|148699|188500|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||148699||148699|188500||2
047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|26937|36351|lyfalmen|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||26937||26937|36351||1
047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|12774|7753|lyfalmen|V0420|7328|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||4952||4952|7753||2
047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|24190|18927|lyfalmen|V0421|18538|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||13053||13053|18927||2
048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5569|8037|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||5569||5569|8037||2
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8851|12774|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8851||8851|12774||2
048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8791|12688|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||8791||8791|12688||2
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|2736|2574|lyfalmen|V0324|2574|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1166||1166|2574||1
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2541|3642|lyfalmen|V0035|3642|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1947||1947|3642||1
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|7888|4734|lyfalmen|V0325|4592|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2745||2745|4734||1
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|7750|4594|lyfalmen|V0326|4451|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2643||2643|4594||1
048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|3975|4516|lyfalmen|V0246|4516|2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2586||2586|4516||1
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|15497|4594|lyfalmen|V0327|4451|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2643||2643|4594||1
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|E|0|MAB|0|0|0|100|DKK|1185|2600|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geđlyf||1185||1185|2600||1
048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14073|20207|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||14073||14073|20207||1
048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|4344|6921|lyfalmen|||1|100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4344||4344|6921||1
048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1816|3463|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1816||1816|3463||1
048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|*|0|ROC|0|0|0|100|DKK|62404|77431|lyfalmen|V0187|37978|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||59670||59670|77431||2
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|0|0|100|XEU|1000334|1257302|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||1000334||1000334|1257302||1
048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|488|1646|lyfalmen|||1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||488||488|1646||1
049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|2478|4369|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2478||2478|4369||1
049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|17553|24574|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||17553||17553|24574||2
049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|2426|4298|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2426||2426|4298||1
049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|6728|10182|lyfalmen|||1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||6728||6728|10182||2
049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1059|2060|lyfalmen|V0108|1616|2|98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||790||790|2060||2
049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1154|2278|lyfalmen|V0109|1750|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||950||950|2278||2
049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|1827|2551|lyfalmen|V0110|2278|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1149||1149|2551||2
049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|NOH|0|0|0|100|IKR|8006|4999|lyfalmen|V0123|3261|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4999||1
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1211|2622|lyfalmen|V0496|2622|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1201||1201|2622||1
049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2496|3674|lyfalmen|||2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1970||1970|3674||1
049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1
049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1
049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1417||1
049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|*|0|ROC|0|0|0|100|DKK|62404|80862|lyfalmen|V0470|76434|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||62404||62404|80862||2
050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|0|0|0|1|0|1|BAP|0|0|0|100|DKK|606355|762858|lyfsjukr|||1|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||606355||606355|762858||2
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|72660|93071|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||72660|93071||1
050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|7624|3671|lyfalmen|V0012|2864|2|56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||1968||1968|3671||2
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1
050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3352|5564|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3352||3352|5564||1
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13129|19022|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13129||13129|19022||1
050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|5572|5210|lyfalmen|V0042|4708|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3093||3093|5210||1
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|4615|5247|lyfalmen|V0002|5247|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5247||1
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|4435|4217|lyfalmen|V0006|4139|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2367||2367|4217||1
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|10567|5077|lyfalmen|||2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2996||2996|5077||1
051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|1726|3340|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1726||1726|3340||1
051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007|31.10.2012|R|0|0|0|0|B|0|DAC|0|0|0|100|DKK|6522|8129|lyfalmen|||3|60|0||D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||5227||5227|8129||2
051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|1782|3417|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1782||1782|3417||1
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|1501|2663|lyfalmen|V0363|2663|2|30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1231||1231|2663||1
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|4081|5685|lyfalmen|V0365|5685|2|100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3440||3440|5685||1
051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|30714|40429|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||30714||30714|40429||1
051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|1596|1967|lyfalmen|V0056|1724|2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||722||722|1967||2
051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|B|0|POF|0|0|0|100|XEU|2701|2440|lyfalmen|V0057|2114|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1068||1068|2440||2
051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|B|0|AZD|0|0|1|100|SEK|1036|2396|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1036||1036|2396||1
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|225|1287|lyfalmen|V0047|1287|2|20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||225||225|1287||1
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|530|1704|lyfalmen|V0305|1018|2|50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||530||530|1704||1
052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|347576|438090|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||347576||347576|438090||1
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|376|1493|lyfalmen|V0439|1493|2|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||376|1493||1
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1205|2627|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1205||1205|2627||1
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|773|2036|lyfalmen|V0305|2036|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||773||773|2036||1
052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|726086|913120|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||726086||726086|913120||1
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|643542|809528|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||643542||643542|809528||1
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|3971|6411|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3971||3971|6411||1
052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír|||||||2
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|37591|49059|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||37591||37591|49059||2
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30559|40234|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||30559||30559|40234||2
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32260|42369|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||32260||32260|42369||2
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26991|35756|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||26991||26991|35756||2
052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|36298|47436|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||36298||36298|47436||2
052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33705|44182|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||33705||33705|44182||2
052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|15690|22236|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||15690||15690|22236||1
052979|J01CF0103|Dicloxacillin Arrow|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.06.2012|31.10.2012|R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|1882|3504|lyfalmen|||0|30|1|3,7500|Distica|Distica - óskráđ lyf|Díkloxacillín||1846||1846|3504||1
053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2507|4012|lyfalmen|V0313|4012|2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2217||2217|4012||1
053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2397|4258|lyfalmen|V0134|3544|1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2397||2397|4258||2
053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|0|0|0|1|0|1|ABT|0|0|0|100|DKK|63203|81202|lyfsjukr|||1|120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||63203||63203|81202||1
053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|5810|8927|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5810||5810|8927||1
053155|N02AA5501|Targin|forđatfl|60|mg|28|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|12294|17974|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||12294||12294|17974||2
053166|N02AA5501|Targin|forđatfl|60|mg|98|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|36615|48497|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||36615||36615|48497||2
053200|N02AA5501|Targin|forđatfl|7,5|mg|98|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|6130|9364|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||6130||6130|9364||2
053211|N02AA5501|Targin|forđatfl|7,5|mg|28|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1797|3432|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1793||1793|3432||2
053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6452|9805|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||6452||6452|9805||1
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|*|0|SDE|0|0|0|100|NOK|41001|54001|lyfalmen|V0453|44077|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||41001||41001|54001||1
053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|*|0|SDE|0|0|0|100|NOK|34416|45737|lyfalmen|V0454|39733|1|100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||34416||34416|45737||1
053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|668|1731|lyfalmen|V0060|1065|2|20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||550||550|1731||1
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|16487|23236|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16487||16487|23236||2
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1572|3129|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1572||1572|3129||1
053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1172|2582|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1172||1172|2582||1
054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|7944|10657|lyfalmen|V0490|10657|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||7075||7075|10657||1
054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|MEX|0|0|0|100|XEU|2653|4608|lyfalmen|||1|0,5|0||Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2653||2653|4608||2
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2771|4769|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2771||2771|4769||1
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|3821|6206|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3821||3821|6206||1
054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|65614|84228|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||65614||65614|84228||2
054376|B05AA0113|Albunorm 20%|irl|200|g/líter|100|ml|1|fl|lausn|B05AA01|01.06.2012||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|10003|14436|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Albúmín||10003||10003|14436||1
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|1|100|SEK|1152|2555|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1152||1152|2555||1
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1670|3263|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1670||1670|3263|31.10.2012|1
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|ALS|0|0|0|100|DKK|4875|9533|vetalmen|||0|10|0||Icepharma hf|Alstoe Limited|Buprenorphinhýdróklóríđ||||4875|9533||2
054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|7895|13772|vetorma|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||7895||7895|13772||2
055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|0|0|0|0|0|0|ALA|0|0|1|100|USD|1774|3406|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1774|3406||1
055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|822|2103|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||822||822|2103||1
055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|9458|13917|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9458||9458|13917||1
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|2064|2939|lyfalmen|V0467|2843|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|2939||1
055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|4539|2449|lyfalmen|V0112|2449|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1075||1075|2449||1
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|6185|2649|lyfalmen|V0113|2381|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1221||1221|2649||1
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|7867|4946|lyfalmen|V0114|4521|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||2900||2900|4946||1
056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|19293|26758|lyfalmen|V0459|25727|1|100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||19293||19293|26758||1
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|27712|48342|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||27712||27712|48342||2
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1338|2809|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1338||1338|2809||1
056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|2|0|0|0|B|0|AGP|0|0|0|100|XEU|3821|6206|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3821|6206||1
056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|2|0|0|0|B|0|AGP|0|0|0|100|XEU|3821|6206|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3821|6206||1
056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|3076|5187|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||3076||3076|5187||1
056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|EPI|0|0|0|100|XEU|239021|301854|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||239021||239021|301854||2
056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|1|0|0|1|0|1|POF|0|0|0|100|DKK|59552|76620|lyfsjukr|||2|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||59552||59552|76620||2
057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3775|6143|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3775||3775|6143||1
057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12011|17619|lyfalmen|V0095|13909|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||12011||12011|17619||1
057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|12058|17015|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||12058||12058|17015||1
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|6934|10007|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||6934||6934|10007||1
057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|256473|323756|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||256473||256473|323756||2
057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|24549|28573|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||20739||20739|28573||2
057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5016|7239|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5016||5016|7239||2
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|3823|5518|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3823||3823|5518||1
057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|376013|473779|lyfsjukr|||1|50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||376013||376013|473779||1
057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|575029|723544|lyfsjukr|||1|120|0||Vistor hf|Janssen-Cilag AB|Abírateron||575029||575029|723544||1
057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|25416|33780|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||25416||25416|33780||2
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|20689|28510|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||20689|28510||1
058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|E|0|BOI|0|0|0|100|DKK|437|1577|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||437||437|1577||1
058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|136029|172599|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||136029||136029|172599||1
058283|QI01AD040|Avipro Thymovac|frţlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|166493|290439|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||166493|290439||2
058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|252919|441205|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||252919|441205||2
058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|17878|24982|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17878||17878|24982||2
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1082|2459|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1082||1082|2459||1
058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|102887|131006|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||102887||102887|131006||1
058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|43928|57675|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||43928||43928|57675||1
058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|1312|2774|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1312||1312|2774||1
058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|2447|4326|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2447||2447|4326||1
058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07CA06|01.03.1999|31.08.2012|R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4540|7189|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4540||4540|7189||1
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|1|0|0|0|E|0|AGT|0|0|0|100|IKR|2374|2842|lyfalmen|V0006|2318|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1362||1362|2842||1
059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|1594|3159|lyfalmen|||1|250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1594||1594|3159||1
059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.06.2012||R|0|0|0|0|E|0|LOL|0|0|1|100|IKR|2297|4121|lyfalmen|||0|5|1||Lyfjaver ehf|Lyfjaver- óskráđ|Klóramfeníkól||2297||2297|4121||3
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|101894|130422|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||101894||101894|130422||1
059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|34851|46283|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||34851||34851|46283||1
059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|0|0|0|1|0|1|POF|0|0|0|100|DKK|92917|118493|lyfsjukr|||2|30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||92917||92917|118493||2
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|1|0|0|0|E|0|BPC|0|0|0|100|SEK|42901|49364|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||37306||37306|49364||1
059870|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.11.2010|31.10.2012|R|0|0|0|1|*|0|APE|0|0|0|100|XEU|54558|71015|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||54558||54558|71015||1
060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|386442|487530|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||386442||386442|487530||1
060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NOE|0|0|0|100|DKK|193237|245058|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||193237||193237|245058||1
060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|5782|8888|lyfalmen|||1|100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5782||5782|8888||1
061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|0|0|0|100|DKK|2818|5584|vetalmen|||0|4|0||Icepharma hf|Pfizer Animal Health|||||2818|5584||2
061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|0|0|0|100|DKK|1476|2936|vetalmen|||0|4|0||Icepharma hf|Pfizer Animal Health|||||1476|2936||2
061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|PFA|1|0|0|100|DKK|8721|16918|vetalmen|||0|20|0||Icepharma hf|Pfizer Animal Health|||||8721|16918||2
061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|0|0|0|0|E|0|DAC|0|0|0|100|DKK|7163|10778|lyfalmen|V0133|10778|3|84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7163||7163|10778||2
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|7164|10779|lyfalmen|V0133|10778|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7164||7164|10779||1
061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|1|spr||QP52AF02|01.04.1992||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|1745|3044|vetorma|||0|26|0||Icepharma hf|Pfizer Oy Animal Health|||||1745|3044||2
061715|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.05.2008||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|163971|207666|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||163971||163971|207666||1
061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|4552|6570|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4552||4552|6570||1
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|16255|22283|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||16255||16255|22283||1
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|22885|30603|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||22885||22885|30603||1
062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|470|1622|lyfalmen|V0307|1480|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||470||470|1622||1
062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|0|0|0|1|*|0|AGP|0|0|0|100|XEU|61203|37978|lyfalmen|V0187|37978|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||28233||28233|37978||1
062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|1691|3292|lyfalmen|||1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1691||1691|3292||1
062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985|31.10.2012|R|0|0|0|1|0|1|PER|0|0|0|100|DKK|6592|9514|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Metótrexat||6592||6592|9514||1
062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985|31.10.2012|R|0|0|0|1|0|1|PER|0|0|0|100|DKK|450|649|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||450||450|649||1
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|949|2277|lyfalmen|V0308|1994|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||949||949|2277||1
062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|E|0|AGT|0|0|1|100|XEU|1897|3574|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1897||1897|3574||1
062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|18458|32199|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||18458||18458|32199||2
062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|42371|55058|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||42371||42371|55058||1
062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|51733|66807|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||51733||51733|66807||1
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|17277|17045|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11745||11745|17045||1
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|4316|6883|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4316||4316|6883||1
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2997||1
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2603|3397|lyfalmen|V0123|3261|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1768||1768|3397||1
063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|1|0|0|0|E|0|DAC|0|0|1|100|XEU|4643|6375|lyfalmen|V0458|4932|3|100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||3945||3945|6375||2
063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|7976|11511|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7976||7976|11511||1
063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|PAS|0|0|0|100|XEU|2601|4537|vetorma|||0|11,8|0||Vistor hf|Pfizer Oy Animal Health|||2601||2601|4537||1
063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|997|2343|lyfalmen|V0309|2058|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||997||997|2343||1
063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2089|3837|lyfalmen|V0310|2820|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2089||2089|3837||1
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1113331|1399113|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1113331|1399113||2
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|445332|560774|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||445332|560774||2
064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2194|3980|lyfalmen|V0311|2820|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2194||2194|3980||1
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4453326|5590807|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4453326|5590807||2
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|2226664|2796346|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2226664|2796346||2
064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|2153|3924|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2153||2153|3924||1
064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|845|2135|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||845||845|2135||2
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|60003|77186|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||60003||60003|77186||1
065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|2001|3716|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||2001||2001|3716||1
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|16118|22111|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||16118||16118|22111||2
065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|2566|3793|lyfalmen|V0376|2184|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2057||2057|3793||1
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|*|0|LVR|0|0|0|100|SEK|64037|79753|lyfalmen|V0451|79753|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||61520||61520|79753||3
065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|7691|11039|lyfalmen|V0376|6551|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7354||7354|11039||1
065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|4999|7215|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4999||4999|7215||2
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4187|8212|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4187||4187|8212||2
066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6849|10348|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6849||6849|10348||1
066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33739|44225|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||33739||33739|44225||2
066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|868|2166|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||868||868|2166||2
066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr|||1|120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603||2
066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|1|0|0|0|B|0|DAC|0|0|0|100|NOK|1594|3159|lyfalmen|V0036|3159|3|30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1594||1594|3159||2
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1
066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|15691|21575|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15691||15691|21575||1
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8852|12776|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8852||8852|12776||2
067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|1|0|0|0|0|0|UCN|0|0|0|100|SEK|1535|3079|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1535||1535|3079||1
067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|0|0|0|0|*|0|APC|0|0|0|100|DKK|1901|2594|lyfalmen|V0376|2184|2|2,5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1181||1181|2594||1
067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|2439|lyfalmen|V0551|2254|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1067||1067|2439||1
067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|6414|lyfalmen|V0552|6059|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||3973||3973|6414||1
067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|664|1768|lyfalmen|V0554|1768|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1768||1
067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1749|lyfalmen|V0555|1749|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1749||1
067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|3187|lyfalmen|V0556|3034|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||1614||1614|3187||1
067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|13437|lyfalmen|V0419|13437|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9107||9107|13437||1
068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|0|0|1|0|0|0|VEQ|1|0|0|100|XEU|6260|12193|vetalmen|||0|50|0||Icepharma hf|Vétoquinol AG|||6260||6260|12193||2
068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|112804|143452|lyfsjukr|||1|15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||112804||112804|143452||1
068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|GTS|0|0|0|100|GBP|82980|106022|lyfsjukr|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||82980||82980|106022||1
068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|B|0|MEB|0|0|0|100|SEK|1880|3551|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1880||1880|3551||1
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|B|0|MEB|0|0|0|100|SEK|6226|9496|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||6226||6226|9496||1
068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|E|0|MED|0|0|0|100|XEU|27169|14840|lyfalmen|V0342|14840|2|98|0|130,6600|Medical ehf|Medical ehf|Dónepezíl||10133||10133|14840||2
068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2579|3722|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríđ||2579||2579|3722||1
068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|3210|4633|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríđ||3210||3210|4633||1
068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068951|V07AB09|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
068960|V07AB09|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|14503|20746|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||14503||14503|20746||1
069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|45777|59995|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||45777||45777|59995||1
069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|441|1407|lyfalmen|V0448|1407|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||313||313|1407||2
070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|19385|26873|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||19385|26873||1
070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|28037|37732|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||28037|37732||1
070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|36310|48114|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||36310|48114||1
070113|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1
070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|48835|63170|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||48835||48835|63170||2
070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|0|0|0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen|||0|100|0||Vistor hf|Pharmaxim AB|||10511||10511|20355||1
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|13176|19081|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13176||13176|19081||1
071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006||R|0|0|0|0|0|0|PAB|0|0|0|100|SEK|6620|12884|vetalmen|||0|1250|0||Vistor hf|Pharmaxim AB|||6620||6620|12884||1
071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|1|0|0|0|*|0|ACA|0|0|0|100|XEU|715|1957|lyfalmen|||2|100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||715||715|1957||1
071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|69908|89617|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||69908||69908|89617||1
071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|349543|440559|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||349543||349543|440559||1
071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|9087|13409|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||9087|13409||1
071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|0|0|0|0|0|0|LYF|0|0|0|100|XEU|11149|9611|lyfalmen|V0144|9099|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||6310||6310|9611||2
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|XEU|95834|122154|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||95834||95834|122154||1
072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|1|0|0|0|E|0|PSA|0|0|0|100|XEU|3233|2003|lyfalmen|V0009|2003|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||749||749|2003||2
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|7195|13988|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||7195||7195|13988||1
072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|1|0|0|0|E|0|PSA|0|0|0|100|XEU|10166|8214|lyfalmen|V0029|8070|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||5289||5289|8214||2
072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|19580|27118|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||19580||19580|27118||1
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|686|990|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||686||686|990||1
072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|0|1|0|1|0|1|ABB|0|0|0|100|DKK|151834|192434|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|Abbott|Adalimumab||151834||151834|192434||1
072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|16941|23806|lyfalmen|||1|1,2|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16941||16941|23806||2
072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|16941|23806|lyfalmen|||1|2,4|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||16941||16941|23806||2
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|78554|100468|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||78554||78554|100468||1
073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1080|2456|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1080||1080|2456||1
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|3985|6430|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3985||3985|6430||1
073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1681|3278|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1681||1681|3278||1
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|52468|22259|lyfalmen|V0185|22219|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||15708||15708|22259||1
073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|734|1607|lyfalmen|V0066|1607|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||459||459|1607||2
073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|312|1406|lyfalmen|V0047|1287|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||312||312|1406||1
073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|769|2031|lyfalmen|V0305|1018|1|50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||769||769|2031||1
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|982|2322|lyfalmen|V0305|2036|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||982||982|2322||1
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|528|1701|lyfalmen|V0439|1493|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||528||528|1701||1
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1435|2942|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1435||1435|2942||1
073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3816|6657|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Doramectinum||3816||3816|6657||2
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|0|0|0|0|*|0|APT|0|0|0|100|GBP|1416|2916|lyfalmen|||1|50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1416||1416|2916||1
074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|0|0|0|0|0|0|DAC|0|0|0|100|DKK|4755|7484|lyfalmen|V0142|7484|3|4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4755||4755|7484||2
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NOE|0|0|0|100|DKK|3676|6007|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3676||3676|6007||1
074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|1|0|0|0|E|0|DAC|0|0|1|100|GBP|426|1556|lyfalmen|V0391|1556|3|28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||422||422|1556||2
074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|18453|25041|lyfsjukr|||1|50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||18453||18453|25041||2
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|491|1651|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||491||491|1651||1
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|814|2092|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||814||814|2092||1
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|1103|2488|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1103||1103|2488||1
074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|SCA|1|0|0|100|DKK|21200|36982|vetorma|||0|25|0||Vistor hf|Scan Vet Animal Health AS|||21200||21200|36982||1
074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|1|0|0|0|B|0|AUK|0|0|0|100|GBP|436|1553|lyfalmen|V0510|1545|2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||420||420|1553||1
074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|1|0|0|0|B|0|AUK|0|0|0|100|GBP|797|2010|lyfalmen|V0512|2010|2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||754||754|2010||1
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|B|0|AEG|0|0|0|100|GBP|1010|2361|lyfalmen|||1|60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||1010||1010|2361||1
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|B|0|APT|0|0|0|100|GBP|538|1715|lyfalmen|||1|100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||538||538|1715||1
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|0|0|0|0|*|0|APT|0|0|0|100|GBP|2697|4623|lyfalmen|||1|100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2664||2664|4623||1
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|0|0|NOE|0|0|1|100|DKK|5006|7827|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5006||5006|7827||1
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|15017|21391|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15017||15017|21391||1
075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1864|3529|lyfalmen|||1|10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1864||1864|3529||1
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|5006|7827|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5006||5006|7827||1
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|2061|2860|lyfalmen|V0363|2663|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1375||1375|2860||1
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|B|0|NOE|0|0|1|100|DKK|15017|21391|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15017||15017|21391||1
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|XEU|1916|3600|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1916||1916|3600||1
075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|NOK|3234|5403|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3234||3234|5403||1
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|XEU|2670|4631|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2670|4631||1
075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|1|0|0|0|E|0|LVR|0|0|1|100|DKK|13597|19609|lyfalmen|V0196|19609|3|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13597||13597|19609||3
075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|1|0|0|0|E|0|LVR|0|0|0|100|DKK|18279|25485|lyfalmen|||3|84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||||18279|25485||3
075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|20441|28199|lyfalmen|V0441|28199|3|90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||20441||20441|28199||3
075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|16643|23432|lyfalmen|V0440|23432|3|90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||16643||16643|23432||3
075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|4206|5568|lyfalmen|V0445|5568|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||3355||3355|5568||2
075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|32653|42862|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||32653||32653|42862||1
075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|122560|155695|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||122560||122560|155695||1
075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|100187|127617|lyfsjukr|||1|1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||100187||100187|127617||2
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|980|1949|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|||980||980|1949||1
075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6212|8965|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6212||6212|8965||2
075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6212|8965|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6212||6212|8965||2
075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6212|8965|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6212||6212|8965||2
075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|467|1618|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||467||467|1618||1
075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|461|1610|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||461||461|1610||1
075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|915|1891|lyfalmen|V0449|1891|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||667||667|1891||2
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|6709|10156|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6709||6709|10156||1
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|22849|31221|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||22849||22849|31221||1
076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|ţpakki||A10BH01|01.10.2012||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|23386|31895|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||23386||23386|31895||1
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5
076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1588|lyfalmen|V0045|1588|2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1588||2
076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|1986|3099|lyfalmen|V0290|3099|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3099||2
076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|*|0|POF|0|0|0|100|IKR|1946|3373|lyfalmen|V0291|3373|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3373||2
076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|1|0|0|0|*|0|SPL|0|0|0|100|DKK|902|2213|lyfalmen|||1|100|0|6,6667|Vistor hf|Schering-Plough Europe|Perfenazín||902||902|2213||1
076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|1|0|0|0|*|0|SPL|0|0|0|100|DKK|1262|2705|lyfalmen|||1|100|0|13,3333|Vistor hf|Schering-Plough Europe|Perfenazín||||1262|2705||1
076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|1|0|0|0|*|0|SPL|0|0|0|100|DKK|1799|3440|lyfalmen|||1|100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1799|3440||1
076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|7307|12747|vetorma|||0|100|0||Vistor hf|Merial (MSD)|Ivermectinum||7307||7307|12747||1
076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009|30.09.2012|R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|7107|10596|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7030||7030|10596||1
076871|G01AF0202|Canesten (D.A.C.)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||||2
077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|236|1302|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||236||236|1302||1
077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|695|1930|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||695||695|1930||1
077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|10165|8214|lyfalmen|V0029|8070|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||5289||5289|8214||1
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|835|2121|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||835||835|2121||1
078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009|31.10.2012|L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|30|0||D.A.C. ehf|D.A.C. ehf|Ekónazól|||||||2
078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól|||||||2
078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009|31.10.2012|L|0|0|0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa|||0|4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín|||||||2
078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009|31.10.2012|L|0|0|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|120|0||D.A.C. ehf|D.A.C. ehf|Ketókónazól|||||||2
078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12606|lyfalmen|V0419|12541|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12606||2
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|558|1742|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||558||558|1742||1
078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|850|2142|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||850||850|2142||1
078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1428|2932|lyfalmen|V0560|2932|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1428||1428|2932||2
078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|2041|3771|lyfalmen|V0561|3771|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||2041||2041|3771||2
078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|0|0|0|1|0|1|SAG|0|0|0|100|DKK|131944|167472|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||131944||131944|167472||2
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9097|6199|lyfalmen|V0069|1830|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3816||3816|6199||1
079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2913|4204|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||2913||2913|4204||2
079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|4936|7124|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||4936||4936|7124||2
079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|9181|13250|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||9181||9181|13250||2
079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3728|6079|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3728||3728|6079||2
079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|*|0|SPL|0|0|0|100|DKK|18834|26182|lyfalmen|||1|10|0|154,5714|Vistor hf|Schering-Plough Europe|Perfenazín||18834||18834|26182||1
079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.05.2010|31.08.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|3571|5864|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3571||3571|5864||1
079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|2115|3052|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2115||2115|3052||1
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1517||1
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1852||1
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1864||1
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2577||1
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745||2
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|4098|8041|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4098|8041||2
080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|*|0|LYF|0|0|0|100|XEU|18002|18538|lyfalmen|V0421|18538|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||12743||12743|18538||2
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|10419|18175|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||10419||10419|18175||2
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|*|0|RAT|0|0|0|100|XEU|16939|10100|lyfalmen|V0170|10100|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||6668||6668|10100||2
080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|*|0|RAT|0|0|0|100|XEU|37431|22219|lyfalmen|V0185|22219|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||15676||15676|22219||2
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|2294|4117|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2294||2294|4117||1
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|6264|9548|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6264||6264|9548||1
080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2710|3620|lyfalmen|V0143|2499|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1931||1931|3620||1
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3253|5429|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3253||3253|5429||1
080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|34875|60838|vetorma|||0|500|0||Vistor hf|Merial (MSD)|Ivermectinum||34875||34875|60838||1
080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|7660|7496|lyfalmen|V0143|7496|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||4764||4764|7496||1
080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2992|3716|lyfalmen|V0144|3033|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2001||2001|3716||1
080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|15265|21040|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||15265||15265|21040||1
080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|11151|9611|lyfalmen|V0144|9099|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||6310||6310|9611||1
080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|30094|39650|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||30094||30094|39650||1
081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.07.2012|30.09.2012|R|0|0|0|0|E|0|ASA|0|0|0|100|SEK|37659|49807|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Astra Zeneca A/S|Natríumhýalúrónat||37659||37659|49807||1
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.05.2010|31.08.2012|L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|8210|5116|lyfalmen|V0515|4832|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3024||3024|5116||2
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|4703|7412|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4703||4703|7412||1
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1863|2689|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1863||1863|2689||2
081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|0|0|0|0|*|0|DAC|0|0|0|100|XEU|19991|15818|lyfalmen|V0456|9608|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||10848||10848|15818||2
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|*|0|SAA|0|0|0|100|NOK|6140|9378|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6140||6140|9378||1
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|*|0|SDE|0|0|0|100|NOK|9223|13596|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9223||9223|13596||1
082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|38762|14981|lyfalmen|V0184|14943|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||10236||10236|14981||1
082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2288|4109|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2288||2288|4109||1
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5
082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|3352|5064|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2986||2986|5064||1
082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|5940|9105|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5940||5940|9105||1
082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|975|2313|lyfalmen|||2|125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||975||975|2313||1
082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||||1
082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4961|7765|lyfalmen|||1|20|0|1,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4961||4961|7765||1
082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|5864|9001|lyfalmen|||1|20|0|3,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5864||5864|9001||1
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9169|12891|lyfalmen|V0080|12891|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||8708||8708|12891||1
082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|13370|19324|lyfalmen|||1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13370||13370|19324||1
083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|*|0|AZA|0|0|0|100|SEK|19856|27464|lyfalmen|V0186|7496|1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19856||19856|27464||1
083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|13964|20070|lyfalmen|V0344|14036|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13964||13964|20070||1
083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|7750|11581|lyfalmen|||1|20|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7750||7750|11581||1
083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|0|0|0|1|0|1|ABL|0|0|0|100|DKK|78034|99815|lyfsjukr|||1|450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||78034||78034|99815||1
083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|30301|40573|lyfalmen|V0346|30146|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30301||30301|40573||1
083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|0|0|0|1|0|1|SNO|0|0|0|100|NOK|8788|12683|lyfsjukr|||1|11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8788||8788|12683||1
084097|C09CA0105|Losartan LYFIS|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.05.2012||R|0|0|0|0|B|0|LYF|0|0|0|100|XEU|2154|1830|lyfalmen|V0069|1830|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Lósartan||622||622|1830||2
084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|273|1352|lyfalmen|||2|10|0|2,5000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||273||273|1352||1
084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|0|0|0|0|0|0|KRK|0|0|1|100|XEU|2069|2820|lyfalmen|V0311|2820|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1346||1346|2820||2
084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|527|1700|lyfalmen|||2|20|0|5,0000|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||527||527|1700||1
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|74359|95203|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||74359||74359|95203||1
084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|62204|79949|lyfsjukr|||1|0,3|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||62204||62204|79949||2
084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|81091|103652|lyfsjukr|||1|0,3|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||81091||81091|103652||2
084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|100321|127785|lyfsjukr|||1|0,3|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||100321||100321|127785||2
084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|20735|27905|lyfsjukr|||1|0,3|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||20735||20735|27905||2
084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|32385|42526|lyfsjukr|||1|0,3|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||32385||32385|42526||2
084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|41469|53926|lyfsjukr|||1|0,3|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||41469||41469|53926||2
084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|12843|18000|lyfsjukr|||1|0,3|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12843|18000||2
084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|48956|63322|lyfsjukr|||1|0,3|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||48956|63322||2
084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|150779|191110|lyfsjukr|||1|0,6|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||150779|191110||2
084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|990|2333|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||990||990|2333||1
084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|11743|17043|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11743||11743|17043||1
084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|38216|50506|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||38216||38216|50506||1
085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|15720|22274|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||15720||15720|22274||1
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|*|0|GAN|0|0|0|100|NOK|45578|59746|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||45578||45578|59746||2
085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2667|4627|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2667||2667|4627||2
085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|30301|40573|lyfalmen|V0345|30146|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30301||30301|40573||1
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|821|2102|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||821||821|2102||1
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|20621|28424|lyfalmen|V0412|23706|1|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||20621||20621|28424||1
085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|35751|47413|lyfalmen|V0412|47413|1|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||35751||35751|47413||1
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|95687|121970|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||95687||95687|121970||2
085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|ţpakki||N07XX02|01.11.2012||R|1|0|0|0|E|0|AGP|0|0|0|100|SEK|44018|57788|lyfalmen|V0579|57788|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||44018||44018|57788||1
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEU|0|0|0|100|DKK|40481|53349|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||40481||40481|53349||1
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|*|0|API|0|0|0|100|SEK|3097|5215|lyfalmen|V0465|4500|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||3097||3097|5215||1
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|*|0|API|0|0|0|100|SEK|9153|13500|lyfalmen|V0465|13500|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||9153||9153|13500||1
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|4282|5367|lyfalmen|V0364|4908|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3208||3208|5367||1
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|5798|6232|lyfalmen|V0365|5685|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3840||3840|6232||1
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|8687|12538|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8687||8687|12538||1
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|15101|20834|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15101||15101|20834||1
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|30642|41001|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||30642||30642|41001||1
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|E|0|FEL|0|0|0|100|DKK|61285|79458|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||61285||61285|79458||1
086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|0|0|100|DKK|54376|70124|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||54376||54376|70124||1
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|19469|26979|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||19469||19469|26979||2
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|50997|65884|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||50997||50997|65884||2
087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|3025|5117|lyfalmen|||1|28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3025||3025|5117||1
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|452|1597|lyfalmen|V0060|1597|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||452||452|1597||1
087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|163261|206775|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||163261||163261|206775||1
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|306|1397|lyfalmen|V0312|449|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||306||306|1397||1
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|269|1347|lyfalmen|V0312|1347|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||269||269|1347||1
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2269|4083|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2269||2269|4083||1
087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3586||1
087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|0|0|0|0|E|0|MEC|0|0|0|100|SEK|922|2240|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||922||922|2240||2
087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|1|0|0|0|E|0|APC|0|0|0|100|XEU|3554|1935|lyfalmen|V0009|1869|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||699||699|1935||1
087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|10896|7753|lyfalmen|V0420|7328|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||4952||4952|7753||1
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|31946|55728|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||31946||31946|55728||2
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1
087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|DKK|4509|8831|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4509||4509|8831||1
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|29448|51371|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||29448||29448|51371||2
088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|E|0|GGL|0|0|1|100|GBP|1411|2909|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1411||1411|2909||1
088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|1606|3176|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1606||1606|3176||1
088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|E|0|MAB|0|0|1|100|SEK|6196|9455|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||6196||6196|9455||1
088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|416|1548|lyfalmen|||1|6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||416||416|1548||1
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|5138|8007|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5138||5138|8007||1
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|9927|14559|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9927||9927|14559||1
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|B|0|LEP|0|0|0|100|DKK|15230|21659|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||15230||15230|21659||1
088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|0|0|0|0|*|0|AGP|0|0|0|100|XEU|23117|18927|lyfalmen|V0421|18538|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||13053||13053|18927||1
088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|6462|6551|lyfalmen|V0376|6551|2|7,5|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4073||4073|6551||2
088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1775|3407|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1775||1775|3407||1
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5674||1
089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|163261|206775|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||163261||163261|206775||1
089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|1|0|0|0|E|0|MYD|0|0|0|100|SEK|4210|6738|lyfalmen|||2|100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4210||4210|6738||1
089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2
089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2
089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||R|0|0|0|0|E|0|LYF|0|0|1|100|XEU|1640|2248|lyfalmen|V0362|2202|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín||928||928|2248||2
089533|V03AE0001|OsvaRen|filmhtfl|||180|stk|1|glas|435 mg / 235 mg|V03AE00|01.10.2012||R|0|0|0|0|0|0|FMC|0|0|0|100|XEU|6776|10248|lyfalmen|||1|180|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Kalsíum asetat og ţungt magnesíum karbón||6776||6776|10248||2
089801|B03AC0601|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC06|01.10.2012||R|0|0|0|0|0|0|PAC|0|0|1|100|DKK|25108|34056|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||25108||25108|34056||1
089913|B03AC0601|Monofer|irl|100|mg/ml|5|ml|5|hgl||B03AC06|01.10.2012||R|0|0|0|0|0|0|PAC|0|0|1|100|DKK|135520|172623|lyfalmen|||1|25|0|25,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||135520||135520|172623||1
089936|B03AC0601|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC06|01.10.2012||R|0|0|0|0|0|0|PAC|0|0|1|100|DKK|100431|128586|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Ferrii oxidum- dextran komplex||100431||100431|128586||1
090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|1|0|0|0|B|0|FRO|0|0|0|100|DKK|2355|4200|lyfalmen|||1|100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2355||2355|4200||1
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1611|3183|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1611||1611|3183||2
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3199|5355|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3199||3199|5355||2
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|961|2293|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||961||961|2293||2
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|5888|8498|lyfsjukr|||1|10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5888||5888|8498||2
090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|1868|3534|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1868||1868|3534||1
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|ACK|0|0|0|100|USD|16697|22837|lyfsjukr|||1|60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||16697|22837||1
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2889|4170|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2889||2889|4170||1
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4994|7208|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4994||4994|7208||1
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|14655|20275|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14655||14655|20275||1
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|3402|5633|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3402||3402|5633||1
091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|1820|2627|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1820|2627||1
091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|7444|10744|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7444|10744||1
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|E|0|CHA|0|0|1|100|DKK|4014|6470|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||4014||4014|6470||1
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|AVP|0|0|0|100|NOK|1323|1919|lyfalmen|V0021|1917|1|90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríđ||687||687|1919||1
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|AVP|0|0|0|100|NOK|2287|2477|lyfalmen|V0022|2410|1|90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1095||1095|2477||1
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|632|1843|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||632||632|1843||1
092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|3911|6329|lyfalmen|||1|15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3911|6329||1
092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|9268|17969|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||9268||9268|17969||2
092241|J01AA0209|Doxycyclin Actavis Disper|töflur|100|mg|8|stk|1|ţpakki|0|J01AA02|01.02.2012|31.08.2012|R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|446|1589|lyfalmen|||2|8|0|8,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||446||446|1589||1
092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|1|0|0|0|E|0|SBM|0|0|0|100|NOK|8316|11266|lyfalmen|V0009|1869|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7520||7520|11266||1
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.08.2010|31.08.2012|L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2296|4120|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2296||2296|4120||1
092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|*|0|DAC|0|0|0|100|DKK|9358|13780|lyfalmen|V0277|13780|3|100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9358||9358|13780||2
092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|24226|32949|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||24226||24226|32949||1
092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|455|1601|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||455||455|1601||1
092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|591|1787|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||591||591|1787||1
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|3392|3715|lyfalmen|V0203|3715|2|12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||2000||2000|3715||2
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|1159|2564|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1159|2564||2
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|2660|4618|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2660|4618||2
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOR|0|0|0|100|DKK|5170|8051|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||5170|8051||2
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|7194|10820|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7194||7194|10820||1
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|B|0|NOH|0|0|0|100|DKK|1482|3006|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1482||1482|3006||1
093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|26712|46598|vetorma|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||26712||26712|46598||2
093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|0|0|0|1|*|0|DAC|0|0|0|100|SEK|64037|80464|lyfalmen|V0451|79753|3|1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||62087||62087|80464||2
093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|1|0|0|0|B|0|DAC|0|0|0|100|XEU|1201|2622|lyfalmen|V0496|2622|3|100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1201||1201|2622||2
093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|16290|22989|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||16290||16290|22989||2
093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010|31.10.2012|R|0|0|0|1|*|0|DAC|0|0|0|100|SEK|23321|31813|lyfalmen|||3|1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||23321||23321|31813||2
093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|45971|60239|lyfalmen|||1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||45971||45971|60239||2
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|576759|725715|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||576759||576759|725715||1
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|621140|781413|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||621140||621140|781413||1
094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|5359|8310|lyfalmen|V0236|7895|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5359||5359|8310||1
094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|E|0|ALM|0|0|0|100|SEK|7941|11842|lyfalmen|V0236|11842|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7941||7941|11842||1
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1800|3581|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1800||1800|3581||1
094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|13149|19047|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13149||13149|19047||1
094296|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.10.2007|31.10.2012|R|0|0|0|1|*|0|APE|0|0|0|100|XEU|18186|25369|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18186||18186|25369||1
094305|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007|31.10.2012|R|0|0|0|1|*|0|APE|0|0|0|100|XEU|81830|105242|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||81830||81830|105242||1
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|84686|108163|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||84686||84686|108163||1
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|47893|62651|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||47893|62651||1
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6534|11398|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6534||6534|11398||2
095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3136|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3136||1
095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|0|0|0|0|0|0|LYF|0|0|0|100|XEU|5106|5310|lyfalmen|V0143|4997|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3166||3166|5310||2
095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|E|0|AGT|0|0|0|100|DKK|6155|9399|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6155||6155|9399||1
095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|18730|26051|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18730||18730|26051||1
095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|18730|26051|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18730||18730|26051||1
095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1939|2798|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1939||1939|2798||2
095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3036|4382|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3036||3036|4382||2
095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|18730|26051|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18730||18730|26051||1
095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2545|3673|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2545|3673||2
095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3522|5083|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3522|5083||2
095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|0|0|E|0|AGP|0|0|1|100|XEU|1076|1508|lyfalmen|V0225|1508|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||387||387|1508||1
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|3679|7237|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3679||3679|7237||2
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|4855|9495|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4855||4855|9495||2
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|XEU|8842|17151|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8842||8842|17151||2
096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7835|11308|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||7835||7835|11308||2
096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|12910|18085|lyfsjukr|||1|10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12910||12910|18085||1
096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|100923|128541|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||100923||100923|128541||1
096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|0|0|0|0|B|0|BLP|0|0|0|100|XEU|2420|1900|lyfalmen|V0088|1900|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||673||673|1900||2
096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|0|0|0|0|B|0|BLP|0|0|0|100|XEU|2519|2042|lyfalmen|V0089|2042|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||777||777|2042||2
096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|2133|3897|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2133||2133|3897||1
096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|16232|22916|lyfalmen|V0347|21647|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16232||16232|22916||1
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|693029|871634|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||693029||693029|871634||2
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|734647|923864|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||734647||734647|923864||2
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|772669|971582|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||772669||772669|971582||2
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|847977|1066094|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||847977||847977|1066094||2
096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|16232|22916|lyfalmen|V0349|21647|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16232||16232|22916||1
096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|E|0|SEV|0|0|0|100|DKK|1497|3027|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1497||1497|3027||2
096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|E|0|NOE|0|0|0|100|DKK|32466|43290|lyfalmen|||1|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||32466||32466|43290||1
096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|E|0|SNO|0|0|0|100|NOK|19437|26939|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||19437||19437|26939||1
097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|27488|36380|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||27488||27488|36380||1
097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|74018|129121|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||74018||74018|129121||2
097080|R06AX2701|Aerius|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|1654|3241|lyfalmen|V0366|2255|1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1654||1654|3241||1
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|8164|15849|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8164|15849||2
097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2210|3984|lyfalmen|V0461|3984|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2197||2197|3984||2
097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|0|0|0|0|E|0|SCP|0|0|1|100|DKK|1074|2448|lyfalmen|||1|120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1074||1074|2448|31.10.2012|1
097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11194|16292|lyfalmen|V0334|5904|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11194||11194|16292||1
097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|21253|29218|lyfalmen|V0335|5904|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||21253|29218||1
097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2445|4324|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2445||2445|4324||1
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|*|0|AVP|0|0|0|100|NOK|3283|2886|lyfalmen|V0023|2800|1|90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1394||1394|2886||1
097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|E|0|AGP|0|0|0|100|IKR|2738|2780|lyfalmen|||2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1244||1317|2780|30.9.2012|1
097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|E|0|AGP|0|0|0|100|IKR|1917|2246|lyfalmen|V0234|2246|2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||926||926|2246||1
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1109|2474|lyfalmen|V0329|2474|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1093||1093|2474||1
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|6635|2711|lyfalmen|V0072|2042|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1266||1266|2711||1
098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|8502|2786|lyfalmen|V0073|2042|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1321||1321|2786||1
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|B|0|BIG|0|0|1|100|SEK|629|1839|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||629||629|1839||2
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|B|0|BIG|0|0|1|100|SEK|629|1839|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||629||629|1839||2
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|XEU|1000|1957|lyfalmen|V0243|1957|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||715||715|1957||2
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|XEU|1705|2469|lyfalmen|V0244|2299|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1089||1089|2469||2
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|XEU|4815|4957|lyfalmen|V0245|4709|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||2908||2908|4957||2
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|E|0|RGM|0|0|0|100|XEU|8628|9481|lyfalmen|V0232|9481|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||6215||6215|9481||2
098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|18825|25508|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||18825||18825|25508||1
098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|17696|24754|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17696||17696|24754||2
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|102435|130438|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||102435||102435|130438||1
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|6128|2853|lyfalmen|V0284|2853|2|100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||1370||1370|2853||1
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|14070|11694|lyfalmen|V0285|11663|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||7833||7833|11694||1
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|*|0|MYL|0|0|0|100|IKR|23001|23671|lyfalmen|V0286|23290|2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||16833||16833|23671||1
099705|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|2962|4020|lyfalmen|V0247|4020|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2223||2223|4020||1
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|4095|6117|lyfalmen|V0248|6117|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3756||3756|6117||1
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|8318|10222|lyfalmen|V0249|10222|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6757||6757|10222||1
099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|737|1987|lyfalmen|V0414|1987|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||737||737|1987||1
100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|13257|19183|lyfalmen|||1|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13257|19183||2
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|13257|19183|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13257|19183||2
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1913|3596|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1913||1913|3596||1
101034|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.10.2012||R|0|0|0|0|E|0|RGM|0|0|1|100|XEU|3548|4932|lyfalmen|V0458|4932|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||2890||2890|4932||2
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|12634|13389|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9072||9072|13389||1
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|17475|24476|lyfalmen|||1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||17475||17475|24476||1
101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|2116|3873|lyfalmen|||1|28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||2116|3873||2
101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|6829|10321|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||6829|10321||2
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|1366|2848|lyfalmen|V0330|2848|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1366||1366|2848||1
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|B|0|AGP|0|0|0|100|XEU|3109|5232|lyfalmen|V0331|5232|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3109||3109|5232||1
101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|3900|2742|lyfalmen|V0088|1939|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1289||1289|2742||1
101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|5567|8594|lyfalmen|V0332|8594|2|96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5567||5567|8594||1
101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|4523|2804|lyfalmen|V0089|2084|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1334||1334|2804||1
101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|1|0|0|0|E|0|DAC|0|0|1|100|DKK|5173|8055|lyfalmen|V0227|7519|3|100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5173||5173|8055||2
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|SEK|18087|34902|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||||18087|34902||1
101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|1|0|0|0|E|0|APR|0|0|0|100|DKK|3224|5389|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3224|5389||1
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|7153|10764|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||7153||7153|10764||2
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|21458|29475|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||21458||21458|29475||2
102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3903|6318|lyfalmen|V0041|3771|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3903||3903|6318||1
102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|1956|2823|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||1956||1956|2823||1
102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|3179|4588|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||3179||3179|4588||1
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|3503|2709|lyfalmen|V0088|1900|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1265||1265|2709||2
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|1488|3014|lyfalmen|V0089|2042|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1488||1488|3014||2
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|2992|2408|lyfalmen|V0069|1830|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1045||1045|2408||2
103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|E|0|POF|0|0|1|100|GBP|2663|2117|lyfalmen|V0033|2117|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||832||832|2117||2
103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|E|0|POF|0|0|1|100|GBP|10534|8752|lyfalmen|V0182|8705|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||5682||5682|8752||2
103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4454|6024|lyfalmen|V0334|6024|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6024||2
103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|7148|6024|lyfalmen|V0335|6024|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3688||3688|6024||2
103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|4008|7869|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníđ og amídín-Klórhexidín í blöndum||4008||4008|7869||1
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1916||1
103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|14233|19745|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||14233||14233|19745||2
104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|0|0|0|0|B|0|LYF|0|0|0|100|XEU|3080|2042|lyfalmen|V0073|2042|2|98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||777||777|2042||2
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|E|0|FEL|0|0|0|100|DKK|3166|5310|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3166||3166|5310||1
104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|1|0|0|0|0|0|NER|0|0|1|100|DKK|2178|3958|lyfalmen|V0574|3352|1|21|0|21,0000|Vistor hf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2178||2178|3958||1
104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|8348|12399|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8348||8348|12399||1
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|4688|7392|lyfalmen|V0017|7392|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4688||4688|7392||1
104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|B|0|FER|0|0|0|100|DKK|5305|8236|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5305||5305|8236||1
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|129639|164579|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||129639|164579||1
105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|0|100|SEK|4308|5987|lyfalmen|||3|28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3661||3661|5987|30.9.2012|2
105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007|31.10.2012|R|1|0|0|0|0|0|DAC|0|0|0|100|SEK|13108|16222|lyfalmen|||3|100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||11143||11143|16222||2
105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|0|100|SEK|17431|19282|lyfalmen|||3|100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13336||13336|19282|30.9.2012|2
105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|DAC|0|0|0|100|SEK|1280|2730|lyfalmen|V0545|2730|3|63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1280||1280|2730||2
105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|3981|6425|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||3981||3981|6425||1
105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|13840|19914|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13840||13840|19914||1
105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|4589|7256|lyfalmen|||1|28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4589||4589|7256||1
105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|15963|22579|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15963||15963|22579||1
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2537|4449|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2537||2537|4449||1
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3000|5083|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||3000||3000|5083||1
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1858|3521|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1858||1858|3521||2
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3715|6061|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3715||3715|6061||2
106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|2688|4656|lyfalmen|||1|14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2688||2688|4656||1
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|19572|26445|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19572||19572|26445||1
106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|10824|15467|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10824||10824|15467||1
106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|*|0|TEV|0|0|0|100|XEU|9363|13787|lyfalmen|V0572|13787|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||9363||9363|13787||2
107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|2046|1846|lyfalmen|V0278|1846|2|28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||634||634|1846||1
107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|0|0|0|0|B|0|ADG|0|0|0|100|XEU|1282|2733|lyfalmen|||2|100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1282||1282|2733||1
107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1585|3147|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1585||1585|3147||1
107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1556|2714|vetorma|||0|6,42|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||||1556|2714||2
107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|933|2255|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||933||933|2255||1
108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|3018|5107|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||3018|5107||2
108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|3324|5526|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3324||3324|5526||1
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|9866|14475|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9866||9866|14475||1
108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|13890|6504|lyfalmen|V0282|6504|3|56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||4039||4039|6504||2
108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|1227|2657|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1227||1227|2657||1
108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|1702|3307|lyfalmen|V0443|3306|1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1702||1702|3307||1
109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2209|2105|lyfalmen|V0004|2066|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||823||823|2105||1
109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|24457|33239|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24457||24457|33239||1
109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|19580|27118|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19580||19580|27118||1
109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|0|0|0|0|E|0|ALK|0|0|0|100|DKK|7601|11377|lyfalmen|||1|3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7601||7601|11377||1
109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól|||||||1
109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1
109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|407|1536|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||407||407|1536|31.10.2012|1
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2
110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|523|1694|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||523||523|1694||2
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5
110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1551|3101|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1551||1551|3101||1
110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|B|0|ORC|0|0|0|100|DKK|3966|6404|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3966||3966|6404||1
110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|113667|144535|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||113667||113667|144535||1
111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|5924|7378|lyfalmen|V0373|7378|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4678||4678|7378||2
111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|755|2012|lyfalmen|||1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||755||755|2012||1
112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|21914|30047|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||21914||21914|30047||1
112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|XEU|8289|3843|lyfalmen|V0203|3715|2|12|0|84,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2094||2094|3843||1
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|8572|12705|lyfalmen|V0024|11507|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8572||8572|12705||1
113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|25479|34521|lyfalmen|V0024|34521|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25479||25479|34521||1
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|8683|12857|lyfalmen|V0025|11631|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8683||8683|12857||1
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|3930|6355|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3930||3930|6355||1
113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|*|0|NOE|0|0|0|100|DKK|25775|34893|lyfalmen|V0025|34893|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25775||25775|34893||1
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|6733|10189|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6733||6733|10189||1
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|671396|844484|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||671396||671396|844484||1
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|750|2005|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||750||750|2005||1
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|953|2283|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||953||953|2283||1
113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1454|2968|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1454||1454|2968||1
114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|999|2345|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||999||999|2345||1
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|52974|68365|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||52974||52974|68365||2
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|E|0|MSD|0|0|1|100|DKK|4163|6674|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4163||4163|6674||1
114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|2375|4228|lyfalmen|V0373|2459|1|5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2375||2375|4228||1
114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2233|4034|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2233||2233|4034||2
114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|6503|9875|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6503||6503|9875||2
115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|1919|3604|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1919||1919|3604||1
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226||1
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1638|3220|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1638||1638|3220||1
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|11510|16724|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11510||11510|16724||1
115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|1919|3604|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1919||1919|3604||1
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|11510|16724|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11510||11510|16724||1
115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|1911|3593|lyfalmen|V0369|2997|1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1911||1911|3593||1
115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|3888|6297|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3888||3888|6297||1
115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|55|0||Icepharma hf|Norpharma |Malatíón|||||||2
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|3904|5634|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3904||3904|5634||1
116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|2041|2946|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2041||2041|2946||1
116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|545|1724|lyfalmen|V0056|1724|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||545||545|1724||2
116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|B|0|BLP|0|0|0|100|IKR|830|2114|lyfalmen|V0057|2114|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||830||830|2114||2
116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||||2
116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2618|4560|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2618||2618|4560||1
116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|3008|5094|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Mómetasón||3008||3008|5094||1
116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|765|2025|lyfalmen|V0562|2023|2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||765||765|2025||1
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|368|1482|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||368||368|1482|31.10.2012|1
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|928|2248|lyfalmen|V0564|2247|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||928||928|2248||1
116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|17841|24936|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17841||17841|24936||1
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7620|10879|lyfalmen|V0081|10879|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||7237||7237|10879||1
116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|6080|9296|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6080||6080|9296||1
116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|6529|9910|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6529||6529|9910||1
116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|E|0|IPI|0|0|0|100|DKK|19274|26734|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||19274||19274|26734||1
116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|0|1|0|0|0|0|IPI|0|0|0|100|DKK|8316|12355|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8316||8316|12355||1
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX00|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|11019|21331|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|||11019||11019|21331||2
117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|3380|5603|lyfalmen|||1|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3380||3380|5603||1
117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|4568|7228|lyfalmen|V0435|7122|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4568||4568|7228||2
117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|15462|21950|lyfalmen|||1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||15462|21950||1
117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|27327|36841|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||27327|36841||1
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|1619|3194|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1619||1619|3194||2
117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|4725|7442|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4725|7442||1
117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|47253|61848|lyfalmen|||1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||47253|61848||1
117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|54655|71137|lyfalmen|||1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||54655|71137||1
117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|69539|89154|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||69539||69539|89154||1
117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9794|17085|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||9794||9794|17085||2
117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|2464|4350|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||2464|4350||2
117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|5891|9037|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||5891|9037||2
117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|8819|13043|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||8819|13043||2
117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|7697|14952|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|||7697||7697|14952||2
117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|13499|26093|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|||13499||13499|26093||2
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|4031|1846|lyfalmen|V0278|1846|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||634||634|1846||1
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|5729|2434|lyfalmen|V0279|2434|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1064||1064|2434||1
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|22219|6895|lyfalmen|V0282|6504|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4325||4325|6895||1
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|16974|8433|lyfalmen|V0283|7921|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5449||5449|8433||1
118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2325|4159|lyfalmen|||1|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2325||2325|4159||1
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728||5
118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1
118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|ţpakki||A02BA02|01.04.1994|31.08.2012|R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|932|2254|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||932||932|2254||1
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|17468|8362|lyfalmen|V0280|7921|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5397||5397|8362||1
118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|7589|11360|lyfalmen|V0015|10596|1|50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7589||7589|11360||1
118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|B|0|FER|0|0|0|100|DKK|23300|31787|lyfalmen|V0015|31787|1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||23300||23300|31787||1
118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|2883|4923|lyfalmen|V0276|4923|3|100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||2883||2883|4923||3
118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|1|0|0|0|*|0|LVR|0|0|0|100|DKK|9358|13780|lyfalmen|V0277|13780|3|100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9358||9358|13780||3
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|1|0|0|0|B|0|AEG|0|0|0|100|XEU|493|1653|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||493||493|1653||1
119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|0|1|0|1|0|1|AEU|0|0|0|100|DKK|77951|99711|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||77951||77951|99711||1
119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|0|0|0|0|0|0|KRK|0|0|1|100|XEU|972|2058|lyfalmen|V0309|2058|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||789||789|2058||2
119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||||2
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|0|0|100|GBP|466304|587094|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||466304||466304|587094||1
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|0|0|100|GBP|466304|587094|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||466304||466304|587094||1
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|E|0|SAL|0|0|0|100|USD|991|2335|lyfalmen|||1|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||991||991|2335||1
120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|0|0|100|XEU|48573|62842|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||48573||48573|62842||2
120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012||L|1|0|0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen|||||||1
120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|32030|42080|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||32030||32030|42080||1
120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008||R|1|0|0|0|0|0|LVR|0|0|0|100|DKK|17959|25084|lyfalmen|V0253|7471|3|100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||17959||17959|25084||3
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|5881|9024|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5881||5881|9024||1
121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|9556|13792|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||9556||9556|13792||1
121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|467|1618|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||467||467|1618||1
121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|8128|5155|lyfalmen|V0011|5012|2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5155||2
121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|1|0|0|0|E|0|AUK|0|0|1|100|GBP|427|1559|lyfalmen|V0391|1556|2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||424||424|1559||1
121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|1775|3407|lyfalmen|V0314|2343|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1775||1775|3407||1
121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|285|1369|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||285||285|1369||1
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|IKR|9600|16747|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9600||9600|16747||1
122577|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|0|0|0|0|E|0|BMM|0|0|0|100|XEU|3149|4734|lyfalmen|V0381|4734|2|10|0|2,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2745||2745|4734||2
122588|A04AA0105|Ondansetron BMM Pharma|filmhtfl|4|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|15536|19444|lyfalmen|||2|50|0|12,5000|LYFIS ehf|BMM Pharma AB|Ondansetrón||13465||13465|19444||2
122610|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|0|0|0|0|E|0|BMM|0|0|0|100|XEU|3596|4734|lyfalmen|V0384|4676|2|10|0|5,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||2745||2745|4734||2
122643|A04AA0105|Ondansetron BMM Pharma|filmhtfl|8|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|E|0|BMM|0|0|0|100|XEU|15536|19444|lyfalmen|||2|50|0|25,0000|LYFIS ehf|BMM Pharma AB|Ondansetrón||13465||13465|19444||2
123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|845|2135|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||845||845|2135||1
123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1140|2538|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1140||1140|2538||1
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|27200|47449|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||27200||27200|47449||2
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|247|1317|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||247|1317||1
123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|0|0|0|0|B|0|BLP|0|0|0|100|XEU|2324|3232|lyfalmen|V0317|3232|2|100|0|50,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1647||1647|3232||2
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|1|0|0|0|E|0|AVS|0|0|0|100|NOK|47779|62508|lyfalmen|V0579|57788|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||47779||47779|62508||1
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1838|3656|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1838|3656||2
124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|39879|52593|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||39879|52593||1
124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|XEU|1927|2255|lyfalmen|V0234|2246|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||933||933|2255||2
124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|E|0|BLP|0|0|0|100|XEU|2753|2790|lyfalmen|V0233|2790|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1324||1324|2790||2
124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|1008|2358|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1008||1008|2358||1
124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|516|1685|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||516||516|1685||1
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|10630|15520|lyfalmen|V0464|15520|0|7,5|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||10630||10630|15520||1
124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|1283|1852|lyfsjukr|||1|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1283||1283|1852||1
125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|848|1607|lyfalmen|V0066|1607|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||459||459|1607||1
125973|D01BA0205|Terbinafin BMM Pharma|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|0|0|0|0|0|0|BMM|0|0|0|100|XEU|2502|3261|lyfalmen|V0123|3261|2|28|0|28,0000|LYFIS ehf|BMM Pharma AB|Terbínafín||1668||1668|3261||2
126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1
126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|118721|150877|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||118721|150877||1
126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|30468|40120|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||30468|40120||1
126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|INN|0|0|0|100|XEU|25581|33987|lyfsjukr|||1|1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||25581||25581|33987||2
126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|INN|0|0|0|100|XEU|8526|12305|lyfsjukr|||1|1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8526||8526|12305||2
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|49107|63512|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||49107||49107|63512||2
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|98240|125174|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||98240||98240|125174||2
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|0|0|100|SEK|196411|248378|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||196411||196411|248378||2
126926|B01AX0601 |Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|39700|52369|lyfalmen|V0031|52369|1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||39700|52369||2
126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|1|0|0|0|E|0|MCS|0|0|0|100|SEK|1079|2455|lyfalmen|V0447|2101|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1079||1079|2455||1
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|8793|6248|lyfalmen|V0279|2434|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3852||3852|6248||2
128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|12385|23954|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíđar í blöndu međ öđrum lyfjum||12385||12385|23954||1
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|E|0|LEP|0|0|0|100|DKK|1241|2677|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1241||1241|2677||1
128777|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.07.1988||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1
128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4156|5998|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||4156||4156|5998||2
129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|31701|30306|lyfalmen|V0280|7921|1|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22120||22120|30306||2
129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|*|0|ELD|0|0|0|100|XEU|34455|23362|lyfalmen|V0282|6504|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16587||16587|23362||2
129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|1|0|0|0|B|0|AUK|0|0|1|100|GBP|239|1306|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||239||239|1306||1
129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3309||1
129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|B|0|BOI|0|0|0|100|DKK|4412|7014|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4412||4412|7014||1
130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|19343|23727|lyfalmen|V0285|11663|1|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16878||16878|23727||1
130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|30619|36077|lyfalmen|V0286|23290|1|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||26719||26719|36077||1
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2432|4306|lyfalmen|||2|10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2432||2432|4306||1
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|14084|27216|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||14084||14084|27216||1
130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|4027|6488|lyfalmen|||2|125|0|31,2500|Vistor hf|Nycomed Danmark A/S|Fúrósemíđ||4027||4027|6488||1
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1901|3579|lyfalmen|||2|10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1901||1901|3579||1
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|11459|16654|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11459|16654||1
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|67456|110054|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||67456|110054||1
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|3485|5746|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3485|5746||1
131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|491|1651|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||491||491|1651||1
131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|774|2038|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||774||774|2038||1
131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1032|2391|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||1032||1032|2391||1
131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1142|2541|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||1142||1142|2541||1
131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|1|0|0|0|E|0|LVR|0|0|0|100|XEU|2633|2939|lyfalmen|V0009|1869|3|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||1433||1433|2939||3
131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|5884|9028|lyfalmen|V0132|9028|1|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5884||5884|9028||1
131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|3960|6396|lyfalmen|V0032|5742|1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||3960||3960|6396||2
131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|11878|17227|lyfalmen|V0032|17227|1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||11878||11878|17227||2
131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|39436|52037|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||39436||39436|52037||2
132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|ţpakki||N06AA09|01.04.2008|31.08.2012|R|1|0|0|0|B|0|AUK|0|0|0|100|GBP|264|1258|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||204||204|1258||1
132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|E|0|POF|0|0|0|100|SEK|8318|11111|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7407||7407|11111||2
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9346|4058|lyfalmen|V0581|3359|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2251||2251|4058||1
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7490|4058|lyfalmen|V0580|3359|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2251||2251|4058||1
132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|E|0|REP|0|0|1|100|SEK|1544|3091|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1544||1544|3091||1
132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|8083|12036|lyfalmen|||1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||8083||8083|12036||1
132761|D08AG0201|Betadine|húđlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAL|0|0|0|100|USD|1130|2525|lyfalmen|||1|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1130||1130|2525||1
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1
132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1438|2946|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1438||1438|2946||1
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|29401|38781|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||29401||29401|38781||1
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|39109|50964|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||39109||39109|50964||1
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|51101|66014|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||51101|66014||1
133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|50|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993|30.09.2012|R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|8214|12215|lyfalmen|||0|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8214||8214|12215||2
134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008|31.10.2012|R|1|0|0|0|0|1|DAC|0|0|0|100|DKK|89738|114504|lyfsjukr|||3|14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||89738||89738|114504||2
134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|0|0|0|0|0|0|ABS|0|0|1|100|DKK|1524|3064|lyfalmen|||1|50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1524||1524|3064||1
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|4030|6492|lyfalmen|V0378|5901|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||4030||4030|6492||2
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|12079|17704|lyfalmen|V0378|17704|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||12079||12079|17704||2
134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4759|6868|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4759||4759|6868||1
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|70688|90596|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||70688||70688|90596||1
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSI|0|0|0|100|DKK|130975|166256|lyfsjukr|||1|30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||130975||130975|166256||3
135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|53242|68701|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||53242||53242|68701||1
135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|B|0|ADG|0|0|0|100|XEU|2143|3910|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2143||2143|3910||1
135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1051|2417|lyfalmen|||2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1051||1051|2417||1
135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2350|4194|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2350||2350|4194||1
136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1731|3347|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1731||1731|3347||1
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|7212|10845|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||7212||7212|10845||1
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|74359|95203|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||74359||74359|95203||1
136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|0|0|0|0|0|0|KRK|0|0|1|100|XEU|462|1480|lyfalmen|V0307|1480|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||366||366|1480||2
136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|SEK|2360|3406|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2360||2360|3406||2
136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|SEK|7391|10667|lyfsjukr|||2|16,7|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7391||7391|10667||2
136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|SEK|5447|7861|lyfsjukr|||2|25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5447||5447|7861||2
136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|SEK|8491|12255|lyfsjukr|||2|50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8491||8491|12255||2
137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5970|8616|lyfsjukr|||2|20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||5970||5970|8616||2
137513|S01XA2011|Oculac|augndr|||10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|0|0|0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1679||1
137521|S01XA2011|Oculac|augndr|||0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|0|0|0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||2061||1
137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|SEK|21723|29145|lyfsjukr|||2|25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||21723||21723|29145||2
137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|6315|9114|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6315||6315|9114||2
137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|XEU|10602|15188|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||10602||10602|15188||2
137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|MAY|0|0|0|100|SEK|6234|8997|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6234||6234|8997||2
137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|748|1080|lyfsjukr|||2|500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||748||748|1080||2
138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|DKK|1518|2191|lyfsjukr|||2|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1518||1518|2191||2
138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1704|3310|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1704||1704|3310||2
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|4745|7378|lyfalmen|V0373|7378|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4678||4678|7378||1
139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||||1
140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|137512|174460|lyfsjukr|||1|20|0||Vistor hf|N.V. Organon|Sugammadex||137512||137512|174460||1
140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|343669|433187|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Sugammadex||343669||343669|433187||1
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|1456|2971|lyfalmen|V0266|1304|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1456||1456|2971||1
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|11781|16668|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11781||11781|16668||1
140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|DES|0|0|0|100|DKK|638|921|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||638||638|921||3
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|1|0|0|100|NOK|97718|187806|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||97718||97718|187806||1
140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1244|2681|lyfalmen|V0413|2397|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1244||1244|2681||1
141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|0|0|0|0|0|1|DAC|0|0|0|100|DKK|4435|6229|lyfsjukr|||3|1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4316||4316|6229||2
141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008|31.10.2012|R|0|0|0|0|0|1|DAC|0|0|0|100|DKK|19681|26582|lyfsjukr|||3|1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||19681||19681|26582||2
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3862|5574|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3862||3862|5574||2
141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|2753|4745|lyfalmen|||1|30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2753||2753|4745||1
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|21104|29031|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||21104||21104|29031||2
141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5004|7824|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||||5004|7824||2
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|8628|12782|lyfalmen|V0267|2574|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8628||8628|12782||1
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2791|3676|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1972||1972|3676||1
142203|QS02QA0301|Otimectin vet.|eyrnahl|1|mg/g|10|g|1|túpa|fyrir ketti|QS02QA03|01.10.2012||L|0|0|0|0|0|0|LEV|1|0|0|100|XEU|1667|2908|vetorma|||0|10|0||Le Vet B.V.|Le Vet B.V.|Ivermectinum||||1667|2908||2
142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3424|4942|lyfsjukr|||1|30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3424||3424|4942||1
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1122|2514|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1122||1122|2514||1
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2995|5076|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2995||2995|5076||1
143139|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1447|2958|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1447||1447|2958||1
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2273|3281|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2273||2273|3281||1
143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|3989|6436|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3989||3989|6436||1
143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|glas||C07AB03|01.10.2012||R|0|0|0|0|B|0|AGP|0|0|0|100|XEU|588|1670|lyfalmen|V0542|1666|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||505||505|1670||1
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAL|0|0|0|100|USD|933|2255|lyfalmen|||1|15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||933||933|2255||1
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1477|2999|lyfalmen|||1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1477||1477|2999||1
143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|1|0|0|0|E|0|BOI|0|0|0|100|DKK|1331|2800|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1331||1331|2800||1
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|*|0|MSD|0|0|0|100|DKK|8446|12533|lyfalmen|V0386|9540|1|56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8446||8446|12533||1
143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|608|1811|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||608||608|1811||1
143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|*|0|AGT|0|0|0|100|DKK|1206|2629|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1206||1206|2629||1
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2030|3756|lyfalmen|V0174|3756|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2030||2030|3756||1
144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|E|0|MSD|0|0|0|100|DKK|2094|3843|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2094||2094|3843||1
144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|23018|31433|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23018||23018|31433||1
144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|80836|103332|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||80836||80836|103332||1
144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|60417|77706|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||60417||60417|77706||1
144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|0|0|100|DKK|37539|48994|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||37539||37539|48994||1
144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|656|1876|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||656||656|1876||1
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|85482|109162|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||85482||85482|109162||1
145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2224|4021|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2224||2224|4021||1
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Recip AB|Pýrvín|||||||1
145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|ţpakki||P02CX01|01.01.1995|30.09.2012|L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|32|0||Vistor hf|Recip AB|Pýrvín|||||||1
145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|20624|20086|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||13977||13977|20086||2
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|32134|42211|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||32134||32134|42211||1
146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|3049|4400|lyfsjukr|||2|2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||3049||3049|4400||2
146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|6195|8941|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||6195||6195|8941||2
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|18053|25202|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18053||18053|25202||2
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|913|2228|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||913||913|2228||1
147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2529|3650|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2529||2529|3650||2
147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1567|2262|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1567||1567|2262||2
147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012||L|0|0|0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól|||||||3
148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|113315|144755|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||113315||113315|144755||2
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1212|2637|lyfalmen|V0577|2637|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||1212||1212|2637||2
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1803|3445|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1803||1803|3445||2
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|6461|9817|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||6461||6461|9817||2
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|BLT|0|0|0|100|DKK|83629|107500|lyfalmen|||1|30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||83629||83629|107500||1
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|BLT|0|0|0|100|DKK|83629|107500|lyfalmen|||1|30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||83629||83629|107500||1
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|1|0|0|0|*|0|LFS|0|0|0|100|DKK|856|2150|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||856||856|2150||1
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814||5
148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|HOP|0|0|0|100|SEK|6579|9495|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6579||6579|9495||2
148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|HOP|0|0|0|100|SEK|13792|19191|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13792||13792|19191||2
148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|HOS|0|0|0|100|SEK|29504|38910|lyfsjukr|||1|1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||29504||29504|38910||2
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3649|7179|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3649||3649|7179||2
149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|2195|3982|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2195||2195|3982||1
149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|2184|2594|lyfalmen|V0376|2184|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1181||1181|2594||2
150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993|31.08.2012|R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|16026|22658|lyfalmen|||0|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16026||16026|22658||2
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|52672|67986|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||52672|67986||1
150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|3805|6184|lyfalmen|||1|28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||3805|6184||1
150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|0|0|0|0|0|0|MSD|0|0|0|100|DKK|6312|9613|lyfalmen|V0120|7546|1|56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6312|9613||1
150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3810|6191|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3810|6191||1
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|6597|10003|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6597||6597|10003||1
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1231|2663|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1231||1231|2663||1
151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|16020|22650|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||16020|22650||1
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|E|0|LBK|0|0|0|100|DKK|49465|61667|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||47109||47109|61667||1
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|5309|8241|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5309||5309|8241||2
151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|5589|4102|lyfalmen|V0148|4051|2|90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2283||2283|4102||1
151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1582|3143|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1582||1582|3143||1
151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|E|0|RAT|0|0|0|100|IKR|2310|4139|lyfalmen|V0006|4139|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2310||2310|4139||2
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|2018|2912|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2018||2018|2912||1
152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|DAC|0|0|0|100|XEU|2603|3515|lyfalmen|V0123|3261|3|28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||1854||1854|3515||2
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1
152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4076|6555|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4076||4076|6555||1
152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|5957|9128|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5957||5957|9128||1
152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|B|0|ASZ|0|0|0|100|SEK|10930|15931|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10930||10930|15931||1
152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1
152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|18951|9675|lyfalmen|V0269|9675|3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||6357||6357|9675||2
152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1302|2760|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1302||1302|2760||1
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1865|3530|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1865||1865|3530||1
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|40003|52086|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||40003|52086||1
153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2355|4200|lyfalmen|V0561|3771|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2355||2355|4200||1
153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1647|3232|lyfalmen|V0560|2932|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1647||1647|3232||1
153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|2305|3356|lyfalmen|V0575|3214|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||1738||1738|3356||1
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GIS|0|0|0|100|DKK|230185|290765|lyfsjukr|||1|10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||230185||230185|290765||3
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|B|0|AGT|0|0|0|100|XEU|549|1730|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||549|1730||1
153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|35375|46941|lyfalmen|V0452|46941|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||35375||35375|46941||1
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4496|7129|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4496||4496|7129||1
153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|323|1421|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||323||323|1421||1
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|535|1711|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||535||535|1711||1
153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010|31.10.2012|R|0|0|0|0|E|0|SHS|0|0|1|100|DKK|1526|3066|lyfalmen|||1|1|0|50,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||1526||1526|3066||1
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|9478|13944|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9478||9478|13944||1
154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1063|2433|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1063||1063|2433||1
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29335|38698|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||29335||29335|38698||2
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|38433|50116|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38433||38433|50116||2
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|42227|54877|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||42227||42227|54877||2
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31254|41106|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||31254||31254|41106||2
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|38446|50132|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||38446||38446|50132||2
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27542|36448|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||27542||27542|36448||2
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|3814|6196|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3814||3814|6196||1
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|35912|46952|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||35912||35912|46952||2
154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1535|3079|lyfalmen|V0259|3079|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1535||1535|3079||1
154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|7706|11520|lyfalmen|V0550|7728|1|90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7706||7706|11520||1
154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|4364|6099|lyfalmen|V0334|5904|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3743||3743|6099||1
154750|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009|31.08.2012|R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2373|2452|lyfalmen|||2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1077||1077|2452||1
154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|B|0|AGP|0|0|0|100|XEU|7004|6099|lyfalmen|V0335|5904|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3743||3743|6099||1
154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|0|1|0|1|0|0|INT|0|0|0|100|DKK|452727|570718|lyfalmen|||1|252|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||452727||452727|570718||1
155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|*|0|APT|0|0|0|100|XEU|1585|3147|lyfalmen|||1|25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Chlorambucíl||1585||1585|3147||1
155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|2231|4020|lyfalmen|V0247|4020|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2223||2223|4020||2
155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|3760|6117|lyfalmen|V0248|6117|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3756||3756|6117||2
155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|E|0|POF|0|0|0|100|XEU|6760|10222|lyfalmen|V0249|10222|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6757||6757|10222||2
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|1531|3073|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1531||1531|3073||1
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|656|1876|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||656||656|1876||1
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|7020|10582|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||7020||7020|10582||1
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|5907|9059|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5907||5907|9059||2
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|5957|9128|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5957||5957|9128||2
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|452|1597|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||452||452|1597||1
156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2370|3421|lyfsjukr|||2|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2370||2370|3421||2
156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1389|2005|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1389||1389|2005||2
156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6492|9370|lyfsjukr|||2|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6492||6492|9370||2
156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|9524|14007|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||9524||9524|14007||2
156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|8695|12549|lyfsjukr|||2|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8695||8695|12549||2
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|907|2220|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||907||907|2220||1
156861|QJ01MA9002|Enrotron Flavour|töflur|50|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1898|3775|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||1898||1898|3775||2
157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|7338|12801|vetorma|||0|260|0||Icepharma hf|Pfizer Oy Animal Health|||7338||7338|12801||2
157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|2737|2434|lyfalmen|V0279|2434|2|28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||1064||1064|2434||1
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|1534|3077|lyfalmen|V0239|3077|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1534||1534|3077||1
158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1644|3228|lyfalmen|||1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1644|3228||1
158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|30291|40560|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||30291|40560||1
158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|957|2288|lyfalmen|V0239|1539|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||957||957|2288||1
158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|104104|132533|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||104104|132533||1
158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|208210|263186|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||208210|263186||1
158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|590374|742802|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||590374|742802||1
158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|53278|68746|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||53278|68746||1
158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|76003|97266|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||76003||76003|97266||1
158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|0|0|0|0|E|0|DES|0|0|0|100|DKK|825|2107|lyfalmen|||1|5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||825||825|2107||3
158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|1074|2448|lyfalmen|V0469|2448|2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1074|2448||1
159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|3400|5630|lyfalmen|V0219|5630|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3400||3400|5630||1
159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|5853|8986|lyfalmen|V0220|8986|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5853||5853|8986||1
159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|7593|11366|lyfalmen|V0221|11366|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7593||7593|11366||1
159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|E|0|AGP|0|0|0|100|XEU|8847|13081|lyfalmen|V0223|13081|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||8847||8847|13081||1
159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|ţpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|3218|3359|lyfalmen|V0581|3359|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1740||1740|3359||2
159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5220|4696|lyfalmen|V0318|1810|1|56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2717||2717|4696||1
159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|20434|28190|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||20434||20434|28190||1
159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13385|12427|lyfalmen|V0320|3309|1|56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8369||8369|12427||1
159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|1893|2656|lyfalmen|V0062|1694|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1226||1226|2656||1
159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3277|3720|lyfalmen|V0067|1562|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2004||2004|3720||1
159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6752|4940|lyfalmen|V0071|2164|1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2896||2896|4940||1
159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|E|0|MYL|0|0|1|100|SEK|550|1731|lyfalmen|||2|25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||550||550|1731||1
159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|E|0|MYL|0|0|1|100|SEK|1669|3262|lyfalmen|||2|100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1669||1669|3262||1
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|101479|129239|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||101479||101479|129239||1
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4239|8312|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4239||4239|8312||2
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|2078|2939|lyfalmen|V0010|2937|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1433||1433|2939||1
160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2288|3302|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2288||2288|3302||1
160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37989|49559|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||37989||37989|49559||2
160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|55313|71300|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||55313||55313|71300||2
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|1042|2404|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1042||1042|2404||1
160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|2384|4240|lyfalmen|||1|50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2384||2384|4240||1
160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|73791|94490|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||73791||73791|94490||2
160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|E|0|BOI|0|0|1|100|DKK|1211|2635|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1211||1211|2635||1
161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|78554|100468|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||78554||78554|100468||1
161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|598|1797|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||598||598|1797||1
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|928|1339|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||928||928|1339||1
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|843|1217|lyfsjukr|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||843||843|1217||1
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|611|1815|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||611||611|1815||1
161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|5228|8131|lyfalmen|V0131|8131|1|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5228||5228|8131||1
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|60772|78814|lyfalmen|V0452|46941|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||60772||60772|78814||1
161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|14321|19744|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14232||14232|19744||1
162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|160150|202871|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||160150||160150|202871||1
162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|785|2053|lyfalmen|V0512|2051|1|100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||785||785|2053||1
162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|437|1577|lyfalmen|V0510|1577|1|100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||437||437|1577||1
162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|550109|692932|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||550109||550109|692932||1
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|1935|3626|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1935||1935|3626||1
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5490|10714|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5490|10714||2
162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.03.2012||R|0|0|0|0|B|0|GUK|0|0|0|100|SEK|2025|3749|lyfalmen|||2|100|0|150,0000|Actavis Group PTC ehf|Generics UK Ltd.|Ísósorbíđ mónónítrat||2025||2025|3749|31.10.2012|1
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|0|0|0|0|*|0|BLP|0|0|0|100|XEU|445|1551|lyfalmen|V0500|1551|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||418||418|1551||2
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|0|0|0|0|*|0|BLP|0|0|0|100|XEU|722|1967|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||722||722|1967||2
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|0|0|0|0|*|0|BLP|0|0|0|100|XEU|890|2196|lyfalmen|||2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||890||890|2196||2
162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|0|0|0|0|E|0|BLP|0|0|0|100|IKR|490|1649|lyfalmen|V0108|1649|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||490||490|1649||2
162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|0|0|0|0|E|0|BLP|0|0|0|100|IKR|590|1786|lyfalmen|V0109|1786|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||590||590|1786||2
162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|0|0|0|0|E|0|BLP|0|0|0|100|IKR|950|2278|lyfalmen|V0110|2278|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||950||950|2278||2
162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|*|0|APC|0|0|0|100|XEU|1655|3173|lyfalmen|V0373|2459|2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1604||1604|3173||1
162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|XEU|4797|4501|lyfalmen|V0148|4501|2|100|0|100,0000|Artasan ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2575||2575|4501||1
162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|2350|4194|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2350||2350|4194||1
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|NOH|0|0|0|100|DKK|1155|2559|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1155||1155|2559||1
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1756|3381|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1756||1756|3381||1
163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|1|0|0|0|E|0|AEA|0|0|0|100|XEU|205|1259|lyfalmen|||2|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||205|1259||1
163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|3474|5064|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2986||2986|5064||1
163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|8140|12114|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12114||1
164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|363092|457563|lyfsjukr|||1|42|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||363092||363092|457563||1
164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|0|0|0|0|*|0|APT|0|0|0|100|XEU|3492|5756|lyfalmen|||1|25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Merkaptópúrín||3492||3492|5756||1
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3916|5652|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3916||3916|5652||2
164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|3134|5266|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3134|5266||1
164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|E|0|MYL|0|0|0|100|SEK|10332|15113|lyfalmen|||2|100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||10332||10332|15113||1
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1081|2458|lyfalmen|||2|100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1081||1081|2458||1
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|997|2343|lyfalmen|V0314|2343|2|100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||997|2343||1
164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|B|0|TIL|0|0|0|100|DKK|7784|11627|lyfalmen|V0014|11552|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7784||7784|11627||2
165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1
165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|845|2135|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||845||845|2135||1
165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6984|13583|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||6984||6984|13583||2
165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|5303|8233|lyfalmen|V0059|3970|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5303||5303|8233||1
165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3423|5661|lyfalmen|V0058|2859|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3423||3423|5661||1
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|278678|351623|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||278678||278678|351623||2
165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37989|49559|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||37989||37989|49559||2
165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|55313|71300|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||55313||55313|71300||2
165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|E|0|UCN|0|0|1|100|SEK|734|1983|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||734||734|1983||1
165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|E|0|UCN|0|0|1|100|SEK|212|1269|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||212||212|1269||1
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1
165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|E|0|MED|0|0|0|100|XEU|24593|13493|lyfalmen|V0341|13493|2|98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||9148||9148|13493||2
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4138|5972|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4138||4138|5972||2
165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|73791|94490|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||73791||73791|94490||2
165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|250141|315809|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||250141||250141|315809||2
166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4723|9241|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4723|9241||1
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1983|3692|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1983||1983|3692||1
166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|E|0|PER|0|0|0|100|DKK|15336|21792|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15336||15336|21792||1
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|2322|4155|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2322||2322|4155||1
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|4396|6992|lyfalmen|V0428|6992|2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4396||4396|6992||1
166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|1|0|0|0|E|0|RAN|0|0|0|100|XEU|4934|7728|lyfalmen|V0550|7728|2|90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||4934||4934|7728||1
166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|0|1|0|1|E|0|IPI|0|0|0|100|DKK|131963|168159|lyfalmen|||1|1|0||Icepharma hf|Pfizer Limited|Clostridíum||131963||131963|168159||1
166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1
167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|454|1600|lyfalmen|V0333|1600|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||454||454|1600||1
168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|1|0|0|0|E|0|AUK|0|0|0|100|GBP|654|1874|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||654|1874||1
168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|IKR|4452|5144|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3045||3045|5144||1
168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|3081|5194|lyfalmen|V0240|5192|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3081||3081|5194||1
168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|5686|8757|lyfalmen|V0433|8754|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5686||5686|8757||1
168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|56459|72739|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||56459||56459|72739||1
169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|245472|309950|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||245472||245472|309950||1
169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|21902|29370|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||21902||21902|29370||2
169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5599|8638|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5599||5599|8638||1
169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|C|0|POF|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827|2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2827||2
169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|C|0|POF|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196|2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4196||2
169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2577||2
169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1864||2
169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1852||2
169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1517||2
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3089|5204|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3089||3089|5204||1
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3325|5527|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3325||3325|5527||1
170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|24519|32654|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||24519|32654||2
170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|60853|78253|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||60853|78253||2
170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6019|9213|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||6019||6019|9213||1
170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|115026|146240|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||115026||115026|146240||2
170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.07.2012||R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|16195|22870|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16195||16195|22870||2
170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|1|0|0|1|B|0|ABS|0|0|0|100|DKK|3937|6365|lyfalmen|||1|100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3937||3937|6365||1
170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|1|0|0|1|B|0|ABS|0|0|0|100|DKK|6891|10405|lyfalmen|||1|100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6891||6891|10405||1
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2527|4436|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2527||2527|4436||1
170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|11550|16378|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11550||11550|16378||1
170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|27784|36751|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||27784||27784|36751||1
170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|41676|54186|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||41676||41676|54186||1
170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|1|0|0|0|E|0|AGP|0|0|0|100|XEU|3392|3715|lyfalmen|V0203|3715|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2000||2000|3715||1
170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|12363|2689|lyfalmen|V0207|2689|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||1250||1250|2689||2
170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|0|0|100|XEU|58171|74887|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||58171||58171|74887||2
171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|1|0|0|100|DKK|2764|5480|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2764||2764|5480||1
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3829|6217|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3829||3829|6217||1
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4125|6622|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||4125||4125|6622||1
171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|0|0|0|0|0|0|LDR|0|0|0|100|NOK|1630|3209|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1630||1630|3209||2
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|4674|7373|lyfalmen|V0247|4020|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4674||4674|7373||1
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|7694|11504|lyfalmen|V0248|6117|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7694||7694|11504||1
171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BAP|0|0|0|100|DKK|45213|58625|lyfsjukr|||1|75|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||45213||45213|58625||2
172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BAP|0|0|0|100|DKK|30143|39712|lyfsjukr|||1|50|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||30143||30143|39712||2
172249|QJ01MA9002|Enrotron Flavour|töflur|150|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|3289|6488|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||3289||3289|6488||2
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|13895|19983|lyfalmen|V0249|10222|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13895||13895|19983||1
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|E|0|JAS|0|0|0|100|SEK|26077|35272|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||26077||26077|35272||1
172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BAP|0|0|0|100|DKK|69327|88888|lyfsjukr|||1|100|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||69327||69327|88888||2
172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|30321|30146|lyfalmen|V0346|30146|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||21993||21993|30146||2
172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|0|0|0|1|*|0|APT|0|0|0|100|XEU|3527|5804|lyfalmen|||1|100|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Búsúlfan||3527||3527|5804||1
172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|12165|17812|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||12165||12165|17812||1
172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|6422|9764|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6422||6422|9764||2
172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|11931|17300|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11931||11931|17300||2
172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|20699|28522|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||20699||20699|28522||2
172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|1|0|0|0|0|0|LVR|0|0|0|100|IKR|830|2114|lyfalmen|V0207|896|3|4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2114||3
172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|617923|778039|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||617923||617923|778039||1
172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|26994|36423|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||26994||26994|36423||2
173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|DKK|433|1571|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||433||433|1571||1
173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|3638|5956|lyfalmen|||2|100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||3638||3638|5956||1
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3599||1
173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|6436|9783|lyfalmen|||2|100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6436||6436|9783||1
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|16772|22802|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16669||16669|22802||1
173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|369|1484|lyfalmen|||2|30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||369||369|1484||1
173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|16016|21983|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||16016||16016|21983||1
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1528|2205|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1528||1528|2205||1
174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|706|1945|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||706||706|1945||1
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|722|1967|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||722||722|1967||1
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|1864|3529|lyfalmen|V0368|2819|1|5|0|25,0000|Vistor hf|Allergan|Brímónidín||1864||1864|3529||1
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|*|0|ALL|0|0|0|100|SEK|5467|8457|lyfalmen|V0368|8457|1|15|0|75,0000|Vistor hf|Allergan|Brímónidín||5467||5467|8457||1
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|2662|2280|lyfalmen|V0033|2117|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||951||951|2280||1
175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5
176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6699|5002|lyfalmen|V0278|1846|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2941||2941|5002||2
176616|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2785|4789|lyfalmen|V0574|4789|2|30|0|30,0000|Nycomed Danmark ApS|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2785||2785|4789||1
177716|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.09.2012|30.09.2012|R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2602|4538|lyfalmen|||1|30|0|30,0000|Nycomed Danmark ApS|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2602||2602|4538||1
178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|1968|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1968||1
178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|0|0|0|0|B|0|BLP|0|0|0|100|XEU|5438|5909|lyfalmen|V0320|5909|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||3604||3604|5909||2
179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|168493|213341|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||168493||168493|213341||1
179333|R02AA0304|Strepsils Menthol|sogtfl|||24|stk|1|ţpakki||R02AA03|01.12.2005|31.08.2012|L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|12976|7471|lyfalmen|V0253|7471|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||4746||4746|7471||2
179552|B01AX0601 |Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|11158|16242|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||11158|16242||2
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|131500|166915|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||131500||131500|166915||2
180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|B|0|UCB|0|0|0|100|DKK|5657|8717|lyfalmen|||1|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5657||5657|8717||1
180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|805|2080|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||805||805|2080||1
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|0|0|0|0|0|0|PFV|0|0|0|100|DKK|8124|15772|vetalmen|||0|100|0||Icepharma hf|Pfizer vet.|||8124||8124|15772||2
181750|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|9876|14254|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9876||9876|14254||1
182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|0|0|0|0|0|0|IBV|0|0|0|100|SEK|6144|11970|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||6144||6144|11970||1
182307|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.11.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|13068|18945|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13068||13068|18945||1
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5446|10630|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5446||5446|10630||1
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|B|0|ALK|0|0|1|100|DKK|5847|8977|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5847|8977||1
183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|0|1|0|1|0|1|JCI|0|0|0|100|SEK|1452360|1824594|lyfsjukr|||1|168|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1452360||1452360|1824594||1
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|B|0|BRS|0|0|0|100|DKK|1201|2622|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1201||1201|2622||1
183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|ţpakki||P01AB01|01.10.1995|31.08.2012|R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|848|2139|lyfalmen|||0|21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||848||848|2139||1
184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|494|1655|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||494||494|1655||1
184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1643|2121|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121||1
184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|627|1837|lyfalmen|||2|15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||627||627|1837||1
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|B|0|TIL|0|0|0|100|DKK|5239|8146|lyfalmen|V0017|7392|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5239||5239|8146||2
184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|21949|30091|lyfalmen|V0170|10100|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||21949||21949|30091||1
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|55782|72552|lyfalmen|V0185|22219|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||55782||55782|72552||1
184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1193|2611|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1193||1193|2611||1
184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|E|0|AZA|0|0|0|100|SEK|5572|8601|lyfalmen|V0235|8145|1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5572||5572|8601||1
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|5190|8079|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||5190||5190|8079||1
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|WTE|0|0|0|100|DKK|77959|99721|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||77959||77959|99721||2
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|E|0|DEA|0|0|0|100|XEU|2962|5031|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2962||2962|5031||1
188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|1|0|0|0|*|0|GPL|0|0|0|100|USD|2031|3757|lyfalmen|||1|100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíđ||2031||2031|3757||2
189052|M05BA0604|Iasibon|irţ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|9750|14072|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||9750||9750|14072||2
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|7232|10438|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7232||7232|10438||1
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|2519|4425|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2519||2519|4425||1
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|1037|2397|lyfalmen|V0413|2397|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1037||1037|2397||1
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|B|0|PER|0|0|1|100|DKK|502|1666|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||502||502|1666||1
189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|465|671|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||465||465|671||1
190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|1007|2356|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1007||1007|2356||1
190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|890|2196|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||890||890|2196||1
191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3901|5630|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3901||3901|5630||2
191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3717|5365|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3717||3717|5365||2
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3835|5535|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3835||3835|5535||2
191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|4695|7401|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4695||4695|7401||1
191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|527|1700|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||527||527|1700||1
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|B|0|AGP|0|0|0|100|XEU|3872|6276|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3872||3872|6276||1
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|E|0|LEP|0|0|0|100|DKK|1623|3199|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1623||1623|3199||1
192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|||25|stk|1|glas||C03AB01|01.12.1972|30.09.2012|R|1|0|0|0|E|0|LEP|0|0|0|100|DKK|423|1558|lyfalmen|||1|25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||423||423|1558||1
192826|L01DB0103|Caelyx|irţ|2|mg/ml|25|ml|1|hgl||L01DB01|01.10.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|163849|207513|lyfsjukr|||1|25|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||163849||163849|207513||1
192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|0|0|100|SEK|195247|247580|lyfalmen|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||195247||195247|247580||1
193583|L01XE1801|Jakavi|töflur|5|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|328664|414356|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||328664||328664|414356||1
193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2233||1
194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985|31.10.2012|R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1039|1500|lyfsjukr|||1|2|0||Icepharma hf|Pfizer ApS|Metótrexat||1039||1039|1500||1
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|B|0|MYL|0|0|0|100|SEK|1919|3604|lyfalmen|||2|250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1919||1919|3604||1
195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|2495|4392|lyfalmen|||2|5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2495||2495|4392||1
195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|0|0|0|0|E|0|AGT|0|0|1|100|DKK|793|2064|lyfalmen|||2|1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||793||793|2064||1
195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|13844|7920|lyfalmen|V0012|5012|2|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||5074||5074|7920||2
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|92893|118463|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||92893||92893|118463||2
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|0|0|100|DKK|168493|213341|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||168493||168493|213341||1
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|790|2060|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||790||790|2060||1
195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|405|1533|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||405||405|1533||1
195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|E|0|REP|0|0|1|100|SEK|858|2153|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||858||858|2153||1
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|B|0|MYL|0|0|0|100|SEK|2452|4333|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2452||2452|4333||1
196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|1553|3103|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1553||1553|3103||2
196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|B|0|APT|0|0|0|100|GBP|6170|9419|lyfalmen|||1|100|0|0,8333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||6170||6170|9419||1
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|26838|35564|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||26838|35564||1
197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|2582|5130|vetalmen|||0|10|0||Vistor hf|Intervet International BV|||2582||2582|5130||1
197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|860|2155|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||860||860|2155||1
197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2814|4828|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2814||2814|4828||1
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2269|4083|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2269||2269|4083||1
198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|0|0|0|1|*|0|APT|0|0|0|100|XEU|2131|3894|lyfalmen|||1|25|0||GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Melphalan||||2131|3894||1
198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7203|10396|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||7203||7203|10396||1
198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|0|0|0|0|0|1|LFS|0|0|0|100|DKK|409|590|lyfsjukr|||1|5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||409||409|590||1
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|36197|47972|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||36197||36197|47972||1
199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|8563|5116|lyfalmen|V0515|4832|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3024||3024|5116||1
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|635|1848|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||635||635|1848||1
199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|7641|5012|lyfalmen|V0011|5012|2|98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2948||2948|5012||1
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|94529|120516|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||94529|120516||1
199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|4686|7389|lyfalmen|V0126|7389|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4686||4686|7389||1
199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|56557|72862|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||56557||56557|72862||0
199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|0|0|100|DKK|2746105|3448244|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2746105||2746105|3448244||1
300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5618|8483|lyfalmen|||0|60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5486||5486|8483||1
370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|677|977|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||677||677|977||2
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|31106|59901|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||31106||31106|59901||1
370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|11531|5012|lyfalmen|V0012|5012|2|98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2948||2948|5012||1
370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|NOM|0|0|0|100|DKK|589|850|lyfsjukr|||1|1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||589||589|850||2
371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|E|0|MAB|0|0|1|100|DKK|10326|15104|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||10326||10326|15104||1
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||10348||1
371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|6642|10065|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||6642||6642|10065||1
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|E|0|ROC|0|0|0|100|DKK|3672|6002|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3672||3672|6002||2
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
372283|N06AB1006|Escitalopram Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4922|4604|lyfalmen|V0325|4592|2|100|0|100,0000|Portfarma ehf|Portfarma|Escítalópram||2650||2650|4604||2
373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2518|4423|lyfalmen|||1|66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2518||2518|4423||1
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|19980|27620|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||19980||19980|27620||1
373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|4303|6865|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4303||4303|6865||1
373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|7108|10702|lyfalmen|V0436|10701|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7108||7108|10702||1
373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|9812|14401|lyfalmen|V0437|14400|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9812||9812|14401||1
373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|*|0|MED|0|0|0|100|XEU|7478|7328|lyfalmen|V0420|7328|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||4641||4641|7328||2
373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.10.2012||R|0|0|0|0|B|0|APC|0|0|0|100|XEU|469|1620|lyfalmen|V0541|1619|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||469||469|1620||1
373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|1586|3148|lyfalmen|V0126|1847|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1586||1586|3148||1
374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|0|1|0|1|0|1|AZA|0|0|0|100|SEK|406445|511971|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||406445||406445|511971||1
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|1|0|0|0|*|0|MCK|0|0|0|100|SEK|714|1956|lyfalmen|V0500|1551|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||714||714|1956||2
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5756|8307|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5756||5756|8307||2
374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|E|0|ASP|0|0|0|100|XEU|4624|7304|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4624||4624|7304||1
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|12003|17609|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12003||12003|17609||1
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|9422|13868|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9422||9422|13868||1
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|11182|16275|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11182||11182|16275||1
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|13064|18940|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||13064||13064|18940||1
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|32412|43222|lyfalmen|V0459|43222|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||32412||32412|43222||1
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|20435|28191|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||20435||20435|28191||1
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|93637|120060|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||93637||93637|120060||1
377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|4305|6868|lyfalmen|||1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4305||4305|6868||1
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|11625|9288|lyfalmen|V0182|9140|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6074||6074|9288||1
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|16458|23200|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||16458||16458|23200||1
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|148699|188500|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||148699||148699|188500||1
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|115456|146780|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||115456||115456|146780||1
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|162670|206033|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||162670||162670|206033||1
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|NOH|0|0|0|100|DKK|205959|260361|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||205959||205959|260361||1
379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1516|3053|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1516||1516|3053||1
379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1874|3542|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1874||1874|3542||1
380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|8422|4832|lyfalmen|V0515|4832|2|100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||2817||2817|4832||2
381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|5629|8679|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5629||5629|8679||2
381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|0|0|0|0|0|0|LYF|0|0|0|100|XEU|7659|7496|lyfalmen|V0143|7496|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4764||4764|7496||2
382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5
383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|7297|10961|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7297||7297|10961||1
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1292|2254|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||||1292|2254||2
383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7781|13574|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||7781||7781|13574||2
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1
383933|L01XE1801|Jakavi|töflur|15|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|657315|826813|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||657315||657315|826813||1
386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|0|0|0|0|0|0|LYF|0|0|0|100|XEU|6194|6066|lyfalmen|V0144|6066|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3719||3719|6066||2
386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|*|0|AZA|0|0|0|100|SEK|60253|78163|lyfalmen|V0184|14943|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||60253||60253|78163||1
387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|0|0|0|0|0|0|KRK|0|0|0|100|XEU|933|1994|lyfalmen|V0308|1994|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||742||742|1994||2
387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|0|0|0|0|0|0|ICE|0|0|0|100|XEU|736|1464|vetalmen|||0|100|0||Icepharma hf|Icepharma hf|||736||736|1464||2
387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|0|0|0|0|0|1|CEP|0|0|0|100|DKK|201884|255247|lyfsjukr|||1|200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||201884||201884|255247||1
388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|163971|207666|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||163971||163971|207666||1
388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3469|5724|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3469||3469|5724||1
388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|4372|6960|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4372||4372|6960||1
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1
388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|8484|12585|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||8484||8484|12585||1
388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|807|1575|lyfalmen|V0466|1575|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||436||436|1575||1
389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|E|0|BIP|0|0|0|100|SEK|2939|4999|lyfalmen|V0410|4999|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2939||2939|4999||1
389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|E|0|BIP|0|0|0|100|DKK|2184|3967|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2184||2184|3967||1
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|E|0|BIP|0|0|0|100|SEK|867|2165|lyfalmen|V0128|2165|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||867||867|2165||1
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|E|0|BIP|0|0|0|100|DKK|641|1856|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||641||641|1856||1
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|E|0|NOH|0|0|1|100|DKK|976|2314|lyfalmen|V0367|1763|1|3|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||976||976|2314||1
389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|0|0|0|0|0|0|LYF|0|0|0|100|XEU|2709|3620|lyfalmen|V0143|2499|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1931||1931|3620||2
389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|5255|2574|lyfalmen|V0267|2574|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1166||1166|2574||2
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|60817|78870|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||60817||60817|78870||2
389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|18836|26184|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||18836||18836|26184||1
390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|82694|105663|lyfsjukr|||1|50|0||Vistor hf|Orion Corporation|Dexmedetómid||82694||82694|105663||1
390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|E|0|BRS|0|0|1|100|DKK|2945|5008|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2945||2945|5008||1
390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|*|0|TEV|0|0|0|100|XEU|3064|5170|lyfalmen|V0578|5170|2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||3064||3064|5170||2
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|7056|10631|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7056||7056|10631||1
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|2787|4791|lyfalmen|V0037|4791|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2787||2787|4791||1
391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|E|0|MSE|0|0|0|100|SEK|31625|42235|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||31625||31625|42235||2
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|13598|19611|lyfalmen|V0196|19609|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13598||13598|19611||1
391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2793|4800|lyfalmen|||1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2793||2793|4800||1
392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|250141|315809|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||250141||250141|315809||2
392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|4601|7273|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4601||4601|7273||1
392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|fl||A04AA01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|12000|17605|lyfalmen|||0|50|1|2,5000|Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17605||1
393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|0|0|0|0|*|0|OPF|0|0|0|100|IKR|17620|24658|lyfalmen|V0286|23290|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||17620||17620|24658||2
393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|5667|11054|vetalmen|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||5667||5667|11054||2
393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|4775|4451|lyfalmen|V0327|4451|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2538||2538|4451||2
394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|149917|188855|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||148982||148982|188855||1
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|0|0|LVR|0|0|0|100|SEK|28718|38077|lyfalmen|V0356||3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||28312||28312|38077|31.10.2012|3
395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BAP|0|0|0|100|DKK|180854|228854|lyfsjukr|||1|300|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||180854||180854|228854||2
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|E|0|APS|0|0|1|100|DKK|4084|6566|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4084||4084|6566||1
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|0|0|100|SEK|37946|49505|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||37946||37946|49505||2
397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|9982|14407|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||9982||9982|14407||2
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|57230|73706|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||57230||57230|73706||2
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||||1
398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3287|lyfalmen|V0012|2864|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1687||1687|3287||2
399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|3554|1935|lyfalmen|V0009|1869|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||699||699|1935||2
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|0|0|E|0|GLP|0|0|1|100|SEK|413|1544|lyfalmen|V0225|1508|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||413||413|1544||1
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|1|0|0|0|E|0|GSK|0|0|0|100|IKR|2049|2620|lyfalmen|V0244|2575|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1200||1200|2620||1
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|9098|13425|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9098||9098|13425||1
399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|42371|55058|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||42371||42371|55058||1
399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||||1
399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|115003|146211|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||115003||115003|146211||2
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|E|0|SNO|0|0|1|100|NOK|1564|3118|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1564||1564|3118||1
400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5196|8087|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5196||5196|8087||1
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|225|1287|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||225||225|1287||1
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|409|1538|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||409||409|1538||1
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|195|1246|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||195||195|1246||1
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|E|0|AZA|0|0|0|100|SEK|11198|16297|lyfalmen|V0459|14407|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||11198||11198|16297||1
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|765|2025|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||765||765|2025||1
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|1224|2653|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1224||1224|2653||1
401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1204|2626|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1204||1204|2626||1
401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1932|3622|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1932||1932|3622||1
402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.12.1998||R|0|0|0|0|0|0|AHP|0|0|0|100|XEU|658|1879|lyfalmen|||1|0,5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir  mótefnavakar||658||658|1879||1
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1684|3350|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1684||1684|3350||1
402873|N06DA0302|Exelon (Lyfjaver)|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|E|0|LVR|0|0|0|100|DKK|15221|21647|lyfalmen|V0349|21647|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15221||15221|21647||3
403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|0|0|0|1|*|0|LYF|0|0|0|100|XEU|20801|25478|lyfalmen|V0470|25478|3|100|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||18273||18273|25478||2
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5181|10121|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||5181||5181|10121||1
403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|5917|9073|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||5917||5917|9073||1
403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|37280|48669|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||37280|48669||1
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|E|0|SNO|0|0|0|100|NOK|1492|3020|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1492||1492|3020||1
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1865||2
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|65663|84290|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||65663||65663|84290||1
404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|690|996|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||690||690|996||2
405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|8202|15922|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8202||8202|15922||2
405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1869|3536|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1869||1869|3536||1
405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|19919|27543|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||19919||19919|27543||1
405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|18275|25480|lyfalmen|||1|28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18275||18275|25480||1
406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813||2
406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|20849|28711|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20849||20849|28711||1
406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|22852|31224|lyfalmen|||1|28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22852||22852|31224||1
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|20614|28416|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20614||20614|28416||1
406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901||2
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|62153|80547|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||62153||62153|80547||1
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|72961|94111|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||72961||72961|94111||1
406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|82722|106361|lyfalmen|||1|100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||82722||82722|106361||1
406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|0|0|0|0|0|0|LBK|0|0|0|100|DKK|6308|9608|lyfalmen|||1|30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6308||6308|9608||1
406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|0|0|100|DKK|80077|102379|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||80077||80077|102379||1
407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|0|0|0|0|B|0|LYF|0|0|0|100|XEU|3368|2042|lyfalmen|V0072|2042|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||777||777|2042||2
407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|2286|4106|lyfalmen|||1|100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2286||2286|4106||1
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|169|1210|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||169||169|1210||1
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|367|1481|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||367||367|1481||1
408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|0|0|0|0|0|0|KRK|0|0|0|100|XEU|1973|2820|lyfalmen|V0310|2820|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1346||1346|2820||2
408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2895|4939|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2895||2895|4939||1
408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|2270|4084|lyfalmen|||1|100|0||Vistor hf|Schering-Plough Europe|Betametasón||2270||2270|4084||1
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|4307|6871|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4307||4307|6871||1
409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|3746|6103|lyfalmen|||1|28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3746||3746|6103||1
409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|E|0|AZD|0|0|1|100|SEK|4430|7039|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4430||4430|7039||1
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|12544|18288|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12544||12544|18288||1
409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|2992|5072|lyfalmen|||1|28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2992||2992|5072||1
409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007|31.10.2012|R|0|0|0|0|0|0|PAB|1|0|0|100|DKK|10315|19979|vetalmen|||0|120|0||Vistor hf|Pharmaxim AB|||10315||10315|19979||1
409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|81382|104680|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||81382||81382|104680||1
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|10164|14883|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10164||10164|14883||1
410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1188|2604|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1188||1188|2604||1
410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|811|2088|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||811||811|2088||1
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|1|0|0|0|E|0|MYL|0|0|1|100|SEK|710|1950|lyfalmen|||2|50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||710||710|1950||1
411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4914|7092|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4914||4914|7092||2
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|26476|35110|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||26476||26476|35110||1
411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|7745|11574|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7745||7745|11574||1
412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|*|0|AZA|0|0|0|100|SEK|23738|32336|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||23738||23738|32336||1
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3923|5662|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3923||3923|5662||1
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|DKK|8592|16670|vetalmen|||0|100|0||Vistor hf|Merial|||8592||8592|16670||1
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|129087|163887|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||129087||129087|163887||2
412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|63294|81979|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||63294||63294|81979||1
412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|*|0|MYL|0|0|0|100|SEK|3567|5858|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3567||3567|5858||1
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|0|0|0|0|*|0|MYL|0|0|0|100|SEK|4382|6973|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4382||4382|6973||1
414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|0|0|0|0|B|0|BLP|0|0|0|100|XEU|890|1815|lyfalmen|V0062|1815|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||611||611|1815||2
414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|E|0|WIH|0|0|0|100|XEU|28714|15124|lyfalmen|V0342|14840|2|98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||10340||10340|15124||2
414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|E|0|SEV|0|0|0|100|DKK|4337|6912|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4337||4337|6912||2
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|1332|2801|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1332||1332|2801||1
415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|2156|3928|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2156||2156|3928||1
415556|B03AC0204|Venofer  (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|0|0|0|0|E|0|DAC|0|0|1|100|CHF|15114|19139|lyfalmen|V0034|19087|3|25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||13222||13222|19139||2
415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|1914|3597|lyfalmen|||1|15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1914||1914|3597||1
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|12976|7754|lyfalmen|V0253|7471|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||4953||4953|7754||2
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9571|9612|lyfalmen|V0088|1900|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6311||6311|9612||1
416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4213|2466|lyfalmen|V0005|2114|2|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1087||1087|2466||2
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5305|8236|lyfalmen|||0|300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||5305||5305|8236||1
416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011||R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|4942|7133|lyfsjukr|||1|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4942||4942|7133||1
416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|E|0|GOG|0|0|1|100|XEU|2918|4971|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2918||2918|4971||2
416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|0|0|0|0|E|0|GOG|0|0|1|100|DKK|26200|35426|lyfalmen|||1|150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||26200||26200|35426||2
416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1308|2768|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1308||1308|2768||2
417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|0|0|0|0|*|0|OPF|0|0|0|100|IKR|8310|12347|lyfalmen|V0285|11663|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||8310||8310|12347||2
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|43335|56268|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||43335||43335|56268||1
417880|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|100187|127617|lyfsjukr|||1|1000|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||100187||100187|127617||1
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|34530|45880|lyfalmen|V0460|45880|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||34530|45880||1
418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|5074|7920|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5074||5074|7920||1
418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|135766|172269|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||135766||135766|172269||1
418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1614|3187|lyfalmen|||1|50|0||Vistor hf|Schering-Plough Europe|Betametasón||1614||1614|3187||1
418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|B|0|SNO|0|0|0|100|NOK|7729|11552|lyfalmen|V0014|11552|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7729||7729|11552||1
418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|23815|19417|lyfalmen|V0475|19417|3|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||13444||13444|19417||2
418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|E|0|APC|0|0|1|100|XEU|3945|5582|lyfalmen|V0458|4932|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||3365||3365|5582||1
418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2063|4104|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2063||2063|4104||1
418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|2676|5311|vetalmen|||0|200|0||Vistor hf|Boehringer Ingelheim Danmark|||2676||2676|5311||1
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|B|0|LEP|0|0|0|100|DKK|3354|5567|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3354||3354|5567||1
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|B|0|LEP|0|0|0|100|DKK|7171|10788|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7171||7171|10788||1
419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|52655|67965|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||52655||52655|67965||1
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|39955|52026|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mecaptamín||39955||39955|52026||3
419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|875|2176|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||875||875|2176||1
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|E|0|PER|0|0|1|100|DKK|12157|17802|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12157||12157|17802||1
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1595|3161|lyfalmen|V0036|3159|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1595||1595|3161||1
422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|1582|3143|lyfalmen|V0051|2984|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1582||1582|3143||1
422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3616|5925|lyfalmen|V0049|4206|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3616||3616|5925||1
422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|6231|9503|lyfalmen|V0054|7353|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||6231||6231|9503||1
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|76681|98117|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||76681||76681|98117||2
423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|6383|3530|lyfalmen|V0011|2864|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1865||1865|3530||2
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|22077|29589|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||22077||22077|29589||1
424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1635|2852|vetorma|||0|24|0||Vistor hf|Intervet International BV|||||1635|2852||1
425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|1126|2519|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||1126||1126|2519||1
425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4812|6899|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4780||4780|6899||1
425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|B|0|ACA|0|0|0|100|SEK|2248|3884|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||2124||2124|3884||1
426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|706|1945|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||706||706|1945||1
426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|922|2240|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||922||922|2240||1
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2738||1
428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|867|2165|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||867||867|2165||1
428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1018|2371|lyfalmen|||1|30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1018||1018|2371||1
428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|51733|66807|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||51733||51733|66807||1
428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|E|0|POF|0|0|0|100|IKR|6185|2649|lyfalmen|V0113|2381|2|100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1221||1221|2649||2
428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|27885|28072|lyfalmen|V0344|28072|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||20340||20340|28072||2
429167|J07CA0602|Pentavac|bóluefni|||0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4263|6810|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4263||4263|6810||2
429225|J07CA0602|Pentavac|bóluefni|||0,5|ml|10|hgl||J07CA06|01.12.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|41943|55184|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||41943||41943|55184||2
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.07.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|101764|129596|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||101764||101764|129596||1
429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|4119|6613|lyfalmen|||1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4119||4119|6613||1
430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|1779|2568|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1779||1779|2568||1
430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1454|2098|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1454||1454|2098||2
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4511|8834|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4511||4511|8834||1
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|0|0|0|0|*|0|WIH|0|0|0|100|XEU|29558|14958|lyfalmen|V0184|14943|2|98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||10219||10219|14958||2
430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|35195|46715|lyfalmen|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||35195||35195|46715||1
430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|0|0|0|0|0|0|LYF|0|0|0|100|XEU|2991|3716|lyfalmen|V0144|3033|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2001||2001|3716||2
430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2474|4363|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2474||2474|4363||2
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|767|2028|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||767||767|2028||1
431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|1217|2644|lyfalmen|||1|100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1217||1217|2644||1
431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|245121|309509|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||245121||245121|309509||1
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|1425|2928|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1425|2928||1
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|E|0|PER|0|0|1|100|DKK|4832|7589|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4832||4832|7589||1
432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|0|0|0|0|E|0|NDR|0|0|0|100|SEK|39321|51893|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||39321|51893||1
432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1159|2564|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1159||1159|2564||1
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3742|7358|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3742||3742|7358||2
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|E|0|ORC|0|0|0|100|DKK|11148|16229|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11148||11148|16229||1
433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2607|4545|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2607||2607|4545||1
433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|5708|8787|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5708||5708|8787||1
433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|8712|12896|lyfalmen|||1|28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8712||8712|12896||1
433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|581|1774|lyfalmen|V0004|516|2|7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||581||581|1774||2
434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1145|1997|vetorma|||0|10|0||Vistor hf|Intervet International BV|||||1145|1997||1
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|938|2262|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||938||938|2262||1
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|B|0|MEB|0|0|1|100|DKK|5847|8977|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5847||5847|8977||1
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|B|0|MEB|0|0|1|100|DKK|5847|8977|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5847||5847|8977||1
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|10371|15166|lyfalmen|||1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10371||10371|15166||2
435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|1|0|0|0|E|0|ASZ|0|0|0|100|SEK|7020|10582|lyfalmen|||1|6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||7020||7020|10582||1
435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|1|0|0|0|E|0|ASZ|0|0|0|100|SEK|4871|7642|lyfalmen|||1|6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4871||4871|7642||1
435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|8663|11315|lyfalmen|V0284|2853|1|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7556||7556|11315||1
435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|929|2073|lyfalmen|V0284|1712|3|60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||800||800|2073||3
435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|1|0|0|0|B|0|REP|0|0|0|100|SEK|2931|4988|lyfalmen|||1|250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2931||2931|4988||1
436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|238025|300604|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||238025||238025|300604||2
436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|NOH|0|0|0|100|DKK|3566|5857|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3566||3566|5857||1
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||||1
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|747|2001|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||747||747|2001||1
436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|244102|308231|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||244102||244102|308231||2
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|1001|2348|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||1001||1001|2348||1
436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|3661|5987|lyfalmen|||1|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3661||3661|5987||1
437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|10165|8070|lyfalmen|V0029|8070|3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||5184||5184|8070||2
437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|0|0|100|DKK|68419|87748|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||68419||68419|87748||2
438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|32942|43225|lyfsjukr|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||32942||32942|43225||2
438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6214|9479|lyfalmen|||1|28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6214||6214|9479||1
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|1249|2687|lyfalmen|||1|10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1249||1249|2687||1
438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3255|5432|lyfalmen|V0259|3079|1|28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3255||3255|5432||1
438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11194|16292|lyfalmen|V0334|5904|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11194||11194|16292||1
438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|349427|440413|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||349427||349427|440413||2
438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín|||||||1
438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|1|0|0|0|0|0|SCP|0|0|1|100|DKK|1896|3573|lyfalmen|||1|30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1896||1896|3573||1
438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|1|0|0|0|E|0|SCP|0|0|1|100|DKK|5970|9146|lyfalmen|V0362|2202|1|100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||5970||5970|9146||1
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|165891|210076|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||165891||165891|210076||1
439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2874|4910|lyfalmen|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2874||2874|4910||1
439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|8950|13222|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8950||8950|13222||1
439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2437|lyfalmen|||1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2437||1
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1493|2155|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1493||1493|2155||1
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2356|3400|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2356||2356|3400||1
441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|933|2255|lyfalmen|V0046|2255|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||933||933|2255||1
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1315|2778|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1315||1315|2778||1
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|126341|160440|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtrícítabín, rilpívírin og tenófóvír||126341||126341|160440||3
441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|0|0|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||0|59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín|||||||1
441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|0|0|0|0|E|0|BAP|0|0|0|100|DKK|1061|2430|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1061||1061|2430||2
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|E|0|BII|0|0|0|100|DKK|11510|16724|lyfalmen|V0460|15293|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11510|16724||1
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|0|0|0|0|*|0|NAS|0|0|1|100|DKK|3476|5734|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3476||3476|5734||1
443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|26499|35801|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||26499||26499|35801||1
444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7673|11475|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7673||7673|11475||1
444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.2012||R|0|0|0|0|0|0|ICE|0|0|0|100|GBP|913|2228|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||913||913|2228||2
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|3150|5288|lyfalmen|||1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3150||3150|5288||2
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|E|0|ROC|0|0|0|100|DKK|2294|4117|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2294||2294|4117||2
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|B|0|LEO|0|0|1|100|DKK|1600|3168|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1600||1600|3168||1
446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1457|2898|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||1457||1457|2898||1
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|E|0|EIS|0|0|0|100|SEK|20370|28109|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||20370||20370|28109||1
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|10671|15576|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10671||10671|15576||1
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|6081|9297|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6081||6081|9297||1
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|7527|11275|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7527||7527|11275||1
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|8958|13233|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8958||8958|13233||1
448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|672|1898|lyfalmen|||1|10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||672||672|1898||2
448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|IGB|0|0|0|100|DKK|1312|2774|lyfalmen|||1|30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1312||1312|2774||2
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|2133|3897|lyfalmen|V0202|3686|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2133||2133|3897||1
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1157|1670|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1157||1157|1670||1
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1459|2975|lyfalmen|||2|98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1459||1459|2975||1
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|5588|8065|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5588||5588|8065||1
449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|*|0|ELI|0|0|0|100|XEU|5433|8411|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5433||5433|8411||2
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4711|9218|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4711||4711|9218||2
450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2382|lyfalmen|V0169|2367|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2382||1
450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|ţpakki||N05CF02|01.10.1992|31.10.2012|R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|892|1764|lyfalmen|||1|20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||574||574|1764||1
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|3192|4241|lyfalmen|V0313|4012|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2385||2385|4241||1
450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7518|13115|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Doramectinum||7518||7518|13115||2
451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|57532|74085|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||57532||57532|74085||2
451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|86300|110189|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||86300||86300|110189||2
451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|115065|146289|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||115065||115065|146289||2
451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5769|8081|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5192||5192|8081||1
451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15237|21668|lyfalmen|||1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15237||15237|21668||1
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1
452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|E|0|ROA|0|0|1|100|DKK|1171|2581|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1171||1171|2581||2
452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|11264|19649|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11264||11264|19649||2
452482|V07AB09|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|12450|18170|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||12450||12450|18170||1
452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|0|0|0|0|0|0|LCC|0|0|0|100|DKK|2363|4211|lyfalmen|||1|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2363||2363|4211||1
452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|2395|4255|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2395||2395|4255||2
452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|7040|10609|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7040||7040|10609||2
452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|4624|7304|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4624||4624|7304||2
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||L|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1488|2596|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||||1488|2596||1
453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|13634|19656|lyfalmen|||1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||13634||13634|19656||2
453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|8850|13085|lyfalmen|||1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||8850||8850|13085||2
453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|E|0|NOP|0|0|0|100|DKK|24851|33733|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||24851||24851|33733||2
453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2776|4006|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2776||2776|4006||1
453795|J07AL0102|Pneumo 23|bóluefni|||0,5|ml|1|dćla||J07AL01|01.09.2003||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2320|4153|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2320||2320|4153||2
454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|15465|21954|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15465||15465|21954||1
454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|43875|39276|lyfalmen|V0341|13493|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||29268||29268|39276||1
454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|2138|2105|lyfalmen|V0004|2066|2|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2105||2
454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|17360|24332|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||17360||17360|24332||1
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|48340|43773|lyfalmen|V0342|14840|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||32851||32851|43773||1
454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1
454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|55837|71958|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||55837||55837|71958||1
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1158|2303|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1158||1158|2303||1
455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|*|0|BAP|0|0|0|100|DKK|1083|2460|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1083||1083|2460||2
455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|*|0|BAP|0|0|0|100|DKK|3889|6299|lyfalmen|||1|120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3889||3889|6299||2
455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|E|0|NOH|0|0|1|100|DKK|22110|30293|lyfalmen|||1|21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||22110||22110|30293||1
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|930|2251|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||930||930|2251||1
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1052|2418|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1052||1052|2418||1
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|2181|3962|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2181||2181|3962||1
457615|N06AB1006|Escitalopram Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.11.2012||R|1|0|0|0|B|0|POF|0|0|0|100|IKR|4787|4470|lyfalmen|V0327|4451|2|100|0|200,0000|Portfarma ehf|Portfarma|Escítalópram||2552||2552|4470||2
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|779|1555|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||421||421|1555|31.10.2012|1
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|SEK|1228|2659|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1228||1228|2659||1
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1454|2968|lyfalmen|V0577|2637|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1454||1454|2968||1
458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|E|0|XEL|0|0|1|100|DKK|24419|33191|lyfalmen|||2|28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||24419||24419|33191||1
459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|2508|1846|lyfalmen|V0278|1846|3|28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||634||634|1846||2
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|864|1247|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||864||864|1247||1
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1582|2283|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1582||1582|2283||1
459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7673|11475|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7673||7673|11475||1
459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|2293|4116|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2293||2293|4116||1
459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|E|0|MAS|0|0|1|100|SEK|4656|7348|lyfalmen|||1|60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4656||4656|7348||1
460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|0|0|0|0|0|0|MEX|0|0|0|100|XEU|4058|6530|lyfalmen|||1|0,5|0||Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4058||4058|6530||2
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|1|0|0|0|E|0|SAD|0|0|0|100|DKK|8301|12334|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8301||8301|12334||2
460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|ţpakki||J01CA04|01.07.1989|31.10.2012|R|0|0|0|0|0|0|ASP|0|0|1|100|XEU|549|1730|lyfalmen|||1|20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||549||549|1730||1
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|7191|13980|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7191||7191|13980||2
460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|áf.spr||J07BB02|01.12.1998||R|0|0|0|0|0|0|AHP|0|0|0|100|XEU|5652|8711|lyfalmen|||1|5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir  mótefnavakar||5652||5652|8711||1
461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|190|1239|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||190||190|1239||1
462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|699|1935|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||699||699|1935||1
462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|699|1935|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||699||699|1935||1
462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|7966|11876|lyfalmen|||1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7966||7966|11876||1
462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|E|0|XEL|0|0|1|100|DKK|12193|17847|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12193||12193|17847||1
462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|6761|13155|vetalmen|||0|20|0||Icepharma hf|Pfizer Oy Animal Health|||||6761|13155||2
463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|9402|13840|lyfalmen|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||9402||9402|13840||1
463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|5393|10528|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||5393||5393|10528||2
463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2
464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|1|0|0|0|*|0|MEL|0|0|0|100|DKK|1785|3421|lyfalmen|||1|100|0|8,3333|Swedish Orphan Biovitrum A/S|MediLink A/S|Melperón||1785||1785|3421||1
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|*|0|APC|0|0|0|100|DKK|4113|6551|lyfalmen|V0376|6551|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||4073||4073|6551||1
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1198|2383|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1198||1198|2383||1
465237|QJ01CR5001|Duplocillin L.A., vet.|stl|||100|ml|1|hgl||QJ01CR50|01.05.1983||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|1131|2250|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1131||1131|2250||1
465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1213|2413|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1213||1213|2413||1
465278|QJ51RC2301|Nafpenzal DC,  vet.|spenalyf|||3|g|4|spr||QJ51RC23|01.04.1985||R|0|0|0|0|0|0|IBV|0|0|0|100|XEU|640|1273|vetalmen|||0|12|0||Vistor hf|Intervet International BV|||640||640|1273||1
466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|673|1900|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||673||673|1900||1
466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2082|3827|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2082||2082|3827||1
466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|1491|3019|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1491||1491|3019||1
466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|5826|8949|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5826||5826|8949||1
466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|2772|4771|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2772||2772|4771||1
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|7983|11899|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7983||7983|11899||1
466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|4559|7215|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4559||4559|7215||1
466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|1|0|0|0|B|0|MAS|0|0|0|100|SEK|4753|7481|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4753||4753|7481||1
467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|15399|21208|lyfsjukr|||1|0,5|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||15399||15399|21208||1
467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|23599|31499|lyfsjukr|||1|0,5|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||23599||23599|31499||1
467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|18639|24500|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18022||18022|24500||1
467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001|30.09.2012|R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|28087|37132|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||28087||28087|37132||1
467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|0|0|0|1|*|0|WTE|0|0|0|100|DKK|34160|45416|lyfalmen|||1|60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||34160||34160|45416||2
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|15574|22091|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||15574||15574|22091||1
467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|55913|69728|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||54060||54060|69728||1
467699|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|7561|11322|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7561||7561|11322||2
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|29653|39760|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||29653||29653|39760||1
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|529|763|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||529||529|763||1
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|6463|6707|lyfalmen|V0317|3232|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4187||4187|6707||1
468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|402|580|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||402||402|580||1
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|B|0|LBK|0|0|0|100|DKK|9410|6389|lyfalmen|V0318|3232|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3955||3955|6389||1
468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|23776|12875|lyfalmen|V0320|5909|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8696||8696|12875||1
468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|4530|3113|lyfalmen|V0207|2689|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1560||1560|3113||1
468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|4172|5077|lyfalmen|V0467|5077|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5077||1
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5682|8752|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5682||5682|8752||1
469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|12209|17867|lyfalmen|V0253|7471|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||12209||12209|17867||1
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7651|11042|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7651||7651|11042||2
469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|0|0|E|0|GRU|0|0|1|100|DKK|6363|9683|lyfalmen|V0228|9683|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6363||6363|9683||2
469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|0|0|E|0|GRU|0|0|1|100|DKK|5174|8057|lyfalmen|V0227|7519|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5174||5174|8057||2
469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|0|0|E|0|GRU|0|0|1|100|DKK|3378|5600|lyfalmen|V0226|4924|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3378||3378|5600||2
470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|B|0|GSK|0|0|0|100|GBP|6159|9404|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6159||6159|9404||1
470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|31170|41001|lyfsjukr|||1|16|0||Vistor hf|Orion Corporation|Dexmedetómid||31170||31170|41001||1
470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|7498|10821|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Jóhexól||7498||7498|10821||2
471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|10008|14443|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||10008||10008|14443||2
471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371||2
471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9998|14430|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9998||9998|14430||2
471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|14359|19903|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jóhexól||14359||14359|19903||2
471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|1|0|0|0|*|0|PER|0|0|0|100|DKK|1228|2659|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1228||1228|2659||1
471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2143|3738|vetorma|||0|20|0||Vistor hf|Intervet International BV|||||2143|3738||1
471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|0|0|0|0|*|0|BAM|0|0|0|100|SEK|3484|5745|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3484||3484|5745||2
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4801|9391|vetalmen|||0|10|0||Vistor hf|Orion Corporation|||4801||4801|9391||1
472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2222|4018|lyfalmen|V0048|2777|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2222||2222|4018||1
472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3285|5473|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3285||3285|5473||1
472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|IKR|13009|5012|lyfalmen|V0012|5012|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2948||2948|5012||2
472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|4632|7315|lyfalmen|V0458|4932|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4632||4632|7315||1
474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|16212|22229|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||16212||16212|22229||1
474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|5325|7685|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5325||5325|7685||1
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2
474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|1|0|0|0|E|0|REP|0|0|0|100|SEK|1069|2441|lyfalmen|||1|30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1069||1069|2441||1
474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2
474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|36840|48117|lyfsjukr|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||36840||36840|48117||1
474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|14560|9608|lyfalmen|V0456|9608|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||6308||6308|9608||2
474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|0|0|0|0|E|0|SPL|0|0|1|100|DKK|1866|3531|lyfalmen|||1|140|0|35,0000|Vistor hf|Schering-Plough Europe|Mómetasón||1866||1866|3531||1
474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|27871|53689|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||27871|53689||2
474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|E|0|LYF|0|0|0|100|XEU|807|1304|lyfalmen|V0266|1304|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||238||238|1304||2
475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|930|2251|lyfalmen|||2|100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||930||930|2251||1
475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|3335|5541|lyfalmen|V0130|5541|1|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3335||3335|5541||1
475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|300|1389|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||300||300|1389||1
475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|366|1480|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||366||366|1480||1
475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|ACA|0|0|1|100|NOK|1022|2377|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1022||1022|2377||1
475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3841|6233|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3841||3841|6233||1
475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|5060|7901|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||5060||5060|7901||1
475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|0|0|0|0|*|0|ELD|0|0|0|100|XEU|5630|8680|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5630||5630|8680||2
476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|0|0|0|0|*|0|ELI|0|0|0|100|XEU|6083|9300|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6083||6083|9300||2
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|78123|99927|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||78123|99927||1
476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|B|0|GSK|0|0|1|100|IKR|1200|2538|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1140||1140|2538||1
476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|*|0|RAN|0|0|0|100|XEU|11977|6861|lyfalmen|V0282|6504|2|56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||4300||4300|6861||1
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5410|8380|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5410||5410|8380||1
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|*|0|APC|0|0|0|100|XEU|500|1551|lyfalmen|V0500|1551|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||418||418|1551||1
479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|*|0|WIL|0|0|0|100|XEU|29632|39733|lyfalmen|V0454|39733|2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||29632||29632|39733||2
480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|E|0|WIH|0|0|0|100|XEU|26433|13776|lyfalmen|V0341|13493|2|98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||9355||9355|13776||2
480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|0|0|0|0|E|0|DSG|0|0|0|100|SEK|13254|19179|lyfalmen|||1|84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||13254||13254|19179||1
481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|14586|20851|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14586||14586|20851||1
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|0|0|E|0|GLP|0|0|1|100|SEK|348|1455|lyfalmen|V0055|1272|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||348||348|1455||1
483217|B01AX0601 |Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|38907|51373|lyfalmen|V0030|51322|1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||38907|51373||2
483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2796|4035|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2796||2796|4035||1
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|E|0|SHS|0|0|1|100|DKK|3563|5853|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3563||3563|5853||1
483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4825|6964|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4825||4825|6964||1
483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|*|0|POF|0|0|0|100|DKK|2444|4322|lyfalmen|V0374|4322|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2444||2444|4322||2
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|1|0|0|0|E|0|AGP|0|0|1|100|XEU|294|1272|lyfalmen|V0055|1272|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||214||214|1272||1
484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|57662|74248|lyfsjukr|||1|3|0|83,9552|Vistor hf|Ferring|Triptórelín||57662||57662|74248||1
484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|5992|9176|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5992||5992|9176||1
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|154329|195565|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||154329||154329|195565||1
484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|E|0|MEB|0|0|1|100|SEK|1440|2949|lyfalmen|||1|300|0||Vistor hf|Meda AB (V)|Benzýdamín||1440||1440|2949||1
484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|56507|73461|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||56507||56507|73461||1
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|E|0|ANS|0|0|1|100|XEU|1254|2694|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1254||1254|2694||1
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen|||||||1
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|477|1631|lyfalmen|||1|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||477||477|1631||1
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|E|0|SAL|0|0|1|100|USD|681|1910|lyfalmen|||1|5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||681||681|1910||1
487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|0|1|0|0|*|0|APC|0|0|0|100|XEU|19853|27461|lyfalmen|V0573|27461|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||19853||19853|27461||1
487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|4775|4451|lyfalmen|V0326|4451|2|100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2538||2538|4451||2
487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|55913|72053|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||55913||55913|72053||1
487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|*|0|WIL|0|0|0|100|XEU|33093|44077|lyfalmen|V0453|44077|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||33093||33093|44077||2
488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|996|2341|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||996||996|2341||1
488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|2769|4767|lyfalmen|V0198|3935|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2769||2769|4767||1
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|B|0|APC|0|0|0|100|DKK|6334|9643|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6334||6334|9643||1
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|B|0|APC|0|0|0|100|DKK|11392|16563|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11392||11392|16563||1
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|104137|132574|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||104137|132574||1
489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|NOH|0|0|1|100|IKR|338|1242|lyfalmen|V0188|463|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1242||1
489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|E|0|NOH|0|0|1|100|IKR|882|1618|lyfalmen|V0188|1389|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1618||1
490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|2492|4388|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2492||2492|4388||1
490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|2626|4571|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2626||2626|4571||1
490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3989|6436|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3989||3989|6436||1
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10917|10663|lyfalmen|V0112|2449|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7079||7079|10663||1
490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5303|8233|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5303||5303|8233||1
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15492|14455|lyfalmen|V0113|2381|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9851||9851|14455||1
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|19704|18147|lyfalmen|V0114|4521|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12432||12432|18147||1
491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|49781|64358|lyfsjukr|||1|3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||49781||49781|64358||1
492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|3310|5507|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3310||3310|5507||2
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13166|19068|lyfalmen|V0002|5247|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||13166||13166|19068||1
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|24200|14999|lyfalmen|V0516|14714|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||10249||10249|14999||1
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|B|0|SNO|0|0|0|100|NOK|1472|2993|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1472||1472|2993||1
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|2488|4382|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2488||2488|4382||1
494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|81496|104160|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||81496||81496|104160||2
494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|203740|257576|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||203740||203740|257576||2
494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2030|3756|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2030||2030|3756||1
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2277|4094|lyfalmen|V0128|2165|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2277||2277|4094||1
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|3310|5507|lyfalmen|V0410|4999|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3310||3310|5507||1
494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|E|0|BII|0|0|0|100|DKK|1882|3553|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1882||1882|3553||1
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|1|0|0|0|E|0|GSK|0|0|0|100|GBP|19445|7014|lyfalmen|V0384|7014|1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4412||4412|7014||1
495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|7563|6659|lyfalmen|V0382|6421|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4152||4152|6659||1
495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|E|0|GSK|0|0|0|100|GBP|10805|10373|lyfalmen|V0383|10042|1|20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||6867||6867|10373||1
495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2967|5038|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2967||2967|5038||1
496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|30321|30146|lyfalmen|V0345|30146|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||21993||21993|30146||2
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4260|8352|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4260|8352||2
496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|0|1|0|0|*|0|APC|0|0|0|100|XEU|12836|18654|lyfalmen|V0572|13787|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||12836||12836|18654||1
496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|0|0|0|0|B|0|APT|0|0|0|100|GBP|6170|9419|lyfalmen|||1|100|0|0,8333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||6170||6170|9419||1
496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|1|0|0|0|B|0|APT|0|0|0|100|GBP|1082|2459|lyfalmen|||1|50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||1082||1082|2459||1
496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|0|0|100|DKK|86663|110645|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||86663||86663|110645||3
496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|1|0|0|0|B|0|APT|0|0|0|100|GBP|3395|5623|lyfalmen|||1|100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Labetalól||3395||3395|5623||1
496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|E|0|PER|0|0|0|100|DKK|473|1626|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||473||473|1626||1
496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|853|2146|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||853||853|2146||1
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|0|0|0|0|0|1|APE|0|0|0|100|XEU|249903|315511|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||249903||249903|315511||1
497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|3254|5430|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3254||3254|5430||1
497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|343|1448|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||343||343|1448||1
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|508|1407|lyfalmen|V0448|1407|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||313||313|1407||1
497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1057|1891|lyfalmen|V0449|1891|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||667||667|1891||1
497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|1519|2997|lyfalmen|V0369|2997|2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1475||1475|2997||2
498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|0|0|0|0|B|0|SPL|0|0|1|100|DKK|1372|2856|lyfalmen|||1|2|0|9,3300|Vistor hf|Schering-Plough Europe|Betametasón||1372||1372|2856||1
498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|17095|23999|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17095||17095|23999||1
498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|18235|25430|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18235||18235|25430||1
499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|22715|31052|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||22715||22715|31052||1
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|27442|36985|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||27442||27442|36985||1
499273|B01AX0601 |Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|11158|16242|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||11158|16242||2
501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|ţpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|0|0|RGM|0|0|0|100|XEU|4880|3883|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||2123||2123|3883||2
501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|2810|4823|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2810||2810|4823||1
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|3086|5200|lyfalmen|V0434|4474|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3086||3086|5200||2
502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|1|0|0|0|B|0|AML|0|0|0|100|DKK|3008|5094|lyfalmen|||1|100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||3008||3008|5094||1
503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|30342|39962|lyfsjukr|||1|1|0|27,9851|Vistor hf|Ferring|Triptórelín||30342||30342|39962||1
503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|XEU|6686|7157|lyfalmen|||3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||4516||4516|7157||2
503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|1669|3124|lyfalmen|V0494|3124|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1568||1568|3124||1
504191|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.07.1988||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1
504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|0|0|0|0|E|0|ORG|0|0|0|100|DKK|2058|3794|lyfalmen|||1|90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2058||2058|3794||1
504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1170|2579|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1170||1170|2579||2
505647|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|300|skammtar|1|fl|2 x 150 úđaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|1|0|0|0|B|0|AML|0|0|0|100|DKK|8276|12300|lyfalmen|||1|100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||8276||8276|12300||1
505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1819|2625|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1819||1819|2625||1
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3633|5243|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3633||3633|5243||1
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|8291|11966|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8291||8291|11966||1
506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|B|0|PER|0|0|0|100|DKK|2484|4377|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2484||2484|4377||1
506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|403|1530|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||403||403|1530||1
507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|664|1158|vetorma|||0|24|0||Icepharma hf|Pfizer Oy Animal Health|||||664|1158||2
507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|2824|4926|vetorma|||0|120|0||Icepharma hf|Pfizer Oy Animal Health|||||2824|4926||2
507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|16210|28278|vetorma|||0|1000|0||Vistor hf|Intervet International BV|||16210||16210|28278||1
508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|2578|4505|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2578||2578|4505||1
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5151|10063|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5151|10063||2
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4131|8105|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4131||4131|8105||2
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12781|24714|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12781||12781|24714||2
508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SOF|0|0|0|100|NOK|753401|947401|lyfsjukr|||1|15|0||Vistor hf|SANOFI|Cabazitaxel||753401||753401|947401||1
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|9167|13519|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9167||9167|13519||1
509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|0|0|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2835||1
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|50292|64999|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||50292||50292|64999||1
510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|16773|22933|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||16773||16773|22933||2
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|25108|33393|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||25108||25108|33393||2
510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|41184|53568|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||41184||41184|53568||2
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|81445|104096|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||81445||81445|104096||2
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|189105|239209|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||189105|239209||1
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|E|0|ACA|0|0|0|100|XEU|4205|5568|lyfalmen|V0445|5568|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||3355||3355|5568||1
511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|2731|4715|lyfalmen|||1|28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2731||2731|4715||1
511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|36715|31239|lyfalmen|V0540|31239|3|28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||22864||22864|31239||2
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|2714|4692|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2714||2714|4692||1
511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|24389|32491|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||24389||24389|32491||1
511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|15257|21030|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||15257||15257|21030||1
512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|4775|4592|lyfalmen|V0325|4592|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2641||2641|4592||2
512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5297|7645|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5297||5297|7645||2
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1
513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|23018|31433|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23018||23018|31433||1
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|2138|4253|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2138||2138|4253||2
514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|B|0|AZD|0|0|1|100|SEK|2137|3902|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2137||2137|3902||1
514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|B|0|ADG|0|0|0|100|XEU|3154|5293|lyfalmen|||2|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||3154||3154|5293||1
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|1|0|0|0|B|0|PER|0|0|0|100|IKR|4301|4222|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4222||1
515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2581||1
515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2594||1
517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|5112|6293|lyfalmen|V0010|6293|2|120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3885||3885|6293||1
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|2978|5053|lyfalmen|V0462|2920|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||2978||2978|5053||1
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3242|5414|lyfalmen|V0471|3060|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3242||3242|5414||1
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|*|0|NAS|0|0|0|100|DKK|3486|5748|lyfalmen|V0472|3300|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3486||3486|5748||1
517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|1|0|0|0|E|0|AGT|0|0|1|100|DKK|925|2244|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||925||925|2244||1
518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|1|0|0|0|E|0|AGT|0|0|1|100|DKK|3408|5641|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3408||3408|5641||1
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2101|3853|lyfalmen|||1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2101||2101|3853||1
518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|12890|14795|lyfalmen|V0286|13974|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||10100||10100|14795||3
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1155|2559|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1155||1155|2559||1
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AEG|0|0|1|100|SEK|1731|3347|lyfalmen|||1|100|0|2,5000|GlaxoSmithKline ehf|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1731||1731|3347||1
519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|7318|10990|lyfalmen|V0431|9536|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||7318||7318|10990||1
520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4852|7616|lyfalmen|V0142|7484|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4852||4852|7616||1
520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|5479|8474|lyfalmen|V0143|2499|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5479||5479|8474||1
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|15438|21920|lyfalmen|V0143|7496|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15438||15438|21920||1
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|5876|9017|lyfalmen|V0144|3033|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5876||5876|9017||1
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|16259|22950|lyfalmen|V0144|9099|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16259||16259|22950||1
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|1355|1737|lyfalmen|V0056|1724|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||554||554|1737||1
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|B|0|ACA|0|0|0|100|IKR|2163|2133|lyfalmen|V0057|2114|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||844||844|2133||1
520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|1|0|0|0|E|0|MEB|0|0|1|100|SEK|372|1488|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||372||372|1488||1
520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1720||1
520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|B|0|NYC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1730||1
521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|E|0|BII|0|0|0|100|DKK|32317|43103|lyfalmen|V0269|9675|1|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||32317||32317|43103||1
521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|18362|25589|lyfalmen|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||18362||18362|25589||1
521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|3046|3062|lyfalmen|V0471|3060|3|90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1523||1523|3062||2
522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8455|16407|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|||8455||8455|16407||1
522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2305|4132|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2305||2305|4132||2
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|187451|237134|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||187451||187451|237134||1
522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|0|0|E|0|GLP|0|0|1|100|SEK|348|1455|lyfalmen|V0055|1272|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||348||348|1455||1
522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|0|0|E|0|GLP|0|0|1|100|SEK|413|1544|lyfalmen|V0225|1508|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||413||413|1544||1
522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|0|0|E|0|GLP|0|0|1|100|DKK|2790|4795|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2790||2790|4795||1
522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|0|0|0|0|E|0|GLP|0|0|1|100|DKK|397|1522|lyfalmen|||1|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||397||397|1522||1
523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|NOK|467|1618|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||467||467|1618||1
523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|0|0|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395||1
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|1|0|0|0|E|0|SNO|0|0|1|100|NOK|1321|2786|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1321||1321|2786||1
524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|465|1615|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||465||465|1615||1
524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2932|4990|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2932||2932|4990||1
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|5951|lyfalmen|V0010|5139|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|5951||1
524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|INI|0|0|0|100|DKK|1915|3809|vetalmen|||0|1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1915||1915|3809||2
525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|1|0|0|0|E|0|MEB|0|0|1|100|SEK|914|2229|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||914||914|2229||1
525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|NOH|0|0|0|100|DKK|779|2045|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||779||779|2045||1
525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|0|0|0|0|E|0|LVR|0|0|0|100|IKR|4621|4194|lyfalmen|V0006|4139|3|100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||2350||2350|4194||3
525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|1505|3038|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1505||1505|3038||1
525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|E|0|ACA|0|0|1|100|XEU|5016|7841|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5016||5016|7841||1
525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|1|0|0|0|0|0|CPA|0|0|0|100|DKK|10918|15914|lyfalmen|||1|30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||10918||10918|15914||1
525720|B01AX0601 |Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|39700|52369|lyfalmen|V0030|52369|1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||39700|52369||2
525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5470|7895|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5470||5470|7895||1
525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4980|7187|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríđ||4980||4980|7187||1
525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
526004|V07AB09|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1
526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|4491|7122|lyfalmen|V0435|7122|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4491||4491|7122||2
526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|4188|6708|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4188||4188|6708||1
526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007|30.09.2012|R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|6274|12220|vetalmen|||0|187,5|0||Vistor hf|Intervet International BV|||6274||6274|12220||1
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|E|0|DEA|0|0|0|100|XEU|3582|5879|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3582||3582|5879||1
527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|15970|21925|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15970||15970|21925||1
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|E|0|ALC|0|0|0|100|USD|1261|2704|lyfalmen|||0|5|0||K.Pétursson hf|Alcon|Emedastín||1261||1261|2704||1
528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|0|0|0|0|E|0|BGB|0|0|0|100|DKK|18297|25508|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||18297||18297|25508||2
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|0|0|LVR|0|0|0|100|SEK|10258|14121|lyfalmen|V0356|12903|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9607||9607|14121||3
528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|0|0|0|0|B|0|FEL|0|0|0|100|DKK|6925|10452|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||6925||6925|10452||1
529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4525|8861|vetalmen|||0|72|0||Icepharma hf|Pfizer Oy Animal Health|||4525||4525|8861||2
529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|PAL|0|0|0|100|DKK|4811|9410|vetalmen|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||4811||4811|9410||2
529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|69074|88570|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||69074||69074|88570||1
529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|28690|14943|lyfalmen|V0184|14943|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||10208||10208|14943||2
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|||0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6897||1
530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|*|0|BLP|0|0|0|100|XEU|11848|7496|lyfalmen|V0186|7496|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||4764||4764|7496||2
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|E|0|NAS|0|0|0|100|DKK|3124|5252|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3124||3124|5252||1
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6005|8667|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6005||6005|8667||2
531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|3105|5226|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3105||3105|5226||1
531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|8257|11917|lyfsjukr|||1|240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8257||8257|11917||1
532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|0|0|0|1|*|0|LYF|0|0|0|100|XEU|20400|12668|lyfalmen|V0187|12659|3|50|0|12,5000|LYFIS ehf|LYFIS ehf|Mýcófenólsýra||8545||8545|12668||2
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|687|1919|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||687||687|1919||1
532504|R06AX2704|Desloratadine ratiopharm|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2012||R|0|0|0|0|E|0|RGM|0|0|1|100|XEU|1226|2255|lyfalmen|V0366|2255|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||933||933|2255||2
532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|363|1475|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||363||363|1475||1
532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1054|2421|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1054||1054|2421||1
532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|292|1378|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||292||292|1378||1
532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1857|3519|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1857||1857|3519||1
533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|14577|7921|lyfalmen|V0283|7921|3|28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5075||5075|7921||2
533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|2105|3858|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2105||2105|3858||1
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|0|0|0|1|*|0|IPI|0|0|0|100|DKK|59123|76745|lyfalmen|V0567|76745|1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||59123||59123|76745||1
535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2
535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|3280|2434|lyfalmen|V0279|2434|3|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1064||1064|2434||2
535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|6836|10330|lyfalmen|||1|84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6836||6836|10330||1
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|*|0|SAL|0|0|0|100|USD|444|1586|lyfalmen|||1|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||444||444|1586||1
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|*|0|SAL|0|0|0|100|USD|567|1755|lyfalmen|||1|10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||567||567|1755||1
536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|12900|11923|lyfalmen|V0115|11923|2|100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||8000||8000|11923||2
536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|ţpakki||A10BA02|01.11.2012||R|1|0|0|0|*|0|APC|0|0|0|100|XEU|408|1537|lyfalmen|V0502|1537|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||408||408|1537||1
536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|30063|39612|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||30063||30063|39612||1
536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|112854|144177|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||112854||112854|144177||1
536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|65884|84567|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||65884||65884|84567||2
537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|593|1034|vetorma|||0|2|0||Icepharma hf|Pfizer Oy Animal Health|||||593|1034||2
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6360|9179|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6360||6360|9179||2
537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2421||1
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|141000|178838|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||141000||141000|178838||2
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|1|0|0|1|E|0|SNO|0|0|0|100|NOK|10959|15970|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10959||10959|15970||1
539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|1|0|0|0|*|0|LVR|0|0|0|100|IKR|5863|7408|lyfalmen|V0285|6998|3|60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||4700||4700|7408||3
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|222|1283|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||222||222|1283||1
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|645|1861|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||645||645|1861||1
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|1809|3454|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1809||1809|3454||1
540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2809|4821|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2809||2809|4821||2
540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|0|0|0|0|*|0|MSD|0|0|0|100|DKK|5925|9084|lyfalmen|V0373|7378|1|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5925||5925|9084||1
541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|9580|14084|lyfalmen|V0199|14084|1|200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9580||9580|14084||3
541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|1|0|0|0|B|0|SGM|0|0|0|100|DKK|15518|22020|lyfalmen|V0200|22020|1|200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15518||15518|22020||3
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5925|8551|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5925||5925|8551||1
542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|4756|7485|lyfalmen|||0|100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7485||2
543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|ţpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|736|1986|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||736||736|1986||1
543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|1|0|0|0|B|0|NOH|0|0|0|100|DKK|2928|4984|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||2928||2928|4984||1
543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|*|0|POF|0|0|0|100|XEU|2233|3173|lyfalmen|V0373|2459|2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1604||1604|3173||2
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1
543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|7435|4875|lyfalmen|V0457|4875|3|28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||2848||2848|4875||2
543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|517475|651314|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||517475||517475|651314||1
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|*|0|ASP|0|0|0|100|XEU|13114|19003|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13114||13114|19003||1
544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|951|2280|lyfalmen|V0005|529|2|7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||951||951|2280||2
545176|G03HB0103|Cypretyl|töflur|||63|stk|1|ţpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|1947|3544|lyfalmen|V0134|3544|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1875||1875|3544||2
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1024|2380|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1024||1024|2380||1
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|912|2226|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||912||912|2226||1
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|*|0|LBK|0|0|0|100|DKK|2250|4057|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2250||2250|4057||1
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|30451|40761|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||30451||30451|40761||1
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|24551|33357|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||24551||24551|33357||1
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|30630|40986|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||30630||30630|40986||1
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|E|0|ALK|0|0|0|100|DKK|26022|35203|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||26022||26022|35203||1
546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1
546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1150|2552|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1150||1150|2552||1
546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|ţpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|B|0|RGM|0|0|0|100|XEU|3218|3359|lyfalmen|V0580|3359|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1740||1740|3359||2
546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|1|0|0|0|E|0|APC|0|0|0|100|IKR|3141|5247|lyfalmen|V0010|5244|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3120||3120|5247||1
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4791||1
547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|3215|2066|lyfalmen|V0004|2066|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||795||795|2066||2
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|10739|15360|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10739||10739|15360||1
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3539|5108|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3539||3539|5108||1
547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|0|0|0|1|E|0|ORG|0|0|0|100|DKK|7857|11727|lyfalmen|||1|0,5|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||7857||7857|11727||1
548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|0|0|0|0|B|0|LYF|0|0|0|100|XEU|577|1666|lyfalmen|V0542|1666|2|100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||502||502|1666||2
548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2
548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|ţpakki||M05BA07|01.03.2001|31.08.2012|R|0|0|0|0|0|0|SNO|0|0|0|100|NOK|15650|22186|lyfalmen|||0|84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||15650||15650|22186||1
549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|0|0|0|0|0|1|ABT|0|0|0|100|DKK|95254|121426|lyfsjukr|||1|1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||95254||95254|121426||1
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|*|0|JAS|0|0|0|100|SEK|9919|14548|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9919||9919|14548||1
549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|0|0|0|0|0|1|ABT|0|0|0|100|DKK|141051|178902|lyfsjukr|||1|1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||141051||141051|178902||1
549674|B01AX0601 |Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|1|1|0|0|E|0|BAP|0|0|0|100|DKK|38907|51373|lyfalmen|V0031|51322|1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||38907|51373||2
550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001|31.08.2012|R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2230|4029|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir  mótefnavakar||2230||2230|4029||1
550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1592||1
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|11382|7921|lyfalmen|V0280|7921|3|56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5075||5075|7921||2
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9468|13665|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9468||9468|13665||2
551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|E|0|AZA|0|0|0|100|SEK|11193|16290|lyfalmen|V0235|16290|1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||11193||11193|16290||1
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|B|0|MAB|0|0|1|100|SEK|1912|3594|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1912||1912|3594||1
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|E|0|MAB|0|0|1|100|SEK|4079|6559|lyfalmen|V0198|6559|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||4079||4079|6559||1
551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|1988|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1988||2
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1752|lyfalmen|V0466|1575|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752||1
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|3931|3432|lyfalmen|V0467|2843|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432||1
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1008|lyfalmen|V0003|876|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1008||1
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1752|lyfalmen|V0003|1752|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752||1
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|1|0|0|0|0|0|EIS|0|0|0|100|IKR|7648|3432|lyfalmen|V0010|2937|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432||1
551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|24200|14714|lyfalmen|V0516|14714|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||10041||10041|14714||2
552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|1|0|0|0|B|0|BAP|0|0|0|100|DKK|3791|6165|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||3791|6165||2
552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1
552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|5261|8176|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5261||5261|8176||1
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|3315|5514|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3315||3315|5514||1
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|12092|17721|lyfalmen|V0237|17721|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12092|17721||1
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|1|0|0|0|E|0|PER|0|0|0|100|DKK|4135|6635|lyfalmen|V0237|5907|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4135||4135|6635||1
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|7665|14891|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||7665||7665|14891||1
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|27891|36886|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||27891||27891|36886||2
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|4912|7698|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4912||4912|7698||1
556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|6680|10117|lyfalmen|V0242|7039|1|50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6680||6680|10117||1
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|E|0|NOH|0|0|0|100|DKK|9576|14078|lyfalmen|V0242|14078|1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9576||9576|14078||1
557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1610|3181|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1610||1610|3181||1
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NOE|0|0|0|100|DKK|282739|356720|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||282739|356720||1
559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|853|2146|lyfalmen|||1|28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||853||853|2146||1
559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|B|0|ABS|0|0|0|100|DKK|1958|3657|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1958||1958|3657||1
559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|0|0|0|0|E|0|GRU|0|0|1|100|DKK|664|1887|lyfalmen|||1|20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||664||664|1887||2
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2
559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1576|3135|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1576||1576|3135||2
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|E|0|PER|0|0|0|100|DKK|5767|8868|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5767||5767|8868||1
559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|0|0|0|0|B|0|MEB|0|0|0|100|SEK|3652|5975|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3652||3652|5975||1
559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|14277|19800|lyfsjukr|||1|240|0||Icepharma hf|Baxter|Desflúran||14277||14277|19800||2
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1426||1
560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|0|0|0|0|B|0|BLP|0|0|0|100|XEU|791|1674|lyfalmen|V0067|1674|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||508||508|1674||2
560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|1|0|0|0|E|0|GSK|0|0|1|100|GBP|3199|5355|lyfalmen|||1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3199||3199|5355||1
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1
560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|1592|3157|lyfalmen|||1|4,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1592||1592|3157||1
560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|6098|9321|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6098||6098|9321||1
560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|E|0|GSK|0|0|1|100|GBP|6612|10024|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6612||6612|10024||1
560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|100973|128604|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||100973||100973|128604||1
560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|466970|587930|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||466970||466970|587930||1
560761|C10AA0505|Atorvastatin Bluefish|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|0|0|0|0|0|0|BLP|0|0|0|100|XEU|9323|12314|lyfalmen|V0115|11923|2|100|0|400,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||8286||8286|12314||2
561145|N03AX2101|Trobalt|filmhtfl|150|mg|63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|5909|9062|lyfalmen|||1|63|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5909||5909|9062||1
561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|1730|3345|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1730||1730|3345||2
562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|B|0|APC|0|0|0|100|XEU|2518|4423|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2518||2518|4423||1
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|107116|136313|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||107116||107116|136313||1
563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|0|1|0|1|0|0|INT|0|0|0|100|DKK|115625|147655|lyfalmen|||1|63|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||115625||115625|147655||1
563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|21318|29299|lyfalmen|V0431|28609|2|6|0|17,1667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||21318||21318|29299||1
563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|35966|47682|lyfalmen|V0431|47682|2|10|0|28,6111|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||35966||35966|47682||1
563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|788|2057|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||788||788|2057||1
563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|B|0|GSK|0|0|1|100|GBP|712|1953|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||712||712|1953||1
563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|1|0|1|0|E|0|PER|0|0|0|100|DKK|1392|2883|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1392||1392|2883||1
563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|E|0|NYC|0|0|0|100|DKK|207364|262787|lyfalmen|||2|60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||207364||207364|262787||1
563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|3611|5919|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3611||3611|5919||2
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|*|0|SAO|0|0|0|100|XEU|3743|6099|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3743||3743|6099||2
563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NOE|0|0|0|100|DKK|467593|589374|lyfalmen|||1|60|0||Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||467593||467593|589374||1
563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|0|0|0|0|E|0|BLP|0|0|0|100|XEU|2262|3161|lyfalmen|V0207|2689|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||1595||1595|3161||2
563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|11461|19993|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11461||11461|19993||2
564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|SCP|0|0|0|100|DKK|82481|105396|lyfsjukr|||1|168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||82481||82481|105396||1
564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|E|0|MLD|0|0|1|100|DKK|1112|2500|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1112||1112|2500||1
565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|B|0|UCB|0|0|0|100|DKK|11635|16895|lyfalmen|||1|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11635||11635|16895||1
565982|H01BA0401|Glypressin|stl|1|mg|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|36564|47770|lyfsjukr|||1|42,5|0|3,5500|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||36564||36564|47770||1
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|1408|2905|lyfalmen|V0444|2220|0|5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1408||1408|2905||1
566373|N05AA0201|Nozinan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|*|0|SNO|0|0|0|100|NOK|5475|8468|lyfalmen|||1|100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5475||5475|8468||1
567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|216176|273183|lyfsjukr|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||216176||216176|273183||1
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|B|0|ALK|0|0|1|100|DKK|5847|8977|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5847|8977||1
567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|3508|5778|lyfalmen|V0291|3373|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3508||3508|5778||1
567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|7100|10691|lyfalmen|V0292|5566|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||7100||7100|10691||1
567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|10378|15175|lyfalmen|V0293|8178|1|60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10378||10378|15175||1
567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|*|0|JAS|0|0|0|100|SEK|13629|19650|lyfalmen|V0294|10467|1|60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13629||13629|19650||1
567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1144|2544|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1144||1144|2544||1
568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|1417|2917|lyfalmen|V0058|2917|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1417||1417|2917||1
568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2246|4051|lyfalmen|V0059|4051|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2246||2246|4051||1
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|17316|23614|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||17316||17316|23614||1
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|19911|26871|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||19911||19911|26871||1
571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|*|0|APE|0|0|0|100|XEU|84754|108911|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||84754||84754|108911||1
572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|12976|7754|lyfalmen|V0253|7471|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4953||4953|7754||1
572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|167032|211508|lyfsjukr|||1|5|0||Icepharma hf|Baxter|Fíbrínógen manna||167032||167032|211508||2
572776|B02BC1001|Tisseel Duo Quick|vefjalím|||1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|198194|250616|lyfsjukr|||1|10|0||Icepharma hf|Baxter|Fíbrínógen manna||198194||198194|250616||2
572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|417362|525672|lyfsjukr|||1|20|0||Icepharma hf|Baxter|Fíbrínógen manna||417362||417362|525672||2
572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|E|0|LYF|0|0|0|100|IKR|9783|5012|lyfalmen|V0011|5012|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2948||2948|5012||2
573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|5300|4615|lyfalmen|V0245|4615|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||2658||2658|4615||1
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|3612|5920|lyfalmen|V0464|5173|0|2,5|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3612||3612|5920||1
573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|E|0|JAS|0|0|0|100|SEK|3384|5608|lyfalmen|V0129|5608|1|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3384||3384|5608||1
573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|97343|124048|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||97343||97343|124048||2
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|25011|33271|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||25011||25011|33271||1
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|42348|55029|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||42348||42348|55029||1
573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|E|0|NOH|0|0|1|100|IKR|2756|2659|lyfalmen|V0189|2116|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2659||1
575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2492|2114|lyfalmen|V0151|1972|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||830||830|2114||1
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|7764|6981|lyfalmen|V0322|4247|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4388||4388|6981||1
575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4596|2114|lyfalmen|V0152|1972|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||830||830|2114||1
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13760|6981|lyfalmen|V0323|6307|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4388||4388|6981||1
575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|40|0||Icepharma hf|Norpharma |Malatíón|||||||2
575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|0|0|0|0|0|1|SAA|0|0|0|100|NOK|7206|10400|lyfsjukr|||1|12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||7206||7206|10400||1
576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|E|0|ACA|0|0|0|100|IKR|1150|1789|lyfalmen|V0243|1644|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||592||592|1789||1
576122|L01XE1801|Jakavi|töflur|20|mg|60|stk|1|glas||L01XE18|01.11.2012||R|1|0|0|1|0|1|NOE|0|0|0|100|DKK|657315|826813|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||657315||657315|826813||1
578259|A04AA0106|Ondansetron Mylan|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|0|0|0|0|E|0|MYL|0|0|0|100|SEK|3864|4831|lyfalmen|V0384|4676|2|10|0|5,0000|Actavis Group PTC ehf|Mylan AB|Ondansetrón||2816||2816|4831||1
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|5788|10097|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||5788||5788|10097||2
579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|B|0|AZD|0|0|0|100|SEK|1348|2823|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1348||1348|2823||1
579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4499|2114|lyfalmen|V0005|2114|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||830||830|2114||2
579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|*|0|PER|0|0|0|100|DKK|711|1952|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||711||711|1952||1
580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|2800|2574|lyfalmen|V0324|2574|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1166||1166|2574||2
580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|2938|2920|lyfalmen|V0462|2920|3|90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1419||1419|2920||2
581328|C10AA0505|Atorvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.10.2012||R|0|0|0|0|E|0|BLP|0|0|0|100|XEU|2837|2381|lyfalmen|V0113|2381|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Atorvastatín||1025||1025|2381||2
581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|*|0|LYF|0|0|0|100|XEU|3390|3310|lyfalmen|V0472|3300|3|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1704||1704|3310||2
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|14514|28042|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14514||14514|28042||2
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|*|0|ALC|0|0|0|100|USD|2350|4194|lyfalmen|||0|2,5|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2350||2350|4194||1
582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|28357|37471|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||28357||28357|37471||2
582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|54725|70562|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||54725||54725|70562||2
582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|109448|139240|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||109448||109448|139240||2
582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|69017|88499|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||69017||69017|88499||2
582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|5003|8727|vetorma|||0|50|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||5003||5003|8727||2
582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|18854|32890|vetorma|||0|200|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||18854||18854|32890||2
582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4597|3741|lyfalmen|V0011|2864|2|56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||2019||2019|3741||2
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46409|60126|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||46409||46409|60126||2
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|105582|134388|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||105582||105582|134388||2
582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|ţpakki||C07AB02|01.12.2001|31.10.2012|R|1|0|0|0|B|0|AZD|0|0|0|100|SEK|838|2125|lyfalmen|||1|28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||838||838|2125||1
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|51159|66087|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||51159||51159|66087||2
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|0|0|100|SEK|55736|71831|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||55736||55736|71831||2
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|101736|129561|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||101736||101736|129561||2
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|1|0|0|0|B|0|MYL|0|0|0|100|SEK|1148|2549|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1148||1148|2549||1
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|121431|154278|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||121431||121431|154278||2
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|55448|71470|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||55448||55448|71470||2
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|114220|145229|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||114220||114220|145229||2
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|124857|158578|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||124857||124857|158578||2
583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3830|5528|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3830||3830|5528||2
584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2320|3348|lyfsjukr|||2|9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2320||2320|3348||2
584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|SCP|0|0|0|100|DKK|18639|25274|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18639||18639|25274||1
584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|1|0|0|0|B|0|MAS|0|0|0|100|SEK|1932|3622|lyfalmen|||1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1932||1932|3622||1
585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4605|6646|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4605||4605|6646||1
585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4636|7321|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4636||4636|7321||1
585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|B|0|LYF|0|0|0|100|XEU|472|1619|lyfalmen|V0541|1619|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||468||468|1619||2
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|*|0|NOH|0|0|0|100|DKK|32729|43620|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32729||32729|43620||1
586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|B|0|ASP|0|0|1|100|XEU|1747|3369|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1747||1747|3369||1
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|14254|19771|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||14254||14254|19771||1
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NOE|0|0|0|100|DKK|380558|479483|lyfsjukr|||1|224|0|20,9100|Vistor hf|Novartis Europharm Ltd|Tobramýcín||380558||380558|479483||1
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|10173|14193|lyfalmen|V0095|14193|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||9660||9660|14193||1
588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|1|1|0|0|E|0|GGL|0|0|0|100|GBP|4825|7579|lyfalmen|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4825||4825|7579||1
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2198|3986|lyfalmen|V0461|3984|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2198||2198|3986||1
588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|1|0|0|0|E|0|SNO|0|0|0|100|NOK|10013|14676|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||10013||10013|14676||1
588772|H05BA0103|Miacalcic Nasal|nefúđi|200|ae/sk|2|ml|1|úđagl|14 skammt|H05BA01|01.03.2002|30.09.2012|R|0|0|0|0|E|0|NOH|0|0|0|100|DKK|8236|12245|lyfalmen|||1|2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8236||8236|12245||1
588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|*|0|AGP|0|0|0|100|XEU|9428|13876|lyfalmen|V0282|11614|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||9428||9428|13876||1
589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|6120|10676|vetorma|||0|3|0||Icepharma hf|Pfizer Animal Health|Selamectinum||6120||6120|10676||2
589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|2372|4138|vetorma|||0|0,75|0||Icepharma hf|Pfizer Animal Health|Selamectinum||2372||2372|4138||2
589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|5905|10301|vetorma|||0|6|0||Icepharma hf|Pfizer Animal Health|Selamectinum||5905||5905|10301||2
589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|3189|5563|vetorma|||0|0,75|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3189||3189|5563||2
589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|XEU|3313|5779|vetorma|||0|1,5|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3313||3313|5779||2
589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|PFA|1|0|0|100|DKK|3190|5565|vetorma|||0|2,25|0||Icepharma hf|Pfizer Animal Health|Selamectinum||3190||3190|5565||2
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2
590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|B|0|ACA|0|0|0|100|XEU|2041|3771|lyfalmen|V0041|3771|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||2041||2041|3771||1
590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|0|0|0|0|*|0|LBK|0|0|0|100|DKK|23028|31445|lyfalmen|||1|10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||23028||23028|31445||1
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|180839|228835|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||180839||180839|228835||1
591260|N06DA0302|Exelon (Lyfjaver)|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|E|0|LVR|0|0|0|100|DKK|15221|21647|lyfalmen|V0347|21647|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15221||15221|21647||3
592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|0|0|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||0|500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||||1
592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|0|1|0|1|0|1|AZA|0|0|0|100|SEK|829327|1042688|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||829327||829327|1042688||1
593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|519|1689|lyfalmen|V0238|746|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||519||519|1689||2
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|920|2237|lyfalmen|V0238|2237|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||920||920|2237||2
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|E|0|ROC|0|0|0|100|DKK|1357|2835|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1357||1357|2835||2
593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|B|0|MAB|0|0|1|100|SEK|21701|29780|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||21701||21701|29780||1
594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|7867|4946|lyfalmen|V0114|4521|2|100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||2900||2900|4946||2
594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|340|593|vetorma|||0|10|0||Icepharma hf|Pfizer Oy Animal Health|||||340|593||2
594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|0|0|0|0|0|0|PAL|0|0|0|100|DKK|2824|4926|vetorma|||0|100|0||Icepharma hf|Pfizer Oy Animal Health|||||2824|4926||2
595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|NOH|0|0|0|100|DKK|5994|8651|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||5994||5994|8651||1
595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|647|1864|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||647||647|1864||1
596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|0|0|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||0|250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín|||||||1
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|AMG|0|0|0|100|DKK|65193|83700|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||65193|83700||1
596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|19482|26332|lyfsjukr|||1|10|0||Vistor hf|Orion Corporation|Dexmedetómid||19482||19482|26332||1
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2348|4191|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2348||2348|4191||1
597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|0|0|100|DKK|686532|863480|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||686532||686532|863480||1
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|473|1626|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||473||473|1626||1
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2
692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|4135|6635|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4135|6635||1
916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|2886|4927|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2886||2886|4927||1
923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1636|lyfalmen|||0|3,5|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1636||1
938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6451|9804|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6451||6451|9804||2
938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|18534|25805|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||18534||18534|25805||2
940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|3024|5116|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||3024||3024|5116||1
944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5433|8411|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5433||5433|8411||1
944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|342|1447|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1447||2
944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1887|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1887||2
945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4116|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4116||1
947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|7864|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7864||2
948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1990|3701|lyfalmen|||0|100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3701||2
951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5433|8411|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5433||5433|8411||1
954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1870|3537|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3537||2
954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5690|8763|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8763||2
961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1960|3660|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3660||2
961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1850|3510|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3510||2
961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|4320|6888|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||4320||4320|6888||2
962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3451|5700|lyfalmen|||0|100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||||3451|5700||2
962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2360|4207|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4207||2
965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|8480|12579|lyfalmen|||0|120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12579||2
967333|N05AH0408|Quetiapin Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|0|0|0|0|*|0|BLP|0|0|0|100|IKR|1200|2073|lyfalmen|V0284|1712|2|60|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||800||800|2073||2
967341|N05AH0408|Quetiapin Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|0|0|0|0|*|0|BLP|0|0|0|100|IKR|6800|6998|lyfalmen|V0285|6998|2|60|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||4400||4400|6998||2
967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|0|0|0|0|*|0|BLP|0|0|0|100|IKR|12500|13974|lyfalmen|V0286|13974|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||9500||9500|13974||2
967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|0|0|0|0|*|0|BLP|0|0|0|100|IKR|25000|26767|lyfalmen|V0287|26767|2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|26767||2